data_2jtm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jtm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.8 mtmt . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 52.8 Cg_endo -92.5 155.67 2.99 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 122.781 2.32 . . . . 0.0 114.761 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 11.9 p -130.96 152.0 36.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -76.54 110.92 11.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -132.71 144.71 35.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.508 0.67 . . . . 0.0 111.865 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -81.56 139.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.64 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 19.8 p -94.01 159.05 35.16 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 16.5 Cg_exo -67.18 -17.42 50.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.0 2.467 . . . . 0.0 111.479 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.06 -11.53 52.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.767 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.53 20.13 10.52 Favored Glycine 0 C--O 1.24 0.53 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.147 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.24 167.9 9.45 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.91 115.01 12.32 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 163.94 35.57 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.17 105.11 17.12 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.7 152.69 24.49 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.424 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.4 p -99.96 126.41 36.82 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.297 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 35.9 Cg_endo -70.07 130.5 19.06 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.833 1.689 . . . . 0.0 111.545 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 4.6 mm-40 -81.36 -27.43 34.9 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.534 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -144.22 131.11 20.34 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.04 138.66 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 O-C-N 123.364 0.415 . . . . 0.0 110.884 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -142.1 158.42 43.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.928 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 154.18 39.7 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.396 0.617 . . . . 0.0 111.526 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.0 mp -129.66 96.11 4.16 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.46 96.11 30.1 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 4.0 Cg_exo -82.22 139.44 10.53 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.653 2.235 . . . . 0.0 110.06 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.53 126.89 30.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.158 0.504 . . . . 0.0 110.92 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -2.3 75.91 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -118.6 -167.54 1.39 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -107.89 150.12 27.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.65 90.56 1.36 Allowed Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.37 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.3 151.82 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -130.2 151.36 50.81 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.82 135.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.79 147.33 16.47 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.26 126.17 40.4 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.16 170.89 9.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.184 0.594 . . . . 0.0 109.894 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -113.64 128.94 56.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.64 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 16.0 t70 -80.58 121.77 81.66 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.74 -1.55 11.7 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 113.305 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.41 -50.62 4.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.376 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 41.3 p -94.44 -37.29 11.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.469 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.3 -6.04 34.0 Favored Glycine 0 N--CA 1.427 -1.948 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.139 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 19.2 ptpt -79.96 163.55 24.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.445 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -97.88 131.46 44.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -129.11 139.62 51.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -91.21 142.32 27.85 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -146.75 136.07 22.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -64.26 135.35 56.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.441 0.639 . . . . 0.0 111.104 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.06 169.96 7.96 Favored Pre-proline 0 C--N 1.271 -2.843 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 19.5 Cg_exo -66.95 151.63 81.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.941 1.761 . . . . 0.0 109.477 175.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.04 -19.11 61.89 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.927 -0.483 . . . . 0.0 111.536 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.86 -1.82 54.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.541 0.686 . . . . 0.0 110.704 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.443 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 52.1 t80 -65.67 127.2 92.87 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.07 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.65 104.53 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.403 2.069 . . . . 0.0 113.652 -175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 60' ' ' ILE . 48.2 pt . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HZ3' ' HB2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 56.5 Cg_endo -84.27 174.85 7.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 121.902 1.735 . . . . 0.0 112.348 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.65 140.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 55.4 tttp -74.41 109.25 7.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.22 142.75 43.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.614 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -76.71 119.55 20.66 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.522 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 p -92.35 173.0 5.54 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.133 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.02 -14.56 38.66 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.003 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.34 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.938 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 1.69 49.32 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.628 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.87 156.56 18.56 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 41.0 tt0 -116.34 107.14 14.45 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.79 34.17 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.97 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 1.7 mp0 -80.55 108.99 14.65 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.363 0.601 . . . . 0.0 110.707 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.51 146.13 45.72 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.3 p -96.62 127.22 40.42 Favored Pre-proline 0 N--CA 1.419 -1.99 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.3 136.29 71.23 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.426 2.084 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.85 -42.33 81.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HZ1' ' HB2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -147.64 150.19 33.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.36 150.57 29.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -156.4 168.56 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.24 147.38 43.66 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.17 113.94 23.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.049 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.6 100.0 10.31 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.68 -67.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.298 1.999 . . . . 0.0 111.896 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -124.35 -142.53 0.31 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.93 84.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.28 0 O-C-N 122.997 0.186 . . . . 0.0 112.994 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 154.12 38.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -42.6 -45.5 4.62 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.475 1.11 . . . . 0.0 113.216 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.45 90.27 2.01 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 m -74.46 115.96 16.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.881 0.848 . . . . 0.0 112.221 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 63.2 mttp -80.97 131.08 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.096 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.7 mt -134.45 142.11 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.25 149.24 18.53 Favored Glycine 0 N--CA 1.424 -2.1 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.44 125.62 43.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 90.0 m-85 -119.52 171.91 8.02 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.714 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -130.45 121.99 26.88 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.4 129.72 85.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.12 -31.5 29.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.145 1.897 . . . . 0.0 114.478 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -97.55 -34.96 10.78 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -88.44 -25.34 22.69 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.466 0.65 . . . . 0.0 109.688 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.56 -5.64 82.85 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.052 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -82.46 150.92 26.78 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 89.5 m-85 -95.09 126.47 40.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.612 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -130.55 139.17 50.47 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -96.08 128.3 42.86 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.51 144.06 47.81 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 62.3 tttt -60.27 139.26 57.7 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 124.039 0.837 . . . . 0.0 109.36 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 31.6 mt -96.99 168.51 10.17 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.98 141.76 65.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.569 1.513 . . . . 0.0 109.728 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.34 -41.87 52.11 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.966 0.906 . . . . 0.0 111.181 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.36 15.63 20.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.965 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.438 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 84.8 t80 -83.31 120.95 76.56 Favored Pre-proline 0 C--O 1.216 -0.66 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.47 114.35 4.01 Favored 'Trans proline' 0 C--O 1.248 1.001 0 C-N-CA 122.096 1.864 . . . . 0.0 112.587 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 118.446 -0.787 . . . . 0.0 110.034 179.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 34.1 Cg_endo -76.09 164.52 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.783 2.322 . . . . 0.0 113.409 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.1 p -139.27 151.31 22.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -67.84 109.11 3.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -130.3 146.72 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.48 130.73 35.03 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.567 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.7 p -89.9 161.48 38.32 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -71.77 -9.49 24.94 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.786 2.324 . . . . 0.0 109.85 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.82 -5.93 59.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.093 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.75 -13.69 57.77 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 173.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -114.71 174.03 6.17 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.8 -0.823 . . . . 0.0 111.559 -178.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.73 153.77 20.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.163 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 152.19 27.53 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.2 mt-10 -89.46 104.43 16.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -112.96 147.98 35.99 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.72 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -92.38 123.14 63.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.57 132.81 28.08 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.964 1.776 . . . . 0.0 112.085 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -47.68 24.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -137.38 142.04 41.73 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.03 144.36 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.373 . . . . 0.0 110.46 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -151.71 164.2 37.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.26 39.63 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.705 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.37 102.8 12.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.63 105.54 45.67 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 13.1 Cg_exo -77.97 3.81 6.68 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.997 2.465 . . . . 0.0 112.831 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 71.67 107.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.042 1.337 . . . . 0.0 111.893 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.63 12.17 38.75 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 92.7 mtt180 -137.63 -166.7 1.99 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -80.34 154.37 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.58 103.87 2.92 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.59 98.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.18 130.03 34.69 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.105 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.39 140.54 47.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.11 149.02 18.77 Favored Glycine 0 N--CA 1.416 -2.636 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 tp -96.13 126.24 41.22 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 92.1 m-85 -121.25 170.34 9.68 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -122.25 119.5 31.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.567 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 17.8 t70 -64.86 135.36 96.36 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.85 -21.26 16.4 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.45 2.1 . . . . 0.0 114.575 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 35.4 tt0 -98.32 -51.12 4.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.438 0.637 . . . . 0.0 111.61 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -86.65 -29.4 22.53 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.72 85.95 Favored Glycine 0 N--CA 1.431 -1.653 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.209 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.0 144.12 41.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.083 0.441 . . . . 0.0 110.995 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 56.5 m-85 -83.37 125.12 31.32 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -126.37 139.74 53.04 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.633 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -96.91 123.82 40.72 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -134.87 147.86 49.98 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 54.3 tttm -62.1 142.51 57.54 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 123.737 0.648 . . . . 0.0 110.122 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 30.7 mt -98.7 171.13 6.08 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.83 73.67 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.837 1.692 . . . . 0.0 109.368 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.42 -33.67 72.84 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 123.688 0.795 . . . . 0.0 110.536 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.19 5.15 51.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.309 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -77.45 123.53 86.82 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.63 120.17 6.31 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.66 2.24 . . . . 0.0 111.959 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.298 -1.655 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.157 178.338 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 39.9 pttt . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 120.948 0.404 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.71 124.64 4.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.391 2.061 . . . . 0.0 113.055 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.98 149.03 8.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.06 109.27 6.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -135.61 145.61 31.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.238 0.542 . . . . 0.0 110.534 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -89.3 134.66 33.97 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.076 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -83.63 169.09 18.4 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.541 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.501 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -70.99 -22.17 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.269 1.979 . . . . 0.0 109.095 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -51.99 66.29 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.423 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.0 -0.17 3.99 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.985 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.47 160.01 15.97 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.62 137.41 39.97 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 163.57 36.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.27 105.4 17.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.54 138.55 51.83 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.57 123.29 67.02 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.304 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.41 142.77 37.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.052 1.835 . . . . 0.0 111.65 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -69.38 -37.27 77.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.79 157.9 38.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.86 139.04 51.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 123.759 0.662 . . . . 0.0 110.054 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -141.94 154.23 44.91 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.32 124.45 32.35 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.012 0.434 . . . . 0.0 111.499 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.1 96.05 10.57 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.47 107.41 21.08 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.627 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.71 -69.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 121.792 1.662 . . . . 0.0 110.248 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -160.04 -63.9 0.07 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.26 82.96 0.8 Allowed Glycine 0 C--N 1.316 -0.559 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -170.58 154.16 4.45 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -57.82 -46.01 85.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.588 0.631 . . . . 0.0 109.366 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.18 112.8 2.66 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.99 98.43 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.99 126.98 32.59 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -129.48 137.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.93 148.16 16.68 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 tp -97.53 121.88 39.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.0 m-85 -118.72 169.57 9.72 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 123.541 0.736 . . . . 0.0 110.195 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -112.03 124.3 52.11 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.501 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 11.9 t70 -77.67 122.92 86.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.85 -2.04 12.1 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 113.844 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -97.53 -54.17 3.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.226 0.536 . . . . 0.0 110.153 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -94.72 -17.47 22.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.722 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.93 74.08 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.982 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -106.28 163.66 12.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 122.54 -0.388 . . . . 0.0 110.312 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.0 m-85 -94.62 132.05 39.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -130.82 140.5 50.27 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.012 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -139.22 150.11 45.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.42 141.61 58.47 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 123.669 0.605 . . . . 0.0 109.617 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.55 170.76 5.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -67.12 141.81 58.93 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.05 1.834 . . . . 0.0 108.77 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.21 -21.96 63.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.099 0.476 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.61 -1.67 57.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' HG3' ' A' ' 6' ' ' LYS . 91.8 t80 -81.35 123.24 81.45 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.8 Cg_endo -78.35 111.78 3.09 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.974 1.783 . . . . 0.0 109.888 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 C--N 1.296 -1.756 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.323 -179.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.0 Cg_endo -75.43 159.46 39.75 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.793 1.662 . . . . 0.0 112.586 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.4 146.87 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -69.06 109.84 4.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.34 139.16 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 121.727 0.775 . . . . 0.0 111.822 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 64.8 mttm -80.98 115.71 20.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.26 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -87.85 158.8 50.05 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.261 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 9.9 Cg_exo -71.03 -12.86 31.04 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.873 2.382 . . . . 0.0 110.702 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.91 64.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.516 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.9 9.42 24.52 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.601 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.26 26.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.706 177.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 48.2 mt-10 -94.31 121.48 35.87 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.34 138.73 52.51 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.93 105.54 14.02 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.27 151.29 39.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.381 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -100.55 127.61 32.28 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.59 143.31 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.008 1.805 . . . . 0.0 112.397 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.85 -37.55 64.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.42 149.01 28.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.91 149.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 123.57 0.544 . . . . 0.0 110.395 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -156.74 159.88 38.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.66 137.08 49.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.9 91.85 7.12 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.22 84.34 20.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.731 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -79.91 89.51 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 121.676 1.584 . . . . 0.0 111.443 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.279 19.2 ptpt 57.37 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 127.301 2.241 . . . . 0.0 116.256 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.0 70.76 0.29 Allowed Glycine 0 N--CA 1.432 -1.607 0 O-C-N 121.971 -0.456 . . . . 0.0 112.544 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -161.07 148.76 15.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.1 -39.18 91.62 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.385 0.428 . . . . 0.0 110.236 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.77 105.82 2.91 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.098 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.15 107.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.906 0.86 . . . . 0.0 109.116 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.46 131.35 34.67 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.753 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.84 140.47 48.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.94 149.49 18.83 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.32 123.47 41.15 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.0 m-85 -118.11 179.9 3.96 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.5 0.72 . . . . 0.0 110.563 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.7 tttp -128.96 113.44 15.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.51 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 10.1 t70 -65.94 133.21 94.82 Favored Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.031 0.932 . . . . 0.0 112.54 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.36 -31.37 62.53 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 123.375 2.717 . . . . 0.0 115.986 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.77 -30.69 12.64 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.615 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -104.21 -20.73 13.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.85 -2.68 67.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.661 -0.304 . . . . 0.0 113.524 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -78.35 160.74 27.65 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.934 0.397 . . . . 0.0 111.266 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 42.2 m-85 -93.0 120.63 33.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.334 176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.46 139.83 53.52 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -93.71 135.85 34.58 Favored 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.368 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -139.61 146.38 39.71 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.5 tttt -64.51 140.28 58.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 28.8 mt -96.51 176.06 2.34 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.93 140.04 53.55 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.663 1.575 . . . . 0.0 108.788 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.31 -24.11 67.12 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -108.28 15.02 24.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.112 -0.367 . . . . 0.0 111.595 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -68.8 128.81 92.76 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.27 108.0 1.28 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 123.341 2.694 . . . . 0.0 114.971 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 69.5 Cg_endo -93.85 -171.37 0.27 Allowed 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 123.117 2.545 . . . . 0.0 112.666 -175.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.4 p -146.45 146.0 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -71.73 110.6 6.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.37 143.07 42.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 120.836 0.35 . . . . 0.0 111.153 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -76.08 117.02 17.35 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.097 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 26.1 p -95.49 165.22 17.15 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.808 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 -23.08 73.95 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.34 2.693 . . . . 0.0 112.262 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.15 -17.05 64.68 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.31 49.38 4.98 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.557 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.22 159.99 44.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.2 111.76 24.5 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.28 150.83 41.79 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.6 mt-10 -85.65 104.57 15.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -115.49 138.12 51.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.527 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -90.77 123.58 64.61 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.25 139.89 62.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.087 1.858 . . . . 0.0 111.907 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -73.2 -49.46 27.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -134.94 143.73 47.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.718 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.62 145.17 31.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 O-C-N 123.505 0.503 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.32 151.92 31.48 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.49 124.32 44.14 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.194 0.521 . . . . 0.0 110.271 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.85 112.93 24.62 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.83 86.48 24.78 Favored Pre-proline 0 C--N 1.305 -1.369 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.783 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.51 149.19 23.92 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.657 2.238 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -71.49 100.53 2.25 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.24 -13.31 5.98 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.95 -176.14 3.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.89 -179.45 4.57 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.78 123.75 6.19 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.64 112.72 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 65.9 mttp -84.6 125.5 32.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.4 mt -131.09 142.14 44.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.0 148.29 18.43 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.07 126.32 43.45 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 91.2 m-85 -125.63 168.19 14.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.292 0.637 . . . . 0.0 110.567 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -120.13 114.81 22.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 15.3 t70 -58.14 132.36 84.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.893 0.877 . . . . 0.0 111.032 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.74 -19.83 30.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.935 2.423 . . . . 0.0 114.728 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.16 -54.08 3.18 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.67 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -82.71 -33.1 27.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.13 18.19 59.72 Favored Glycine 0 N--CA 1.426 -1.98 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.837 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.86 161.42 13.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.388 0.594 . . . . 0.0 110.755 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 61.9 m-85 -89.45 133.12 34.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.647 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.77 139.74 42.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -100.48 125.76 46.82 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -136.73 145.19 44.37 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.2 tttt -60.94 144.01 53.98 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.549 0.531 . . . . 0.0 109.958 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.3 mt -101.37 170.58 6.33 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.73 141.17 71.03 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.701 1.601 . . . . 0.0 109.319 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.43 -30.58 63.0 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.547 0.739 . . . . 0.0 112.37 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.71 18.7 21.53 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.407 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 77.3 t80 -78.84 128.31 77.2 Favored Pre-proline 0 C--N 1.316 -0.859 0 O-C-N 122.458 -0.151 . . . . 0.0 110.774 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.64 119.97 6.74 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 122.307 2.005 . . . . 0.0 111.442 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.727 179.646 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 39.0 Cg_endo -90.34 156.82 4.56 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.954 2.436 . . . . 0.0 112.507 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.4 154.92 22.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.18 115.83 14.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.11 138.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-O 121.17 0.51 . . . . 0.0 109.678 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -91.15 118.69 30.64 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.674 0.749 . . . . 0.0 109.16 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -69.5 161.02 76.86 Favored Pre-proline 0 C--N 1.281 -2.373 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.712 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.99 -19.49 57.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.76 2.307 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.86 -25.02 60.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.42 -13.42 12.2 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.5 -0.857 . . . . 0.0 114.715 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.7 147.28 24.58 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.155 0.977 . . . . 0.0 110.995 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.35 121.8 34.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.09 158.25 44.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -94.87 105.47 17.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.85 153.97 41.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.827 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.5 p -107.25 128.52 25.85 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.885 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -68.18 137.84 41.65 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.804 1.669 . . . . 0.0 112.429 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.43 -44.5 44.11 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.293 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -137.51 146.69 44.49 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.38 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.11 144.65 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 O-C-N 123.654 0.596 . . . . 0.0 109.878 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -152.73 155.58 37.48 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.28 134.12 55.33 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.96 0.409 . . . . 0.0 111.35 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.49 120.67 41.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.91 122.34 53.04 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.859 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.13 61.77 4.95 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.752 2.302 . . . . 0.0 109.505 173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 64.15 53.53 1.78 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.763 1.225 . . . . 0.0 110.462 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.07 -118.6 6.01 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.392 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 70.97 -66.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 110.734 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 179.55 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.79 132.5 4.14 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.99 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.62 118.6 33.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.03 125.41 41.46 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.9 mt -124.56 136.94 58.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.76 148.27 16.71 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.3 tp -98.85 125.82 44.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 89.6 m-85 -120.25 168.85 10.82 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 123.201 0.601 . . . . 0.0 109.907 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -131.9 120.0 21.93 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.62 124.23 83.79 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 -14.75 25.03 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.772 2.315 . . . . 0.0 113.721 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.34 -46.83 7.18 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.734 0.302 . . . . 0.0 111.28 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 p -82.84 -36.8 25.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.485 0.66 . . . . 0.0 109.268 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 25.62 24.56 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.213 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -124.44 162.68 23.4 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.672 0.736 . . . . 0.0 111.491 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 59.8 m-85 -91.64 142.99 27.02 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.212 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.93 139.92 25.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -94.92 141.53 28.54 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -146.95 149.0 32.32 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.264 0.0 OUTLIER -78.25 145.03 35.69 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.073 -179.966 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.6 mt -96.64 172.92 4.56 Favored Pre-proline 0 C--N 1.276 -2.598 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.51 142.88 66.86 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.449 1.433 . . . . 0.0 109.275 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.02 -24.32 67.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 0.0 111.288 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.32 -12.91 45.09 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -64.62 121.15 71.44 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.504 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -79.08 107.78 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.157 1.904 . . . . 0.0 112.587 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 N--CA 1.426 -1.637 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.827 177.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 pttm . . . . . 0 C--O 1.236 0.383 0 CA-C-O 119.834 -0.127 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 12.1 Cg_endo -58.47 141.06 96.91 Favored 'Trans proline' 0 C--O 1.256 1.378 0 C-N-CA 122.957 2.438 . . . . 0.0 113.989 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.17 150.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.24 109.13 8.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.55 153.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.619 -173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 16.3 ptpt -88.22 134.22 33.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -102.2 172.61 4.2 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.664 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.79 -10.44 27.73 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.962 2.441 . . . . 0.0 111.841 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.48 -5.79 51.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.08 33.59 28.94 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.944 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.79 168.55 19.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 11' ' ' LYS . 42.6 mt-10 -120.26 130.75 54.64 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 165.11 32.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.38 110.7 21.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.204 0.526 . . . . 0.0 109.889 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 79.3 mt -122.16 152.21 40.18 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.721 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.34 124.5 42.74 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.23 131.69 21.09 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 121.779 1.653 . . . . 0.0 110.323 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.95 -34.34 66.46 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.801 0.81 . . . . 0.0 109.175 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -144.66 144.17 31.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 139.79 50.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.707 0.629 . . . . 0.0 109.798 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -147.28 148.01 30.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 110.861 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.21 129.99 53.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.891 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.08 89.49 3.08 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.82 84.41 25.44 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.837 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.68 125.68 9.03 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.115 1.877 . . . . 0.0 108.194 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.92 106.16 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.32 -12.75 8.42 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -105.45 -173.22 2.25 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.505 -0.409 . . . . 0.0 111.328 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -70.6 -50.05 41.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.14 103.42 1.6 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.24 165.07 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.188 0.518 . . . . 0.0 111.798 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -117.82 140.24 49.97 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -131.14 138.7 52.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.74 145.34 15.86 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.2 121.95 36.24 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.1 m-85 -114.4 172.76 6.82 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -130.63 116.42 18.06 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.72 130.5 88.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.0 -24.76 28.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.436 2.091 . . . . 0.0 114.762 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -97.45 -37.85 9.83 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 34.7 p -87.03 -36.87 17.96 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.38 -0.54 71.52 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.471 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 21.8 ptmt -85.22 143.92 28.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.326 0.584 . . . . 0.0 111.607 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.8 m-85 -83.98 129.14 34.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.97 174.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -133.58 139.69 46.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -93.21 133.12 36.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -136.71 148.55 47.39 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.99 139.05 58.72 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 123.936 0.772 . . . . 0.0 109.675 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.2 mt -101.93 170.59 6.24 Favored Pre-proline 0 C--N 1.293 -1.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.34 147.19 77.54 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.515 2.144 . . . . 0.0 109.939 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.32 -33.33 75.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.129 0.49 . . . . 0.0 111.144 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 7.91 31.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.919 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -84.12 115.86 62.1 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.84 117.23 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.408 2.072 . . . . 0.0 113.115 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 C--N 1.3 -1.567 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.176 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttp . . . . . 0 N--CA 1.436 -1.157 0 CA-C-O 120.988 0.423 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 46.0 Cg_endo -73.53 158.73 47.33 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.938 1.759 . . . . 0.0 111.882 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.72 151.21 34.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.99 109.47 8.47 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.62 149.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.252 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -85.85 128.36 34.8 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.597 0.713 . . . . 0.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 170.57 14.55 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.592 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 23.9 Cg_exo -66.72 -16.79 51.39 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.618 2.212 . . . . 0.0 110.788 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.34 -21.02 58.7 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.393 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.04 12.75 48.48 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.685 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.26 166.62 11.65 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.82 137.81 31.98 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.461 0.476 . . . . 0.0 110.581 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.09 154.53 21.79 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 105.36 17.76 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.556 0.693 . . . . 0.0 109.179 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.1 139.18 43.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.42 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -91.8 118.22 68.17 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.26 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.29 136.47 24.28 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.962 2.442 . . . . 0.0 113.408 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.4 -41.23 18.38 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.576 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -129.1 143.77 50.97 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.28 137.96 50.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -151.29 164.42 36.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.74 132.71 35.19 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.134 0.492 . . . . 0.0 110.92 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.88 95.56 9.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.17 103.24 14.09 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.61 -56.44 1.01 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.386 2.057 . . . . 0.0 111.083 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -169.85 -64.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.57 47.86 2.33 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -141.65 152.92 44.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -64.61 -33.99 77.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.088 0.867 . . . . 0.0 110.18 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.9 130.85 6.75 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.457 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.28 105.91 16.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -83.59 132.37 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.2 mt -135.64 144.11 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.74 150.95 19.84 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.7 123.38 42.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.8 m-85 -120.36 168.04 11.7 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.293 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -128.23 120.97 28.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 15.3 t70 -76.61 123.74 87.7 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 7.7 Cg_exo -73.1 -20.53 21.58 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 C-N-CA 122.332 2.021 . . . . 0.0 113.742 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.55 -45.56 8.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.964 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -82.82 -31.12 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.433 0.635 . . . . 0.0 109.515 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.28 67.34 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.867 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -90.98 154.32 19.53 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 44.3 m-85 -91.14 132.13 36.26 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.962 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -135.89 139.92 43.71 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -95.81 126.39 41.04 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -130.58 144.19 51.25 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -172.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -65.98 144.04 57.0 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.693 0.62 . . . . 0.0 109.448 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.97 168.66 8.49 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.05 145.03 72.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.592 2.195 . . . . 0.0 109.16 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.25 -41.92 72.8 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -88.96 5.31 44.75 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.54 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.88 125.18 90.51 Favored Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 121.844 -0.535 . . . . 0.0 110.047 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.06 113.58 3.73 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 122.318 2.012 . . . . 0.0 110.363 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.296 -1.719 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.754 0.312 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -81.08 157.26 20.28 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 121.846 1.697 . . . . 0.0 111.609 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.2 p -141.69 148.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.52 111.51 6.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.63 138.03 55.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 121.03 0.443 . . . . 0.0 109.817 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 123.69 29.87 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 p -92.91 165.69 18.18 Favored Pre-proline 0 N--CA 1.418 -2.054 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.32 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.3 -27.01 82.62 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.051 2.5 . . . . 0.0 112.445 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.27 -25.79 63.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.652 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.62 -12.29 8.33 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.113 -1.518 . . . . 0.0 115.085 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.66 154.44 18.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 118.253 1.026 . . . . 0.0 110.211 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.47 106.06 14.11 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.43 165.05 18.43 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.23 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.2 mp0 -82.82 104.77 13.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.118 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.22 157.12 20.47 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.86 129.03 24.39 Favored Pre-proline 0 N--CA 1.403 -2.818 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.071 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.13 123.56 7.9 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.775 1.65 . . . . 0.0 111.351 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.52 -35.22 65.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.35 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -134.52 136.92 43.44 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 139.05 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.36 0.412 . . . . 0.0 110.4 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.53 155.39 40.25 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.74 136.51 53.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.58 0.705 . . . . 0.0 111.057 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.6 mp -108.01 100.02 9.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.81 96.34 16.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 123.243 0.34 . . . . 0.0 110.676 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 6.2 Cg_exo -80.7 155.4 20.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.523 2.149 . . . . 0.0 109.848 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.85 127.86 33.79 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.064 0.459 . . . . 0.0 110.111 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 33' ' ' ARG . . . 99.36 -15.48 60.1 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.231 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD2' ' C ' ' A' ' 32' ' ' GLY . 6.1 mpt_? -117.46 159.06 23.42 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.324 -0.515 . . . . 0.0 110.485 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.26 -33.3 73.03 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.467 0.479 . . . . 0.0 111.19 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.85 163.07 22.23 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.74 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.28 156.75 40.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.42 137.64 51.23 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.04 141.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.83 150.65 19.38 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 tp -94.8 124.99 39.16 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.14 -179.86 4.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.246 1.018 . . . . 0.0 109.162 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 49' ' ' TYR . 84.0 tttt -134.05 132.09 39.61 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.76 121.34 82.26 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.99 -9.8 20.95 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.262 1.975 . . . . 0.0 114.851 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -99.13 -41.44 7.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.105 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -92.21 -25.95 18.42 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.982 0.42 . . . . 0.0 111.088 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.64 36.46 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.065 -0.516 . . . . 0.0 113.266 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -119.85 145.23 46.85 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.642 -0.328 . . . . 0.0 110.259 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 46.0 m-85 -80.55 138.53 36.51 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.3 140.2 33.78 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -93.54 137.82 32.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -142.51 147.03 35.34 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -68.94 144.53 54.14 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.179 0.514 . . . . 0.0 110.428 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.66 169.16 7.86 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -67.1 151.28 81.85 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.704 2.269 . . . . 0.0 109.895 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.22 -36.16 83.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.75 6.99 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.003 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.69 122.85 74.77 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.47 -0.769 . . . . 0.0 109.986 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.87 98.59 1.22 Allowed 'Trans proline' 0 N--CA 1.437 -1.794 0 C-N-CA 122.444 2.096 . . . . 0.0 111.916 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.2 pt . . . . . 0 N--CA 1.423 -1.79 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.002 179.463 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -78.81 141.95 17.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.945 1.764 . . . . 0.0 111.203 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 14.6 p -120.96 149.82 23.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 60.6 mttp -75.07 108.82 8.06 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.24 141.0 47.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.162 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -78.54 115.64 18.39 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.52 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.592 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 76.6 p -83.49 165.03 42.5 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.11 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.52 -17.4 57.21 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.436 2.091 . . . . 0.0 111.18 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.28 -17.97 61.26 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.674 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.4 31.24 6.55 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 114.772 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.64 38.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.601 0.701 . . . . 0.0 109.932 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' A' ' 9' ' ' LYS . 36.7 tt0 -91.84 93.57 8.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.942 0.877 . . . . 0.0 109.563 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.29 160.28 14.82 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.535 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 52.3 mt-10 -92.29 105.61 17.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.462 0.649 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.1 mt -117.54 141.89 47.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.136 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.9 p -95.63 125.08 50.69 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 12.5 Cg_exo -66.6 141.17 59.53 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.145 1.896 . . . . 0.0 114.088 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.22 -47.12 65.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -142.26 144.32 33.25 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.527 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 m -124.99 152.73 31.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -157.36 153.48 27.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.074 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.96 125.05 42.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.239 0.542 . . . . 0.0 110.761 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.43 87.16 6.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 98.85 8.96 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.43 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.77 -66.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.646 1.564 . . . . 0.0 108.501 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 175.39 148.19 0.09 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.26 -5.6 79.67 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -105.85 150.18 25.83 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -57.88 -39.1 77.03 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.298 0.374 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.48 95.34 2.21 Favored Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.19 104.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -89.69 126.23 35.57 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.502 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.6 mt -129.19 142.72 43.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.86 147.66 18.49 Favored Glycine 0 N--CA 1.422 -2.294 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.35 125.37 40.8 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 95.0 m-85 -123.23 173.98 7.57 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 122.979 0.511 . . . . 0.0 109.972 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -125.34 125.3 43.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.592 ' OD2' ' HB ' ' A' ' 12' ' ' THR . 9.0 t70 -78.38 120.03 79.56 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.5 -12.37 27.06 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.728 2.285 . . . . 0.0 115.022 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.07 -34.38 10.8 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.907 -0.496 . . . . 0.0 112.053 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -93.77 -34.41 13.21 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.29 0.567 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.69 30.83 22.93 Favored Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.373 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.94 151.34 43.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.0 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 78.3 m-85 -87.83 129.81 35.08 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.971 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -134.59 139.33 45.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -95.23 131.68 41.02 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -139.07 149.96 45.19 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.22 142.02 57.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.5 mt -97.85 -179.82 0.95 Allowed Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 31.2 Cg_exo -64.12 137.87 59.02 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.579 1.519 . . . . 0.0 108.162 172.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.11 -20.28 57.48 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.392 0.677 . . . . 0.0 112.625 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -112.26 11.62 20.2 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.632 0.73 . . . . 0.0 111.01 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 8' ' ' VAL . 13.8 t80 -67.09 127.72 93.6 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.35 92.36 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.308 2.005 . . . . 0.0 113.535 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.202 177.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tttp . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -80.01 159.63 23.97 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.514 1.476 . . . . 0.0 112.342 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.2 p -140.87 150.52 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -72.1 109.32 5.81 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -125.22 137.68 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 121.658 0.742 . . . . 0.0 109.859 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -83.6 119.81 25.2 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.4 p -92.18 155.64 42.64 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.8 -16.09 33.21 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.905 2.404 . . . . 0.0 110.476 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.24 72.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.343 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.3 -18.47 4.42 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.016 -1.087 . . . . 0.0 114.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 173.51 6.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 118.102 0.951 . . . . 0.0 112.141 -174.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.38 126.16 32.97 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.31 144.89 50.89 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.7 mt-10 -94.74 104.42 16.33 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.99 141.5 48.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.854 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -90.35 121.72 68.19 Favored Pre-proline 0 N--CA 1.416 -2.151 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.36 134.69 60.32 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.168 1.912 . . . . 0.0 111.448 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.62 -32.43 64.06 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.276 1.03 . . . . 0.0 108.633 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -153.02 138.74 17.89 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.74 144.86 31.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -153.9 160.66 42.23 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.68 130.62 30.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.25 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.11 97.05 8.21 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.76 97.71 32.56 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.79 -64.78 0.08 OUTLIER 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.612 2.208 . . . . 0.0 111.794 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.3 tttm 169.69 119.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.531 1.132 . . . . 0.0 108.963 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.26 43.73 89.31 Favored Glycine 0 C--O 1.246 0.886 0 CA-C-O 121.79 0.661 . . . . 0.0 111.93 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -140.21 176.2 8.96 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -70.21 107.83 3.88 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.55 89.84 0.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.63 100.47 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.252 1.025 . . . . 0.0 112.167 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.59 127.55 32.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.109 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 54.9 mt -128.86 139.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.95 145.75 15.93 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -93.9 126.18 38.96 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.31 178.46 4.52 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -129.71 125.44 35.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 11.0 t70 -63.66 127.78 91.89 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 124.074 0.859 . . . . 0.0 109.375 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 26.1 Cg_exo -63.31 -40.86 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.463 2.109 . . . . 0.0 114.183 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -88.44 -48.93 7.26 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -90.52 -19.93 23.24 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.06 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.95 0.54 89.72 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 115.003 0.761 . . . . 0.0 115.003 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -73.87 138.81 44.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 117.011 0.405 . . . . 0.0 111.272 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -81.45 121.29 26.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -126.32 139.44 53.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -96.02 134.03 39.54 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -137.33 139.95 41.17 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.21 139.19 52.24 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.035 178.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.71 173.12 6.83 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -66.61 140.0 55.23 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 N-CA-C 107.788 -1.658 . . . . 0.0 107.788 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.23 -28.31 68.63 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.34 -4.94 57.18 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.801 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -79.27 122.07 83.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -82.39 112.31 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.428 2.086 . . . . 0.0 111.658 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--N 1.298 -1.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.103 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.436 -1.165 0 CA-C-O 121.044 0.45 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.89 123.94 3.33 Favored 'Trans proline' 0 N--CA 1.425 -2.538 0 C-N-CA 121.585 1.524 . . . . 0.0 110.645 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -104.83 148.39 9.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -81.13 109.65 15.89 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.19 153.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 -172.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 54.1 mttp -86.09 135.47 33.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.032 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.7 p -88.75 170.45 11.08 Favored Pre-proline 0 N--CA 1.425 -1.676 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.401 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 48.8 Cg_exo -61.06 -13.62 28.75 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.315 2.01 . . . . 0.0 112.526 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.65 -6.76 58.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.919 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.4 15.1 62.69 Favored Glycine 0 C--N 1.328 0.123 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 49.9 mtpt -98.02 163.92 12.56 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -129.41 125.64 37.0 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.727 -176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.77 164.58 36.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.32 121.57 28.25 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.35 137.89 52.89 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.22 126.15 61.61 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.99 141.02 68.67 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.11 1.873 . . . . 0.0 113.159 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 49' ' ' TYR . 20.4 mm-40 -72.78 -45.61 57.64 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.919 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -139.63 148.7 42.83 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -131.83 143.5 40.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 O-C-N 123.406 0.441 . . . . 0.0 109.942 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -149.61 156.05 41.28 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.726 0.298 . . . . 0.0 110.62 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.67 125.2 33.36 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.676 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.78 92.84 7.31 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 87.74 17.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.083 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.19 -41.2 80.88 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.014 2.476 . . . . 0.0 110.685 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -171.68 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.29 92.98 0.31 Allowed Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -153.43 37.66 0.48 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 70.72 -55.04 0.64 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.017 1.727 . . . . 0.0 111.315 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.96 72.74 0.91 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -74.69 114.44 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -96.89 130.7 44.15 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.8 mt -133.64 142.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.55 146.16 16.66 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp -96.19 128.14 42.83 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.74 169.54 10.02 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.977 0.418 . . . . 0.0 110.5 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -122.28 116.82 24.76 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 8.6 t70 -53.95 123.23 39.01 Favored Pre-proline 0 C--N 1.316 -0.881 0 C-N-CA 125.256 1.422 . . . . 0.0 109.689 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.79 -26.13 52.8 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.964 2.443 . . . . 0.0 114.087 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.05 -48.19 4.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -94.79 -13.14 25.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.405 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.25 18.67 79.12 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.862 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.97 148.04 22.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.886 0.343 . . . . 0.0 111.384 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.464 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 19.9 m-85 -87.86 128.4 35.35 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.14 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -136.47 140.45 43.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -97.88 132.34 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.246 0.546 . . . . 0.0 110.37 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -138.5 141.1 39.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.8 ptmt -70.89 149.24 46.96 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 118.01 -1.476 . . . . 0.0 109.86 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.401 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 28.9 mt -94.6 175.29 3.0 Favored Pre-proline 0 C--N 1.28 -2.431 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.96 141.65 59.16 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 N-CA-C 108.177 -1.509 . . . . 0.0 108.177 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -66.87 -23.06 65.97 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.482 0.658 . . . . 0.0 110.243 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -88.34 -5.25 58.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.413 1.485 . . . . 0.0 111.732 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.29 136.76 81.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.9 115.69 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.434 2.089 . . . . 0.0 114.538 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.925 173.271 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.49 131.85 14.17 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.453 1.435 . . . . 0.0 112.167 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.39 147.55 19.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.135 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -69.05 108.63 3.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 151.72 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 121.497 0.665 . . . . 0.0 111.624 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.46 141.17 28.89 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.252 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.0 p -93.14 171.69 6.97 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.67 -12.88 35.83 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.1 1.867 . . . . 0.0 111.581 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.16 -20.75 47.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.148 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.66 -16.7 36.96 Favored Glycine 0 C--O 1.242 0.635 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.906 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.76 158.14 21.85 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -112.17 145.04 40.56 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.48 154.87 32.5 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.47 104.88 17.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -117.04 148.23 41.67 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.498 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.6 p -96.18 125.97 45.98 Favored Pre-proline 0 N--CA 1.426 -1.66 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.85 142.07 27.9 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.99 1.793 . . . . 0.0 111.871 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.33 -40.73 64.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.353 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -145.85 147.34 31.71 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.856 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.29 144.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -146.5 155.98 42.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.06 32.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.132 0.491 . . . . 0.0 110.719 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.81 85.85 2.47 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.7 94.85 24.43 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.12 136.62 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.721 1.614 . . . . 0.0 108.413 170.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -60.86 113.63 2.61 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.108 0.48 . . . . 0.0 111.933 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 2.01 56.07 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.138 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -116.47 -72.83 0.67 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -142.25 174.66 10.41 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 120.679 0.276 . . . . 0.0 111.15 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.54 42.28 0.89 Allowed Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.16 149.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.352 0.596 . . . . 0.0 110.826 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -127.65 144.58 51.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.8 mt -136.11 143.82 34.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.57 148.9 19.16 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.2 tp -98.22 122.72 41.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.53 173.41 6.85 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.038 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -134.64 125.77 27.82 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.54 128.5 77.3 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.54 -12.8 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.085 2.523 . . . . 0.0 114.254 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -97.68 -52.62 3.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.26 0.552 . . . . 0.0 111.69 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 45.0 p -82.79 -35.14 26.74 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.379 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.25 62.4 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.025 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.9 ptpt -88.29 150.0 23.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.265 0.555 . . . . 0.0 111.87 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -95.15 136.5 35.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -143.93 139.92 29.41 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.98 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -100.38 119.92 39.18 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 121.38 0.609 . . . . 0.0 109.77 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -127.49 144.28 51.08 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -68.58 141.48 55.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.611 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 mt -93.95 172.15 6.13 Favored Pre-proline 0 C--N 1.284 -2.272 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.92 140.48 55.15 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.526 1.484 . . . . 0.0 108.412 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.05 -26.72 68.97 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.36 0.6 . . . . 0.0 109.775 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.12 0.26 56.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.779 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 66.1 t80 -80.31 126.68 78.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.6 Cg_exo -76.96 107.88 2.53 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.145 1.897 . . . . 0.0 112.54 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.0 pt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -84.55 120.03 2.38 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.328 2.019 . . . . 0.0 111.611 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.8 p -103.91 145.46 12.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.162 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.94 108.45 7.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -130.48 149.52 33.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.05 124.39 28.24 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.741 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.401 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 30.4 p -76.41 169.17 22.24 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.51 -24.38 36.22 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.266 1.978 . . . . 0.0 110.148 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.53 85.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.589 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.61 31.37 1.25 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.463 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.53 160.01 41.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.331 0.565 . . . . 0.0 109.772 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.202 0.525 . . . . 0.0 111.505 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.23 146.96 52.37 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -89.87 105.3 17.71 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.99 0.9 . . . . 0.0 108.952 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.01 141.74 48.42 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.535 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.97 121.87 68.39 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.44 134.72 36.83 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.073 1.849 . . . . 0.0 112.28 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -61.27 -48.98 78.93 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -145.89 153.98 41.45 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.648 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.94 152.0 30.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 O-C-N 123.628 0.58 . . . . 0.0 110.544 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -155.53 168.37 27.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.256 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.56 139.79 36.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.006 0.431 . . . . 0.0 110.758 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 94.56 4.91 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 91.82 40.06 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.006 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.73 173.67 10.19 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.43 2.087 . . . . 0.0 108.621 172.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.39 139.62 51.92 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.682 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.21 32.4 25.87 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.741 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -156.37 154.12 30.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -69.93 -45.75 66.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.82 117.94 2.21 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.921 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.15 119.93 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 121.42 0.629 . . . . 0.0 110.078 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.04 136.5 35.29 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.14 140.11 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.07 149.6 18.58 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 tp -96.14 125.51 40.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -122.88 175.07 6.76 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -133.4 122.93 24.47 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.3 t70 -78.74 125.72 83.75 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 3.2 Cg_exo -80.13 -8.34 14.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.247 1.965 . . . . 0.0 113.354 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.44 -40.74 8.54 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -90.29 -34.16 15.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.346 0.593 . . . . 0.0 109.577 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.79 22.78 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.704 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -118.89 144.24 46.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.912 0.356 . . . . 0.0 111.6 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.68 124.65 29.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.725 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -135.4 140.05 44.66 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -92.76 138.83 31.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -144.43 147.91 33.93 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.46 146.52 50.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.647 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.07 168.98 8.2 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.89 143.47 66.75 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.919 1.746 . . . . 0.0 108.908 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.05 -15.25 61.51 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.842 -0.536 . . . . 0.0 110.868 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.25 -1.82 57.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.597 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 89.0 t80 -81.7 133.83 51.68 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 122.761 0.424 . . . . 0.0 111.059 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.4 Cg_exo -78.95 106.19 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.572 2.182 . . . . 0.0 112.256 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.665 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 82.2 mttt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 19' ' ' GLU . 47.2 Cg_endo -71.67 138.91 32.9 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.104 1.869 . . . . 0.0 112.914 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.06 143.09 41.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 27.6 mtmm -74.43 108.51 7.25 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.15 144.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.112 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -75.52 115.67 15.43 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.297 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.2 p -83.85 162.75 51.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.957 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.47 -18.03 44.25 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.419 2.746 . . . . 0.0 114.782 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.04 -5.52 59.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.884 0.373 . . . . 0.0 111.803 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.41 9.54 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.568 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -140.33 166.25 25.2 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -113.65 147.51 37.99 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.212 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 146.7 28.67 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 7' ' ' PRO . 31.1 tt0 -92.32 105.89 18.0 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.56 145.56 48.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.296 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.82 128.37 46.25 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.09 144.7 93.07 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.453 2.102 . . . . 0.0 113.789 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.03 -42.51 23.64 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.726 1.211 . . . . 0.0 109.447 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -145.31 141.4 28.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.43 139.97 49.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 123.31 0.381 . . . . 0.0 110.009 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -146.33 158.2 43.86 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.95 125.78 38.22 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.3 mp -79.73 89.6 5.19 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.76 116.6 34.53 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.662 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.28 -48.85 12.33 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.695 1.597 . . . . 0.0 107.986 172.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp 177.92 -64.52 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.044 -1.435 . . . . 0.0 108.197 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.59 103.77 2.09 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.5 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -169.91 -79.23 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -172.11 -56.13 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.071 1.749 . . . . 0.0 106.693 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 112.56 2.34 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.564 -1.815 . . . . 0.0 108.564 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' LEU . 59.4 t -75.33 105.42 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -80.68 125.93 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.534 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.0 mt -132.26 139.36 50.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.1 147.39 17.3 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.5 tp -94.9 130.01 41.68 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.5 m-85 -124.89 176.4 6.66 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 122.917 0.487 . . . . 0.0 110.084 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -130.58 115.84 17.31 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.61 126.02 92.01 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 -20.47 25.38 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 122.196 1.931 . . . . 0.0 113.39 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -60.46 2.1 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 39.8 p -82.52 -32.05 28.89 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.04 -3.88 62.45 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.113 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.3 ptpt -80.98 153.63 27.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 10.2 m-85 -90.9 125.37 35.74 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.138 177.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.69 139.78 47.83 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -94.06 138.3 32.29 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -143.99 144.51 31.71 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HZ2' ' CG ' ' A' ' 56' ' ' ASP . 61.1 tttm -62.53 142.94 57.73 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.655 0.597 . . . . 0.0 109.761 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.5 mt -102.39 172.14 4.62 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -67.01 139.77 52.25 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.093 1.862 . . . . 0.0 107.708 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 46.9 m-20 -74.84 -11.17 60.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.718 -0.614 . . . . 0.0 110.382 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -95.39 0.52 53.57 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.714 1.205 . . . . 0.0 110.448 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' A' ' 6' ' ' LYS . 77.4 t80 -80.75 119.49 76.33 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.36 104.71 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.487 2.125 . . . . 0.0 112.444 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.56 -179.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 7.9 tmtt? . . . . . 0 N--CA 1.414 -2.243 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -83.28 149.25 13.26 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.946 1.764 . . . . 0.0 112.373 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.0 p -121.52 144.92 29.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -73.57 108.39 6.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.8 p -121.28 141.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.05 -174.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.93 117.26 19.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.506 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 46.0 p -85.96 169.01 16.74 Favored Pre-proline 0 C--N 1.286 -2.191 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.577 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 31.2 Cg_exo -63.16 -22.26 72.82 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.143 2.562 . . . . 0.0 111.079 174.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.8 -14.75 62.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.51 4.74 62.12 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.17 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -115.64 161.09 19.16 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.496 -0.414 . . . . 0.0 110.049 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 52.6 mt-10 -102.29 135.57 43.66 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.132 0.492 . . . . 0.0 110.521 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.5 45.26 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.9 mt-10 -89.85 105.22 17.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.98 138.14 51.76 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.961 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.59 121.75 62.44 Favored Pre-proline 0 N--CA 1.415 -2.213 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.11 140.55 90.11 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.472 2.114 . . . . 0.0 113.013 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.2 -43.65 77.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.276 1.036 . . . . 0.0 109.005 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.32 138.34 38.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.201 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.06 144.41 32.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.191 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -152.2 161.84 42.02 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.57 128.16 32.69 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.248 0.547 . . . . 0.0 111.497 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -93.54 94.79 8.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.887 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.83 110.35 63.61 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.3 -69.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.19 1.926 . . . . 0.0 111.505 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -164.4 115.47 1.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.884 0.473 . . . . 0.0 110.153 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.16 45.34 96.24 Favored Glycine 0 C--N 1.318 -0.469 0 O-C-N 123.505 0.503 . . . . 0.0 112.724 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -127.07 167.4 16.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.83 -34.95 76.34 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.31 120.67 4.77 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.245 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.6 t -76.08 103.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -86.83 137.02 32.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.224 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 60.5 mt -136.38 141.47 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 147.32 18.37 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.5 tp -95.76 124.12 39.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -118.97 170.1 9.32 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.697 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -117.21 125.99 52.05 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.577 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 16.0 t70 -69.56 132.54 89.26 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.9 -12.52 10.84 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.118 1.879 . . . . 0.0 114.185 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -97.48 -51.02 4.29 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.367 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 p -88.27 -37.28 16.16 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.899 0.479 . . . . 0.0 110.522 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -4.98 55.15 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.513 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -81.44 151.95 27.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.175 0.487 . . . . 0.0 111.641 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -89.63 125.33 35.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.184 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -127.25 140.66 52.07 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -101.4 136.6 40.96 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.63 143.82 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.47 139.54 51.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.79 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.67 174.78 3.53 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 25.1 Cg_exo -64.62 141.46 73.11 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 N-CA-C 108.183 -1.507 . . . . 0.0 108.183 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -26.05 68.39 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.226 0.536 . . . . 0.0 110.998 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.11 12.19 37.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.194 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.411 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 34.0 t80 -72.8 128.08 88.72 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.16 103.34 1.73 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.647 1.565 . . . . 0.0 113.397 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.739 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 pttp . . . . . 0 N--CA 1.431 -1.421 0 CA-C-O 121.441 0.639 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.32 143.65 14.03 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.407 2.072 . . . . 0.0 110.995 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.12 135.69 37.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -70.43 109.31 4.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -127.77 145.94 34.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.554 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 67.4 mttm -78.06 124.47 28.07 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -81.63 163.12 55.57 Favored Pre-proline 0 C--N 1.282 -2.333 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 -7.1 20.49 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.482 2.122 . . . . 0.0 111.404 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.89 -32.37 20.24 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.177 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.96 -39.44 1.66 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.808 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -71.67 164.91 25.06 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 120.844 0.354 . . . . 0.0 110.379 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 33.2 mt-10 -115.77 129.25 56.38 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.48 147.49 37.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.178 0.299 . . . . 0.0 110.209 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.53 105.26 11.64 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.61 138.14 51.65 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.948 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.39 122.08 63.72 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.86 146.41 77.96 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.89 2.393 . . . . 0.0 113.39 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -67.0 -45.94 76.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.45 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -149.63 152.55 35.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.598 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.68 151.14 33.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 123.576 0.547 . . . . 0.0 110.465 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -148.72 161.4 41.85 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.133 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.53 137.31 40.14 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.857 0.36 . . . . 0.0 111.289 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.47 119.98 41.09 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.12 90.91 47.7 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.21 105.55 2.1 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 122.708 2.272 . . . . 0.0 112.233 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 70.08 -64.08 0.37 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.682 1.593 . . . . 0.0 112.124 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.03 111.44 0.49 Allowed Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -159.95 163.8 33.9 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -79.3 -9.8 59.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.061 0.934 . . . . 0.0 108.712 176.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 100.12 108.14 2.96 Favored Glycine 0 N--CA 1.418 -2.563 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.834 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.99 112.44 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 60.0 mttp -99.1 136.3 39.26 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.847 -171.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -132.33 136.77 55.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.75 146.43 16.2 Favored Glycine 0 N--CA 1.422 -2.233 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.2 tp -96.6 123.68 40.35 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.79 174.17 6.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.664 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -132.41 127.56 35.65 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.0 t70 -86.93 116.34 65.69 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 11.3 Cg_exo -72.34 -8.68 23.11 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.006 2.471 . . . . 0.0 113.108 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.3 -53.57 4.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.507 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.3 p -84.68 -30.73 24.58 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.225 0.536 . . . . 0.0 111.1 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.71 30.62 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.177 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -123.53 152.0 42.26 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.789 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.22 135.51 33.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -137.06 139.86 41.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -99.37 129.57 45.58 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -134.37 147.48 50.53 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 38.7 ttmt -66.83 140.77 57.83 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mt -101.51 172.4 4.47 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -67.17 139.52 50.74 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.607 1.538 . . . . 0.0 109.641 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.45 -30.48 68.54 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.098 0.475 . . . . 0.0 110.539 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.31 -1.09 57.2 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.895 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -74.76 126.65 88.25 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 121.599 -0.688 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.86 120.99 6.01 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 112.581 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.131 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 tttp . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 14.0 Cg_endo -72.35 141.91 36.24 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.597 1.532 . . . . 0.0 110.134 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 141.8 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.82 109.08 5.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.12 146.27 31.07 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.847 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -79.08 120.7 24.0 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.56 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.0 p -78.48 161.3 70.29 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.063 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.66 -15.99 37.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.487 2.125 . . . . 0.0 110.194 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.41 -51.28 24.84 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.893 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.8 -17.09 2.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.93 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -92.24 168.3 11.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -110.71 130.69 55.51 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.912 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.26 152.46 51.54 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.96 104.74 16.57 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.62 141.93 44.58 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.9 p -93.13 125.55 54.33 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.96 116.86 3.94 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 121.403 1.402 . . . . 0.0 110.525 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.81 -17.61 62.14 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.247 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -152.76 140.26 19.71 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.46 138.95 52.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 123.27 0.356 . . . . 0.0 110.421 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -152.24 154.32 35.51 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.4 137.92 54.04 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.495 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 5.2 mp -112.08 106.78 15.51 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.51 102.1 12.0 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 8.4 Cg_exo -73.94 154.46 48.01 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.024 1.816 . . . . 0.0 109.847 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -61.32 -44.59 96.95 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.81 26.72 20.14 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -136.07 -176.81 4.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -87.38 -56.43 3.36 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.393 0.616 . . . . 0.0 110.053 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.31 137.17 2.67 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.56 124.31 70.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.325 0.583 . . . . 0.0 109.998 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.83 128.27 43.62 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.247 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 47.4 mt -125.27 140.54 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.019 0.438 . . . . 0.0 109.99 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -128.05 149.92 18.26 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 tp -94.25 126.13 39.3 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.81 166.61 14.09 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.377 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.494 ' HZ3' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -126.93 122.68 35.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.56 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 18.2 t70 -65.83 129.57 94.32 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 -4.18 12.5 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.869 2.379 . . . . 0.0 113.095 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 16.6 tp10 -93.79 -51.46 4.89 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.329 0.585 . . . . 0.0 109.647 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 31.2 p -108.78 -22.01 12.41 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.72 11.99 69.89 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.538 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 ptpt -84.31 147.64 27.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.58 142.71 27.47 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.645 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -149.99 138.97 21.03 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -93.15 139.76 30.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -143.01 143.7 32.0 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.282 0.1 OUTLIER -74.46 140.19 44.45 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.604 179.529 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' A' ' 39' ' ' GLY . 17.8 mt -85.86 -177.22 0.89 Allowed Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -67.27 132.94 28.98 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 105.185 -2.659 . . . . 0.0 105.185 166.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.43 -7.97 54.74 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.921 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.34 -14.4 40.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.363 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -60.16 129.56 88.62 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.204 1.001 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.15 118.24 2.29 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.678 2.252 . . . . 0.0 112.757 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--N 1.293 -1.854 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.671 177.045 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 pttt . . . . . 0 N--CA 1.432 -1.333 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.67 136.4 45.8 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.913 1.742 . . . . 0.0 111.462 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.3 p -114.23 149.78 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.36 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -68.71 109.18 3.7 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.29 136.56 60.46 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.944 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 60.9 mttp -79.37 115.72 19.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -85.42 166.48 30.33 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.52 -18.69 64.76 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.556 2.171 . . . . 0.0 111.875 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.43 -14.82 62.27 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.94 50.11 4.51 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.017 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 22.1 ptmt -148.43 164.77 33.13 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.06 120.37 41.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.02 149.43 50.37 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -90.01 104.15 16.75 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -118.01 147.23 43.41 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.638 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.18 129.36 26.44 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.0 129.92 20.54 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.225 1.284 . . . . 0.0 111.645 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.25 -51.18 60.08 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.973 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -132.78 153.26 51.41 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.685 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.66 148.65 33.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 124.266 0.979 . . . . 0.0 109.429 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -157.18 163.97 38.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.47 132.91 39.84 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.127 0.489 . . . . 0.0 110.36 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 mp -97.99 92.11 5.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 100.31 52.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.12 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.46 -69.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.717 2.278 . . . . 0.0 112.426 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -168.62 -50.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.568 0.347 . . . . 0.0 111.893 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -128.58 40.37 1.73 Allowed Glycine 0 C--N 1.317 -0.507 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.809 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.36 25.98 5.42 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.55 -65.42 0.35 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.358 1.063 . . . . 0.0 112.514 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.44 118.82 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.31 116.67 37.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -89.16 131.04 35.48 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 66.8 mt -134.42 142.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.95 150.32 19.34 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.0 tp -94.63 124.29 38.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -117.62 170.66 8.59 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.076 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.82 125.87 45.45 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.06 119.99 79.53 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.46 -24.79 42.18 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.82 2.347 . . . . 0.0 114.164 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.22 -21.86 17.04 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.8 p -111.45 -18.73 12.8 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.672 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 9.74 85.27 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.522 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -100.22 156.97 16.92 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.515 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -94.82 146.99 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.49 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -147.57 139.47 24.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -94.49 133.46 38.08 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -141.38 149.53 41.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 21.5 ptmt -69.46 150.38 47.28 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.467 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . 43.6 mt -104.86 171.16 5.23 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.014 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.403 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 18.8 Cg_exo -67.34 148.72 80.28 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.922 2.415 . . . . 0.0 109.167 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.55 -23.53 63.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.84 4.62 53.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.369 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -73.12 122.66 88.2 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.7 101.45 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.813 2.342 . . . . 0.0 113.783 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 C--N 1.31 -1.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.91 175.82 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -70.24 137.62 50.99 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.976 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -83.57 120.18 25.63 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.043 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.03 -84.15 0.2 Allowed Glycine 0 N--CA 1.428 -1.878 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.02 167.17 13.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.8 mtmt -138.63 122.02 11.08 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 52.8 Cg_endo -92.5 155.67 2.99 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 122.781 2.32 . . . . 0.0 114.761 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 11.9 p -130.96 152.0 36.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -76.54 110.92 11.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -132.71 144.71 35.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.508 0.67 . . . . 0.0 111.865 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -81.56 139.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.64 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 19.8 p -94.01 159.05 35.16 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 16.5 Cg_exo -67.18 -17.42 50.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.0 2.467 . . . . 0.0 111.479 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.06 -11.53 52.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.767 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.53 20.13 10.52 Favored Glycine 0 C--O 1.24 0.53 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.147 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.24 167.9 9.45 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -135.91 115.01 12.32 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 163.94 35.57 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.17 105.11 17.12 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.7 152.69 24.49 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.424 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.4 p -99.96 126.41 36.82 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.297 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 35.9 Cg_endo -70.07 130.5 19.06 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.833 1.689 . . . . 0.0 111.545 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.479 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 4.6 mm-40 -81.36 -27.43 34.9 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.534 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -144.22 131.11 20.34 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.04 138.66 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 O-C-N 123.364 0.415 . . . . 0.0 110.884 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -142.1 158.42 43.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.928 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 154.18 39.7 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.396 0.617 . . . . 0.0 111.526 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.0 mp -129.66 96.11 4.16 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.46 96.11 30.1 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 4.0 Cg_exo -82.22 139.44 10.53 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.653 2.235 . . . . 0.0 110.06 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.53 126.89 30.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.158 0.504 . . . . 0.0 110.92 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -2.3 75.91 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -118.6 -167.54 1.39 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -107.89 150.12 27.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.65 90.56 1.36 Allowed Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.37 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.3 151.82 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -130.2 151.36 50.81 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.2 mt -136.82 135.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.79 147.33 16.47 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 tp -95.26 126.17 40.4 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.16 170.89 9.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.184 0.594 . . . . 0.0 109.894 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -113.64 128.94 56.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.64 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 16.0 t70 -80.58 121.77 81.66 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.74 -1.55 11.7 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 113.305 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.41 -50.62 4.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.376 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 41.3 p -94.44 -37.29 11.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.469 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.3 -6.04 34.0 Favored Glycine 0 N--CA 1.427 -1.948 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.139 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 19.2 ptpt -79.96 163.55 24.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.445 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -97.88 131.46 44.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -129.11 139.62 51.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -91.21 142.32 27.85 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -146.75 136.07 22.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.4 ptmt -64.26 135.35 56.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.441 0.639 . . . . 0.0 111.104 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.06 169.96 7.96 Favored Pre-proline 0 C--N 1.271 -2.843 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 19.5 Cg_exo -66.95 151.63 81.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.941 1.761 . . . . 0.0 109.477 175.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.04 -19.11 61.89 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.927 -0.483 . . . . 0.0 111.536 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.86 -1.82 54.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.541 0.686 . . . . 0.0 110.704 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.443 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 52.1 t80 -65.67 127.2 92.87 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.07 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.65 104.53 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.403 2.069 . . . . 0.0 113.652 -175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 60' ' ' ILE . 48.2 pt . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 m -87.85 78.79 8.27 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -87.45 87.49 7.42 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.515 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.73 -64.86 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.11 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -89.84 -173.28 3.85 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.999 0.52 . . . . 0.0 109.947 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HZ3' ' HB2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -91.53 129.19 43.74 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 56.5 Cg_endo -84.27 174.85 7.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 121.902 1.735 . . . . 0.0 112.348 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.65 140.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 55.4 tttp -74.41 109.25 7.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.22 142.75 43.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.614 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -76.71 119.55 20.66 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.522 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 p -92.35 173.0 5.54 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.133 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.02 -14.56 38.66 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.003 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.34 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.938 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 1.69 49.32 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.628 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.87 156.56 18.56 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 41.0 tt0 -116.34 107.14 14.45 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.79 34.17 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.97 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 1.7 mp0 -80.55 108.99 14.65 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.363 0.601 . . . . 0.0 110.707 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.51 146.13 45.72 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.3 p -96.62 127.22 40.42 Favored Pre-proline 0 N--CA 1.419 -1.99 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.3 136.29 71.23 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.426 2.084 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.85 -42.33 81.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HZ1' ' HB2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -147.64 150.19 33.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.36 150.57 29.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.9 p90 -156.4 168.56 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.24 147.38 43.66 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.17 113.94 23.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.049 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.6 100.0 10.31 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.68 -67.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.298 1.999 . . . . 0.0 111.896 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -124.35 -142.53 0.31 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.93 84.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.28 0 O-C-N 122.997 0.186 . . . . 0.0 112.994 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.69 154.12 38.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -42.6 -45.5 4.62 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.475 1.11 . . . . 0.0 113.216 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.45 90.27 2.01 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 m -74.46 115.96 16.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.881 0.848 . . . . 0.0 112.221 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 63.2 mttp -80.97 131.08 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.096 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.7 mt -134.45 142.11 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.25 149.24 18.53 Favored Glycine 0 N--CA 1.424 -2.1 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.44 125.62 43.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 90.0 m-85 -119.52 171.91 8.02 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.714 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -130.45 121.99 26.88 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.4 129.72 85.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.12 -31.5 29.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.145 1.897 . . . . 0.0 114.478 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -97.55 -34.96 10.78 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -88.44 -25.34 22.69 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.466 0.65 . . . . 0.0 109.688 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.56 -5.64 82.85 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.052 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -82.46 150.92 26.78 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 89.5 m-85 -95.09 126.47 40.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.612 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -130.55 139.17 50.47 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -96.08 128.3 42.86 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.51 144.06 47.81 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 62.3 tttt -60.27 139.26 57.7 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 124.039 0.837 . . . . 0.0 109.36 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 31.6 mt -96.99 168.51 10.17 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.98 141.76 65.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.569 1.513 . . . . 0.0 109.728 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.34 -41.87 52.11 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.966 0.906 . . . . 0.0 111.181 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.36 15.63 20.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.965 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.438 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 84.8 t80 -83.31 120.95 76.56 Favored Pre-proline 0 C--O 1.216 -0.66 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.47 114.35 4.01 Favored 'Trans proline' 0 C--O 1.248 1.001 0 C-N-CA 122.096 1.864 . . . . 0.0 112.587 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.6 pt . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 118.446 -0.787 . . . . 0.0 110.034 179.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 C--O 1.24 0.59 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 74.05 116.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.491 1.516 . . . . 0.0 111.722 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m -81.62 -24.48 36.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.451 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.1 -25.8 17.3 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -141.44 147.19 37.51 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 124.196 0.999 . . . . 0.0 108.484 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -149.39 90.2 4.67 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 34.1 Cg_endo -76.09 164.52 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.783 2.322 . . . . 0.0 113.409 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.1 p -139.27 151.31 22.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -67.84 109.11 3.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -130.3 146.72 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.48 130.73 35.03 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.567 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.7 p -89.9 161.48 38.32 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -71.77 -9.49 24.94 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.786 2.324 . . . . 0.0 109.85 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.82 -5.93 59.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.093 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.75 -13.69 57.77 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 173.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HZ3' ' CD ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -114.71 174.03 6.17 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.8 -0.823 . . . . 0.0 111.559 -178.121 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.73 153.77 20.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.163 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 152.19 27.53 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.2 mt-10 -89.46 104.43 16.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -112.96 147.98 35.99 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.72 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -92.38 123.14 63.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.57 132.81 28.08 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.964 1.776 . . . . 0.0 112.085 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -47.68 24.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -137.38 142.04 41.73 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.03 144.36 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.373 . . . . 0.0 110.46 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -151.71 164.2 37.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.26 39.63 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.705 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.37 102.8 12.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.63 105.54 45.67 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 13.1 Cg_exo -77.97 3.81 6.68 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.997 2.465 . . . . 0.0 112.831 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 71.67 107.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.042 1.337 . . . . 0.0 111.893 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.63 12.17 38.75 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 92.7 mtt180 -137.63 -166.7 1.99 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -80.34 154.37 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.58 103.87 2.92 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.59 98.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.18 130.03 34.69 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.105 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.39 140.54 47.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.11 149.02 18.77 Favored Glycine 0 N--CA 1.416 -2.636 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 tp -96.13 126.24 41.22 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 92.1 m-85 -121.25 170.34 9.68 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -122.25 119.5 31.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.567 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 17.8 t70 -64.86 135.36 96.36 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.85 -21.26 16.4 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.45 2.1 . . . . 0.0 114.575 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.514 ' CD ' ' HZ3' ' A' ' 16' ' ' LYS . 35.4 tt0 -98.32 -51.12 4.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.438 0.637 . . . . 0.0 111.61 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -86.65 -29.4 22.53 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.72 85.95 Favored Glycine 0 N--CA 1.431 -1.653 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.209 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.0 144.12 41.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.083 0.441 . . . . 0.0 110.995 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 56.5 m-85 -83.37 125.12 31.32 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -126.37 139.74 53.04 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.633 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -96.91 123.82 40.72 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -134.87 147.86 49.98 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 54.3 tttm -62.1 142.51 57.54 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 123.737 0.648 . . . . 0.0 110.122 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 30.7 mt -98.7 171.13 6.08 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.83 73.67 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.837 1.692 . . . . 0.0 109.368 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.42 -33.67 72.84 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 123.688 0.795 . . . . 0.0 110.536 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.19 5.15 51.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.309 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -77.45 123.53 86.82 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.63 120.17 6.31 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.66 2.24 . . . . 0.0 111.959 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.298 -1.655 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.157 178.338 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 54.79 82.61 0.09 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.114 0.966 . . . . 0.0 111.573 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.4 m -147.05 92.98 2.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.047 -0.408 . . . . 0.0 110.11 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.63 -27.87 16.0 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.726 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -93.37 136.55 33.53 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 111.607 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 39.9 pttt -153.21 106.41 2.61 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.71 124.64 4.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.391 2.061 . . . . 0.0 113.055 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.98 149.03 8.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.06 109.27 6.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -135.61 145.61 31.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.238 0.542 . . . . 0.0 110.534 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -89.3 134.66 33.97 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.076 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -83.63 169.09 18.4 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.541 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.501 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -70.99 -22.17 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.269 1.979 . . . . 0.0 109.095 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -51.99 66.29 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.423 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.0 -0.17 3.99 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.985 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.47 160.01 15.97 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.62 137.41 39.97 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 163.57 36.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.27 105.4 17.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.54 138.55 51.83 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.57 123.29 67.02 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.304 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.41 142.77 37.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.052 1.835 . . . . 0.0 111.65 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -69.38 -37.27 77.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.79 157.9 38.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.86 139.04 51.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 123.759 0.662 . . . . 0.0 110.054 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -141.94 154.23 44.91 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.32 124.45 32.35 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.012 0.434 . . . . 0.0 111.499 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.1 96.05 10.57 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.47 107.41 21.08 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.627 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.71 -69.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 121.792 1.662 . . . . 0.0 110.248 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -160.04 -63.9 0.07 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.26 82.96 0.8 Allowed Glycine 0 C--N 1.316 -0.559 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -170.58 154.16 4.45 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -57.82 -46.01 85.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.588 0.631 . . . . 0.0 109.366 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.18 112.8 2.66 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.99 98.43 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.99 126.98 32.59 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -129.48 137.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.93 148.16 16.68 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 tp -97.53 121.88 39.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.0 m-85 -118.72 169.57 9.72 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 123.541 0.736 . . . . 0.0 110.195 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -112.03 124.3 52.11 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.501 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 11.9 t70 -77.67 122.92 86.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.85 -2.04 12.1 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 113.844 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -97.53 -54.17 3.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.226 0.536 . . . . 0.0 110.153 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -94.72 -17.47 22.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.722 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.93 74.08 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.982 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -106.28 163.66 12.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 122.54 -0.388 . . . . 0.0 110.312 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.0 m-85 -94.62 132.05 39.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -130.82 140.5 50.27 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.012 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -139.22 150.11 45.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.42 141.61 58.47 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 123.669 0.605 . . . . 0.0 109.617 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.55 170.76 5.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -67.12 141.81 58.93 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.05 1.834 . . . . 0.0 108.77 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.21 -21.96 63.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.099 0.476 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.61 -1.67 57.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' HG3' ' A' ' 6' ' ' LYS . 91.8 t80 -81.35 123.24 81.45 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.8 Cg_endo -78.35 111.78 3.09 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.974 1.783 . . . . 0.0 109.888 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 C--N 1.296 -1.756 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.323 -179.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.763 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -90.29 82.45 5.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 121.772 0.796 . . . . 0.0 111.547 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 t -110.85 -66.79 1.04 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.93 -70.88 1.45 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.814 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -106.26 146.39 30.41 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 146.27 22.76 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.0 Cg_endo -75.43 159.46 39.75 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.793 1.662 . . . . 0.0 112.586 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.4 146.87 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -69.06 109.84 4.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.34 139.16 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 121.727 0.775 . . . . 0.0 111.822 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 64.8 mttm -80.98 115.71 20.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.26 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -87.85 158.8 50.05 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.261 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 9.9 Cg_exo -71.03 -12.86 31.04 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.873 2.382 . . . . 0.0 110.702 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.91 64.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.516 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.9 9.42 24.52 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.601 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.26 26.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.706 177.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 48.2 mt-10 -94.31 121.48 35.87 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.34 138.73 52.51 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.93 105.54 14.02 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.27 151.29 39.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.381 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -100.55 127.61 32.28 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.59 143.31 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.008 1.805 . . . . 0.0 112.397 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.85 -37.55 64.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.42 149.01 28.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.91 149.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 123.57 0.544 . . . . 0.0 110.395 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -156.74 159.88 38.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.66 137.08 49.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.9 91.85 7.12 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.22 84.34 20.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.731 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -79.91 89.51 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 121.676 1.584 . . . . 0.0 111.443 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.279 19.2 ptpt 57.37 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 127.301 2.241 . . . . 0.0 116.256 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.0 70.76 0.29 Allowed Glycine 0 N--CA 1.432 -1.607 0 O-C-N 121.971 -0.456 . . . . 0.0 112.544 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -161.07 148.76 15.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.1 -39.18 91.62 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.385 0.428 . . . . 0.0 110.236 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.77 105.82 2.91 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.098 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.15 107.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.906 0.86 . . . . 0.0 109.116 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.46 131.35 34.67 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.753 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.84 140.47 48.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.94 149.49 18.83 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.32 123.47 41.15 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.0 m-85 -118.11 179.9 3.96 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.5 0.72 . . . . 0.0 110.563 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.7 tttp -128.96 113.44 15.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.51 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 10.1 t70 -65.94 133.21 94.82 Favored Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.031 0.932 . . . . 0.0 112.54 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.36 -31.37 62.53 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 123.375 2.717 . . . . 0.0 115.986 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.77 -30.69 12.64 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.615 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -104.21 -20.73 13.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.85 -2.68 67.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.661 -0.304 . . . . 0.0 113.524 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -78.35 160.74 27.65 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.934 0.397 . . . . 0.0 111.266 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 42.2 m-85 -93.0 120.63 33.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.334 176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.46 139.83 53.52 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -93.71 135.85 34.58 Favored 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.368 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -139.61 146.38 39.71 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.5 tttt -64.51 140.28 58.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.465 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 28.8 mt -96.51 176.06 2.34 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.93 140.04 53.55 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.663 1.575 . . . . 0.0 108.788 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.31 -24.11 67.12 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -108.28 15.02 24.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.112 -0.367 . . . . 0.0 111.595 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -68.8 128.81 92.76 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.27 108.0 1.28 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 123.341 2.694 . . . . 0.0 114.971 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -59.24 113.02 1.94 Allowed 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.496 0.497 . . . . 0.0 110.27 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 p -149.68 157.13 42.95 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.716 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.56 -33.31 2.78 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -132.59 173.32 11.45 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -131.8 84.34 54.67 Favored Pre-proline 0 C--N 1.264 -3.137 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 69.5 Cg_endo -93.85 -171.37 0.27 Allowed 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 123.117 2.545 . . . . 0.0 112.666 -175.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.4 p -146.45 146.0 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -71.73 110.6 6.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.37 143.07 42.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 120.836 0.35 . . . . 0.0 111.153 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -76.08 117.02 17.35 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.097 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 26.1 p -95.49 165.22 17.15 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.808 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 -23.08 73.95 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.34 2.693 . . . . 0.0 112.262 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.15 -17.05 64.68 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.31 49.38 4.98 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.557 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.22 159.99 44.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -106.2 111.76 24.5 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.28 150.83 41.79 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.6 mt-10 -85.65 104.57 15.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -115.49 138.12 51.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.527 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -90.77 123.58 64.61 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.25 139.89 62.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.087 1.858 . . . . 0.0 111.907 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -73.2 -49.46 27.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -134.94 143.73 47.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.718 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.62 145.17 31.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 O-C-N 123.505 0.503 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.32 151.92 31.48 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.49 124.32 44.14 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.194 0.521 . . . . 0.0 110.271 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.85 112.93 24.62 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.83 86.48 24.78 Favored Pre-proline 0 C--N 1.305 -1.369 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.783 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.51 149.19 23.92 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.657 2.238 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -71.49 100.53 2.25 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.24 -13.31 5.98 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.95 -176.14 3.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.89 -179.45 4.57 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.78 123.75 6.19 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.64 112.72 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 65.9 mttp -84.6 125.5 32.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.4 mt -131.09 142.14 44.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.0 148.29 18.43 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.1 tp -98.07 126.32 43.45 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 91.2 m-85 -125.63 168.19 14.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.292 0.637 . . . . 0.0 110.567 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -120.13 114.81 22.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 15.3 t70 -58.14 132.36 84.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.893 0.877 . . . . 0.0 111.032 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.74 -19.83 30.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.935 2.423 . . . . 0.0 114.728 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.16 -54.08 3.18 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.67 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -82.71 -33.1 27.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.13 18.19 59.72 Favored Glycine 0 N--CA 1.426 -1.98 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.837 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.86 161.42 13.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.388 0.594 . . . . 0.0 110.755 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 61.9 m-85 -89.45 133.12 34.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.647 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.77 139.74 42.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -100.48 125.76 46.82 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -136.73 145.19 44.37 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.2 tttt -60.94 144.01 53.98 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.549 0.531 . . . . 0.0 109.958 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.3 mt -101.37 170.58 6.33 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.73 141.17 71.03 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.701 1.601 . . . . 0.0 109.319 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.43 -30.58 63.0 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.547 0.739 . . . . 0.0 112.37 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.71 18.7 21.53 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.407 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 77.3 t80 -78.84 128.31 77.2 Favored Pre-proline 0 C--N 1.316 -0.859 0 O-C-N 122.458 -0.151 . . . . 0.0 110.774 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.64 119.97 6.74 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 122.307 2.005 . . . . 0.0 111.442 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.727 179.646 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ptp . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -155.1 -54.93 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 m -110.17 138.11 46.99 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.93 -62.13 0.29 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' HB2' HG21 ' A' ' 21' ' ' VAL . 51.2 mtmt 57.37 -162.18 0.21 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.792 0.837 . . . . 0.0 110.95 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -104.99 112.79 65.24 Favored Pre-proline 0 C--N 1.309 -1.194 0 O-C-N 122.067 -0.396 . . . . 0.0 110.062 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 39.0 Cg_endo -90.34 156.82 4.56 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.954 2.436 . . . . 0.0 112.507 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.4 154.92 22.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.18 115.83 14.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.11 138.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-O 121.17 0.51 . . . . 0.0 109.678 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -91.15 118.69 30.64 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.674 0.749 . . . . 0.0 109.16 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -69.5 161.02 76.86 Favored Pre-proline 0 C--N 1.281 -2.373 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.712 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.99 -19.49 57.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.76 2.307 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.86 -25.02 60.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.42 -13.42 12.2 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.5 -0.857 . . . . 0.0 114.715 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.7 147.28 24.58 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.155 0.977 . . . . 0.0 110.995 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.35 121.8 34.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.09 158.25 44.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -94.87 105.47 17.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.85 153.97 41.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.827 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 5' ' ' LYS . 14.5 p -107.25 128.52 25.85 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.885 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -68.18 137.84 41.65 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.804 1.669 . . . . 0.0 112.429 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.43 -44.5 44.11 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.293 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -137.51 146.69 44.49 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.38 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.11 144.65 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 O-C-N 123.654 0.596 . . . . 0.0 109.878 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -152.73 155.58 37.48 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.28 134.12 55.33 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.96 0.409 . . . . 0.0 111.35 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.49 120.67 41.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.91 122.34 53.04 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.859 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.13 61.77 4.95 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.752 2.302 . . . . 0.0 109.505 173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 64.15 53.53 1.78 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.763 1.225 . . . . 0.0 110.462 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.07 -118.6 6.01 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.392 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 70.97 -66.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 110.734 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 179.55 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.79 132.5 4.14 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.99 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.62 118.6 33.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.03 125.41 41.46 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.9 mt -124.56 136.94 58.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.76 148.27 16.71 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.3 tp -98.85 125.82 44.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 89.6 m-85 -120.25 168.85 10.82 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 123.201 0.601 . . . . 0.0 109.907 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -131.9 120.0 21.93 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.62 124.23 83.79 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 -14.75 25.03 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.772 2.315 . . . . 0.0 113.721 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.34 -46.83 7.18 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.734 0.302 . . . . 0.0 111.28 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 p -82.84 -36.8 25.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.485 0.66 . . . . 0.0 109.268 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 25.62 24.56 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.213 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -124.44 162.68 23.4 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.672 0.736 . . . . 0.0 111.491 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 59.8 m-85 -91.64 142.99 27.02 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.212 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.93 139.92 25.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -94.92 141.53 28.54 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -146.95 149.0 32.32 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.264 0.0 OUTLIER -78.25 145.03 35.69 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.073 -179.966 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.6 mt -96.64 172.92 4.56 Favored Pre-proline 0 C--N 1.276 -2.598 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.51 142.88 66.86 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.449 1.433 . . . . 0.0 109.275 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.02 -24.32 67.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 0.0 111.288 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.32 -12.91 45.09 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -64.62 121.15 71.44 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.504 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -79.08 107.78 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.157 1.904 . . . . 0.0 112.587 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 N--CA 1.426 -1.637 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.827 177.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 CA--C 1.496 -1.1 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -104.35 132.44 50.6 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.08 0.467 . . . . 0.0 110.79 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.8 m -146.29 44.48 1.23 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.34 -66.87 3.81 Favored Glycine 0 C--O 1.247 0.963 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -84.93 151.14 24.46 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 113.389 -1.406 . . . . 0.0 107.617 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -153.12 137.77 11.01 Favored Pre-proline 0 C--N 1.294 -1.839 0 C-N-CA 122.87 0.468 . . . . 0.0 111.04 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 12.1 Cg_endo -58.47 141.06 96.91 Favored 'Trans proline' 0 C--O 1.256 1.378 0 C-N-CA 122.957 2.438 . . . . 0.0 113.989 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.17 150.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.24 109.13 8.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.55 153.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.619 -173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 16.3 ptpt -88.22 134.22 33.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -102.2 172.61 4.2 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.664 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.79 -10.44 27.73 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.962 2.441 . . . . 0.0 111.841 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.48 -5.79 51.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.08 33.59 28.94 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.944 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.79 168.55 19.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 11' ' ' LYS . 42.6 mt-10 -120.26 130.75 54.64 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 165.11 32.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.38 110.7 21.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.204 0.526 . . . . 0.0 109.889 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 79.3 mt -122.16 152.21 40.18 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.721 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.34 124.5 42.74 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.23 131.69 21.09 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 121.779 1.653 . . . . 0.0 110.323 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.95 -34.34 66.46 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.801 0.81 . . . . 0.0 109.175 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -144.66 144.17 31.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 139.79 50.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.707 0.629 . . . . 0.0 109.798 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -147.28 148.01 30.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 110.861 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.21 129.99 53.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.891 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.08 89.49 3.08 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.82 84.41 25.44 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.837 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.68 125.68 9.03 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.115 1.877 . . . . 0.0 108.194 175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.92 106.16 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.32 -12.75 8.42 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -105.45 -173.22 2.25 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.505 -0.409 . . . . 0.0 111.328 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -70.6 -50.05 41.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.14 103.42 1.6 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.24 165.07 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.188 0.518 . . . . 0.0 111.798 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -117.82 140.24 49.97 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -131.14 138.7 52.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.74 145.34 15.86 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.2 121.95 36.24 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.1 m-85 -114.4 172.76 6.82 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -130.63 116.42 18.06 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.72 130.5 88.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.0 -24.76 28.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.436 2.091 . . . . 0.0 114.762 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -97.45 -37.85 9.83 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 34.7 p -87.03 -36.87 17.96 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.38 -0.54 71.52 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.471 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 21.8 ptmt -85.22 143.92 28.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.326 0.584 . . . . 0.0 111.607 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.8 m-85 -83.98 129.14 34.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.97 174.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -133.58 139.69 46.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -93.21 133.12 36.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -136.71 148.55 47.39 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.99 139.05 58.72 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 123.936 0.772 . . . . 0.0 109.675 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.2 mt -101.93 170.59 6.24 Favored Pre-proline 0 C--N 1.293 -1.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.34 147.19 77.54 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.515 2.144 . . . . 0.0 109.939 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.32 -33.33 75.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.129 0.49 . . . . 0.0 111.144 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 7.91 31.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.919 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -84.12 115.86 62.1 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.84 117.23 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.408 2.072 . . . . 0.0 113.115 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 C--N 1.3 -1.567 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.176 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.378 0.132 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 m -88.73 -5.58 58.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.239 0.542 . . . . 0.0 109.688 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -56.03 121.6 9.72 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 124.733 1.213 . . . . 0.0 110.122 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.02 -36.05 4.61 Favored Glycine 0 C--N 1.302 -1.358 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 89.8 mttt 61.19 -162.2 0.28 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.845 1.658 . . . . 0.0 111.065 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -128.74 107.66 18.59 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 46.0 Cg_endo -73.53 158.73 47.33 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.938 1.759 . . . . 0.0 111.882 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.72 151.21 34.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.99 109.47 8.47 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.62 149.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.252 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -85.85 128.36 34.8 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.597 0.713 . . . . 0.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 170.57 14.55 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.592 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 23.9 Cg_exo -66.72 -16.79 51.39 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.618 2.212 . . . . 0.0 110.788 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.34 -21.02 58.7 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.393 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.04 12.75 48.48 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.685 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.26 166.62 11.65 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.82 137.81 31.98 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.461 0.476 . . . . 0.0 110.581 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.09 154.53 21.79 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 105.36 17.76 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.556 0.693 . . . . 0.0 109.179 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.1 139.18 43.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.42 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 5' ' ' LYS . 7.2 p -91.8 118.22 68.17 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.26 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.29 136.47 24.28 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.962 2.442 . . . . 0.0 113.408 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.4 -41.23 18.38 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.576 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -129.1 143.77 50.97 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.28 137.96 50.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -151.29 164.42 36.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.74 132.71 35.19 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.134 0.492 . . . . 0.0 110.92 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.88 95.56 9.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.17 103.24 14.09 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.61 -56.44 1.01 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.386 2.057 . . . . 0.0 111.083 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -169.85 -64.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.57 47.86 2.33 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -141.65 152.92 44.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -64.61 -33.99 77.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.088 0.867 . . . . 0.0 110.18 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.9 130.85 6.75 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.457 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.28 105.91 16.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -83.59 132.37 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.2 mt -135.64 144.11 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.74 150.95 19.84 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.7 123.38 42.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.8 m-85 -120.36 168.04 11.7 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.293 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -128.23 120.97 28.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 15.3 t70 -76.61 123.74 87.7 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 7.7 Cg_exo -73.1 -20.53 21.58 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 C-N-CA 122.332 2.021 . . . . 0.0 113.742 -174.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.55 -45.56 8.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.964 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -82.82 -31.12 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.433 0.635 . . . . 0.0 109.515 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.28 67.34 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.867 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -90.98 154.32 19.53 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 44.3 m-85 -91.14 132.13 36.26 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.962 177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -135.89 139.92 43.71 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -95.81 126.39 41.04 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -130.58 144.19 51.25 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -172.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -65.98 144.04 57.0 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.693 0.62 . . . . 0.0 109.448 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.97 168.66 8.49 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.05 145.03 72.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.592 2.195 . . . . 0.0 109.16 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.25 -41.92 72.8 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -88.96 5.31 44.75 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.54 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -73.88 125.18 90.51 Favored Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 121.844 -0.535 . . . . 0.0 110.047 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -76.06 113.58 3.73 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 122.318 2.012 . . . . 0.0 110.363 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.296 -1.719 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -139.41 20.1 2.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.507 0.67 . . . . 0.0 110.238 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -80.19 -30.43 38.76 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.459 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.22 -125.25 8.2 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.2 mttm 67.62 -178.9 0.22 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.874 0.87 . . . . 0.0 111.418 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -128.47 105.88 19.24 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-O 120.754 0.312 . . . . 0.0 110.988 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -81.08 157.26 20.28 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 121.846 1.697 . . . . 0.0 111.609 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.2 p -141.69 148.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -71.52 111.51 6.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.63 138.03 55.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 121.03 0.443 . . . . 0.0 109.817 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 123.69 29.87 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 p -92.91 165.69 18.18 Favored Pre-proline 0 N--CA 1.418 -2.054 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.32 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.3 -27.01 82.62 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.051 2.5 . . . . 0.0 112.445 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.27 -25.79 63.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.652 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.62 -12.29 8.33 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.113 -1.518 . . . . 0.0 115.085 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.66 154.44 18.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 118.253 1.026 . . . . 0.0 110.211 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.47 106.06 14.11 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.43 165.05 18.43 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.23 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.2 mp0 -82.82 104.77 13.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.118 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.22 157.12 20.47 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.86 129.03 24.39 Favored Pre-proline 0 N--CA 1.403 -2.818 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.071 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.13 123.56 7.9 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.775 1.65 . . . . 0.0 111.351 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.52 -35.22 65.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.35 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -134.52 136.92 43.44 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 139.05 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.36 0.412 . . . . 0.0 110.4 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.53 155.39 40.25 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.74 136.51 53.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.58 0.705 . . . . 0.0 111.057 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.6 mp -108.01 100.02 9.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.81 96.34 16.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 123.243 0.34 . . . . 0.0 110.676 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 6.2 Cg_exo -80.7 155.4 20.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.523 2.149 . . . . 0.0 109.848 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.85 127.86 33.79 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.064 0.459 . . . . 0.0 110.111 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 33' ' ' ARG . . . 99.36 -15.48 60.1 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.231 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.433 ' HD2' ' C ' ' A' ' 32' ' ' GLY . 6.1 mpt_? -117.46 159.06 23.42 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.324 -0.515 . . . . 0.0 110.485 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.26 -33.3 73.03 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.467 0.479 . . . . 0.0 111.19 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.85 163.07 22.23 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.74 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.28 156.75 40.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.42 137.64 51.23 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.9 mt -134.04 141.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.83 150.65 19.38 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.8 tp -94.8 124.99 39.16 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.14 -179.86 4.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.246 1.018 . . . . 0.0 109.162 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 49' ' ' TYR . 84.0 tttt -134.05 132.09 39.61 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.76 121.34 82.26 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.99 -9.8 20.95 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.262 1.975 . . . . 0.0 114.851 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -99.13 -41.44 7.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.105 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -92.21 -25.95 18.42 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.982 0.42 . . . . 0.0 111.088 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.64 36.46 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.065 -0.516 . . . . 0.0 113.266 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -119.85 145.23 46.85 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.642 -0.328 . . . . 0.0 110.259 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 46.0 m-85 -80.55 138.53 36.51 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.3 140.2 33.78 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -93.54 137.82 32.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -142.51 147.03 35.34 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -68.94 144.53 54.14 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.179 0.514 . . . . 0.0 110.428 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.66 169.16 7.86 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -67.1 151.28 81.85 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.704 2.269 . . . . 0.0 109.895 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.22 -36.16 83.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.75 6.99 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.003 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -84.69 122.85 74.77 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.47 -0.769 . . . . 0.0 109.986 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.87 98.59 1.22 Allowed 'Trans proline' 0 N--CA 1.437 -1.794 0 C-N-CA 122.444 2.096 . . . . 0.0 111.916 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.2 pt . . . . . 0 N--CA 1.423 -1.79 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.002 179.463 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.307 0.099 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 62.41 74.44 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.415 1.086 . . . . 0.0 111.827 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.7 m -141.36 70.04 1.34 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.062 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.36 53.49 2.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.0 -172.95 3.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.03 134.93 9.05 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -78.81 141.95 17.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.945 1.764 . . . . 0.0 111.203 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 14.6 p -120.96 149.82 23.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 60.6 mttp -75.07 108.82 8.06 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.24 141.0 47.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.162 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -78.54 115.64 18.39 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.52 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.592 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 76.6 p -83.49 165.03 42.5 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.11 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.52 -17.4 57.21 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.436 2.091 . . . . 0.0 111.18 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.28 -17.97 61.26 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.674 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.4 31.24 6.55 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 114.772 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.64 38.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.601 0.701 . . . . 0.0 109.932 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HG2' ' HB3' ' A' ' 9' ' ' LYS . 36.7 tt0 -91.84 93.57 8.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.942 0.877 . . . . 0.0 109.563 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.29 160.28 14.82 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.535 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 52.3 mt-10 -92.29 105.61 17.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.462 0.649 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.1 mt -117.54 141.89 47.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.136 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.9 p -95.63 125.08 50.69 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 12.5 Cg_exo -66.6 141.17 59.53 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.145 1.896 . . . . 0.0 114.088 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.22 -47.12 65.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -142.26 144.32 33.25 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.527 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 m -124.99 152.73 31.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -157.36 153.48 27.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.074 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.96 125.05 42.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.239 0.542 . . . . 0.0 110.761 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -89.43 87.16 6.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 98.85 8.96 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.43 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.77 -66.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.646 1.564 . . . . 0.0 108.501 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 175.39 148.19 0.09 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.26 -5.6 79.67 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -105.85 150.18 25.83 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -57.88 -39.1 77.03 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.298 0.374 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.48 95.34 2.21 Favored Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.19 104.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -89.69 126.23 35.57 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.502 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.6 mt -129.19 142.72 43.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.86 147.66 18.49 Favored Glycine 0 N--CA 1.422 -2.294 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.35 125.37 40.8 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 95.0 m-85 -123.23 173.98 7.57 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 122.979 0.511 . . . . 0.0 109.972 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -125.34 125.3 43.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.592 ' OD2' ' HB ' ' A' ' 12' ' ' THR . 9.0 t70 -78.38 120.03 79.56 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.5 -12.37 27.06 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.728 2.285 . . . . 0.0 115.022 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.07 -34.38 10.8 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.907 -0.496 . . . . 0.0 112.053 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -93.77 -34.41 13.21 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.29 0.567 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.69 30.83 22.93 Favored Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.373 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.94 151.34 43.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.0 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 78.3 m-85 -87.83 129.81 35.08 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.971 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -134.59 139.33 45.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -95.23 131.68 41.02 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -139.07 149.96 45.19 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.22 142.02 57.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.5 mt -97.85 -179.82 0.95 Allowed Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 31.2 Cg_exo -64.12 137.87 59.02 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.579 1.519 . . . . 0.0 108.162 172.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.11 -20.28 57.48 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.392 0.677 . . . . 0.0 112.625 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -112.26 11.62 20.2 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.632 0.73 . . . . 0.0 111.01 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 8' ' ' VAL . 13.8 t80 -67.09 127.72 93.6 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.35 92.36 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.308 2.005 . . . . 0.0 113.535 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.202 177.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -139.81 169.66 17.32 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.805 0.336 . . . . 0.0 111.591 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -151.91 79.92 1.26 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.062 0.945 . . . . 0.0 108.725 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.73 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.797 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -85.17 83.07 8.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.578 0.704 . . . . 0.0 109.654 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -127.16 115.82 21.75 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -80.01 159.63 23.97 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.514 1.476 . . . . 0.0 112.342 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.2 p -140.87 150.52 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -72.1 109.32 5.81 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -125.22 137.68 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 121.658 0.742 . . . . 0.0 109.859 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -83.6 119.81 25.2 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.4 p -92.18 155.64 42.64 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.8 -16.09 33.21 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.905 2.404 . . . . 0.0 110.476 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.24 72.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.343 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.3 -18.47 4.42 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.016 -1.087 . . . . 0.0 114.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 173.51 6.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 118.102 0.951 . . . . 0.0 112.141 -174.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.38 126.16 32.97 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.31 144.89 50.89 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.7 mt-10 -94.74 104.42 16.33 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.99 141.5 48.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.854 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -90.35 121.72 68.19 Favored Pre-proline 0 N--CA 1.416 -2.151 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.36 134.69 60.32 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.168 1.912 . . . . 0.0 111.448 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.62 -32.43 64.06 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.276 1.03 . . . . 0.0 108.633 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -153.02 138.74 17.89 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.74 144.86 31.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -153.9 160.66 42.23 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.68 130.62 30.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.25 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.11 97.05 8.21 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.76 97.71 32.56 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.79 -64.78 0.08 OUTLIER 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.612 2.208 . . . . 0.0 111.794 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.3 tttm 169.69 119.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.531 1.132 . . . . 0.0 108.963 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.26 43.73 89.31 Favored Glycine 0 C--O 1.246 0.886 0 CA-C-O 121.79 0.661 . . . . 0.0 111.93 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -140.21 176.2 8.96 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -70.21 107.83 3.88 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.55 89.84 0.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.63 100.47 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.252 1.025 . . . . 0.0 112.167 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.59 127.55 32.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.109 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 54.9 mt -128.86 139.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.95 145.75 15.93 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -93.9 126.18 38.96 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.31 178.46 4.52 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -129.71 125.44 35.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 11.0 t70 -63.66 127.78 91.89 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 124.074 0.859 . . . . 0.0 109.375 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 26.1 Cg_exo -63.31 -40.86 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.463 2.109 . . . . 0.0 114.183 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -88.44 -48.93 7.26 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -90.52 -19.93 23.24 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.06 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.95 0.54 89.72 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 115.003 0.761 . . . . 0.0 115.003 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -73.87 138.81 44.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 117.011 0.405 . . . . 0.0 111.272 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -81.45 121.29 26.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -126.32 139.44 53.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -96.02 134.03 39.54 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -137.33 139.95 41.17 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.21 139.19 52.24 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.035 178.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.71 173.12 6.83 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -66.61 140.0 55.23 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 N-CA-C 107.788 -1.658 . . . . 0.0 107.788 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.23 -28.31 68.63 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.34 -4.94 57.18 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.801 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -79.27 122.07 83.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -82.39 112.31 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.428 2.086 . . . . 0.0 111.658 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--N 1.298 -1.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.103 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tmm? . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -95.11 -40.71 9.48 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.355 0.598 . . . . 0.0 110.455 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -124.76 107.33 10.82 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-O 121.321 0.581 . . . . 0.0 109.885 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.92 46.0 1.23 Allowed Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -72.97 82.05 1.21 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.013 -0.594 . . . . 0.0 111.959 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.36 78.59 67.52 Favored Pre-proline 0 C--N 1.296 -1.736 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.427 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.89 123.94 3.33 Favored 'Trans proline' 0 N--CA 1.425 -2.538 0 C-N-CA 121.585 1.524 . . . . 0.0 110.645 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -104.83 148.39 9.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -81.13 109.65 15.89 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.19 153.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 -172.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 54.1 mttp -86.09 135.47 33.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.032 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.7 p -88.75 170.45 11.08 Favored Pre-proline 0 N--CA 1.425 -1.676 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.401 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 48.8 Cg_exo -61.06 -13.62 28.75 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.315 2.01 . . . . 0.0 112.526 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.65 -6.76 58.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.919 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.4 15.1 62.69 Favored Glycine 0 C--N 1.328 0.123 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 49.9 mtpt -98.02 163.92 12.56 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -129.41 125.64 37.0 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.727 -176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.77 164.58 36.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.32 121.57 28.25 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.35 137.89 52.89 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.22 126.15 61.61 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.99 141.02 68.67 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.11 1.873 . . . . 0.0 113.159 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 49' ' ' TYR . 20.4 mm-40 -72.78 -45.61 57.64 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.919 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -139.63 148.7 42.83 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -131.83 143.5 40.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 O-C-N 123.406 0.441 . . . . 0.0 109.942 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -149.61 156.05 41.28 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.726 0.298 . . . . 0.0 110.62 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.67 125.2 33.36 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.676 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.78 92.84 7.31 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 87.74 17.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.083 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.19 -41.2 80.88 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.014 2.476 . . . . 0.0 110.685 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -171.68 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.29 92.98 0.31 Allowed Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -153.43 37.66 0.48 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 70.72 -55.04 0.64 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.017 1.727 . . . . 0.0 111.315 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.96 72.74 0.91 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -74.69 114.44 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -96.89 130.7 44.15 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.8 mt -133.64 142.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.55 146.16 16.66 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp -96.19 128.14 42.83 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.74 169.54 10.02 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.977 0.418 . . . . 0.0 110.5 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -122.28 116.82 24.76 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 8.6 t70 -53.95 123.23 39.01 Favored Pre-proline 0 C--N 1.316 -0.881 0 C-N-CA 125.256 1.422 . . . . 0.0 109.689 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.79 -26.13 52.8 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.964 2.443 . . . . 0.0 114.087 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.05 -48.19 4.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -94.79 -13.14 25.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.405 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.25 18.67 79.12 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.862 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.97 148.04 22.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.886 0.343 . . . . 0.0 111.384 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.464 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 19.9 m-85 -87.86 128.4 35.35 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.14 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -136.47 140.45 43.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -97.88 132.34 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.246 0.546 . . . . 0.0 110.37 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -138.5 141.1 39.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.8 ptmt -70.89 149.24 46.96 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 118.01 -1.476 . . . . 0.0 109.86 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.401 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 28.9 mt -94.6 175.29 3.0 Favored Pre-proline 0 C--N 1.28 -2.431 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.96 141.65 59.16 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 N-CA-C 108.177 -1.509 . . . . 0.0 108.177 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -66.87 -23.06 65.97 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.482 0.658 . . . . 0.0 110.243 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -88.34 -5.25 58.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.413 1.485 . . . . 0.0 111.732 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.29 136.76 81.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.9 115.69 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.434 2.089 . . . . 0.0 114.538 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.925 173.271 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tmm? . . . . . 0 C--O 1.243 0.72 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.7 m 64.86 88.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.782 1.233 . . . . 0.0 111.5 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 t -94.79 -2.22 51.35 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.232 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.53 -60.11 0.6 Allowed Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 99.0 mttt -104.69 151.99 23.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -142.4 135.18 13.81 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.49 131.85 14.17 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.453 1.435 . . . . 0.0 112.167 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.39 147.55 19.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.135 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -69.05 108.63 3.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 151.72 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 121.497 0.665 . . . . 0.0 111.624 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.46 141.17 28.89 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.252 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.0 p -93.14 171.69 6.97 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.67 -12.88 35.83 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.1 1.867 . . . . 0.0 111.581 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.16 -20.75 47.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.148 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.66 -16.7 36.96 Favored Glycine 0 C--O 1.242 0.635 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.906 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.76 158.14 21.85 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -112.17 145.04 40.56 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.48 154.87 32.5 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.47 104.88 17.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -117.04 148.23 41.67 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.498 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.445 ' CG2' ' HB3' ' A' ' 5' ' ' LYS . 14.6 p -96.18 125.97 45.98 Favored Pre-proline 0 N--CA 1.426 -1.66 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.85 142.07 27.9 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.99 1.793 . . . . 0.0 111.871 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.33 -40.73 64.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.353 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -145.85 147.34 31.71 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.856 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.29 144.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -146.5 155.98 42.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.06 32.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.132 0.491 . . . . 0.0 110.719 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.81 85.85 2.47 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.7 94.85 24.43 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.12 136.62 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.721 1.614 . . . . 0.0 108.413 170.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -60.86 113.63 2.61 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.108 0.48 . . . . 0.0 111.933 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 2.01 56.07 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.138 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -116.47 -72.83 0.67 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -142.25 174.66 10.41 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 120.679 0.276 . . . . 0.0 111.15 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.54 42.28 0.89 Allowed Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.16 149.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.352 0.596 . . . . 0.0 110.826 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -127.65 144.58 51.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.8 mt -136.11 143.82 34.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.57 148.9 19.16 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.2 tp -98.22 122.72 41.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.53 173.41 6.85 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.038 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -134.64 125.77 27.82 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.54 128.5 77.3 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.54 -12.8 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.085 2.523 . . . . 0.0 114.254 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -97.68 -52.62 3.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.26 0.552 . . . . 0.0 111.69 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 45.0 p -82.79 -35.14 26.74 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.379 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.25 62.4 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.025 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.9 ptpt -88.29 150.0 23.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.265 0.555 . . . . 0.0 111.87 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -95.15 136.5 35.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -143.93 139.92 29.41 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.98 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -100.38 119.92 39.18 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 121.38 0.609 . . . . 0.0 109.77 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -127.49 144.28 51.08 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -68.58 141.48 55.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.611 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 mt -93.95 172.15 6.13 Favored Pre-proline 0 C--N 1.284 -2.272 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.92 140.48 55.15 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.526 1.484 . . . . 0.0 108.412 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.05 -26.72 68.97 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.36 0.6 . . . . 0.0 109.775 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.12 0.26 56.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.779 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 66.1 t80 -80.31 126.68 78.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.6 Cg_exo -76.96 107.88 2.53 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.145 1.897 . . . . 0.0 112.54 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.0 pt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.479 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -92.99 95.38 9.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.299 0.571 . . . . 0.0 110.847 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -95.33 86.3 4.49 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.573 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 -143.33 17.87 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.578 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -89.63 138.33 31.56 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.571 0.701 . . . . 0.0 112.829 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -139.39 94.17 9.66 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -84.55 120.03 2.38 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.328 2.019 . . . . 0.0 111.611 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.8 p -103.91 145.46 12.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.162 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.94 108.45 7.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -130.48 149.52 33.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.05 124.39 28.24 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.741 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.401 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 30.4 p -76.41 169.17 22.24 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.51 -24.38 36.22 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.266 1.978 . . . . 0.0 110.148 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.53 85.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.589 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.61 31.37 1.25 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.463 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.53 160.01 41.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.331 0.565 . . . . 0.0 109.772 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.202 0.525 . . . . 0.0 111.505 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.23 146.96 52.37 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -89.87 105.3 17.71 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.99 0.9 . . . . 0.0 108.952 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.01 141.74 48.42 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.535 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.97 121.87 68.39 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.44 134.72 36.83 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.073 1.849 . . . . 0.0 112.28 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -61.27 -48.98 78.93 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -145.89 153.98 41.45 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.648 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.94 152.0 30.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 O-C-N 123.628 0.58 . . . . 0.0 110.544 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -155.53 168.37 27.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.256 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.56 139.79 36.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.006 0.431 . . . . 0.0 110.758 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 94.56 4.91 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 91.82 40.06 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.006 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.73 173.67 10.19 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.43 2.087 . . . . 0.0 108.621 172.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.39 139.62 51.92 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.682 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.21 32.4 25.87 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.741 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -156.37 154.12 30.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -69.93 -45.75 66.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.82 117.94 2.21 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.921 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.15 119.93 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 121.42 0.629 . . . . 0.0 110.078 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.04 136.5 35.29 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.4 mt -133.14 140.11 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.07 149.6 18.58 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 tp -96.14 125.51 40.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -122.88 175.07 6.76 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -133.4 122.93 24.47 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.3 t70 -78.74 125.72 83.75 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 3.2 Cg_exo -80.13 -8.34 14.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.247 1.965 . . . . 0.0 113.354 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.44 -40.74 8.54 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -90.29 -34.16 15.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.346 0.593 . . . . 0.0 109.577 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.79 22.78 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.704 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -118.89 144.24 46.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.912 0.356 . . . . 0.0 111.6 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.68 124.65 29.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.725 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -135.4 140.05 44.66 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -92.76 138.83 31.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -144.43 147.91 33.93 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.46 146.52 50.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.647 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.07 168.98 8.2 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.89 143.47 66.75 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.919 1.746 . . . . 0.0 108.908 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.05 -15.25 61.51 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.842 -0.536 . . . . 0.0 110.868 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.25 -1.82 57.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.597 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 89.0 t80 -81.7 133.83 51.68 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 122.761 0.424 . . . . 0.0 111.059 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.4 Cg_exo -78.95 106.19 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.572 2.182 . . . . 0.0 112.256 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.665 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 t 62.67 -158.64 0.32 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -139.59 111.59 7.43 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.49 -82.99 1.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 55.68 73.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.433 1.093 . . . . 0.0 111.517 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 82.2 mttt -121.81 99.4 44.49 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.622 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.438 ' HB2' ' HG2' ' A' ' 19' ' ' GLU . 47.2 Cg_endo -71.67 138.91 32.9 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.104 1.869 . . . . 0.0 112.914 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.06 143.09 41.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 27.6 mtmm -74.43 108.51 7.25 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.15 144.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.112 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -75.52 115.67 15.43 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.297 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.2 p -83.85 162.75 51.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.957 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.47 -18.03 44.25 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.419 2.746 . . . . 0.0 114.782 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.04 -5.52 59.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.884 0.373 . . . . 0.0 111.803 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.41 9.54 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.568 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -140.33 166.25 25.2 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -113.65 147.51 37.99 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.212 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 146.7 28.67 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HG2' ' HB2' ' A' ' 7' ' ' PRO . 31.1 tt0 -92.32 105.89 18.0 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.56 145.56 48.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.296 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.82 128.37 46.25 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.09 144.7 93.07 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.453 2.102 . . . . 0.0 113.789 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.03 -42.51 23.64 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.726 1.211 . . . . 0.0 109.447 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -145.31 141.4 28.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.43 139.97 49.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 123.31 0.381 . . . . 0.0 110.009 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -146.33 158.2 43.86 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.95 125.78 38.22 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.3 mp -79.73 89.6 5.19 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.76 116.6 34.53 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.662 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.28 -48.85 12.33 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.695 1.597 . . . . 0.0 107.986 172.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp 177.92 -64.52 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.044 -1.435 . . . . 0.0 108.197 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.59 103.77 2.09 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.5 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -169.91 -79.23 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -172.11 -56.13 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.071 1.749 . . . . 0.0 106.693 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 112.56 2.34 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.564 -1.815 . . . . 0.0 108.564 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' LEU . 59.4 t -75.33 105.42 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -80.68 125.93 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.534 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.0 mt -132.26 139.36 50.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.1 147.39 17.3 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.5 tp -94.9 130.01 41.68 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.5 m-85 -124.89 176.4 6.66 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 122.917 0.487 . . . . 0.0 110.084 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -130.58 115.84 17.31 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.61 126.02 92.01 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 -20.47 25.38 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 122.196 1.931 . . . . 0.0 113.39 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -60.46 2.1 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 39.8 p -82.52 -32.05 28.89 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.04 -3.88 62.45 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.113 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.482 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.3 ptpt -80.98 153.63 27.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 10.2 m-85 -90.9 125.37 35.74 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.138 177.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.69 139.78 47.83 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -94.06 138.3 32.29 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -143.99 144.51 31.71 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.521 ' HZ2' ' CG ' ' A' ' 56' ' ' ASP . 61.1 tttm -62.53 142.94 57.73 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.655 0.597 . . . . 0.0 109.761 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.5 mt -102.39 172.14 4.62 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -67.01 139.77 52.25 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.093 1.862 . . . . 0.0 107.708 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.521 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 46.9 m-20 -74.84 -11.17 60.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.718 -0.614 . . . . 0.0 110.382 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -95.39 0.52 53.57 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.714 1.205 . . . . 0.0 110.448 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.414 ' OH ' ' HB2' ' A' ' 6' ' ' LYS . 77.4 t80 -80.75 119.49 76.33 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.36 104.71 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.487 2.125 . . . . 0.0 112.444 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.56 -179.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 C--O 1.217 -0.616 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -57.9 113.59 1.94 Allowed 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 111.806 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m 63.75 44.56 4.93 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.289 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.88 92.99 1.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.184 -1.967 . . . . 0.0 108.184 173.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -92.13 147.37 22.99 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.119 0.962 . . . . 0.0 113.576 -170.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 7.9 tmtt? -150.19 104.6 3.15 Favored Pre-proline 0 N--CA 1.414 -2.243 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 168.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -83.28 149.25 13.26 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.946 1.764 . . . . 0.0 112.373 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.0 p -121.52 144.92 29.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -73.57 108.39 6.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.8 p -121.28 141.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.05 -174.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.93 117.26 19.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.506 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 46.0 p -85.96 169.01 16.74 Favored Pre-proline 0 C--N 1.286 -2.191 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.577 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 31.2 Cg_exo -63.16 -22.26 72.82 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.143 2.562 . . . . 0.0 111.079 174.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.8 -14.75 62.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.51 4.74 62.12 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.17 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -115.64 161.09 19.16 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.496 -0.414 . . . . 0.0 110.049 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 52.6 mt-10 -102.29 135.57 43.66 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.132 0.492 . . . . 0.0 110.521 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.5 45.26 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.9 mt-10 -89.85 105.22 17.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.98 138.14 51.76 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.961 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.59 121.75 62.44 Favored Pre-proline 0 N--CA 1.415 -2.213 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.11 140.55 90.11 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.472 2.114 . . . . 0.0 113.013 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.2 -43.65 77.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.276 1.036 . . . . 0.0 109.005 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.32 138.34 38.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.201 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.06 144.41 32.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.191 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -152.2 161.84 42.02 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.57 128.16 32.69 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.248 0.547 . . . . 0.0 111.497 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -93.54 94.79 8.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.887 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.83 110.35 63.61 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.3 -69.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.19 1.926 . . . . 0.0 111.505 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -164.4 115.47 1.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.884 0.473 . . . . 0.0 110.153 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.16 45.34 96.24 Favored Glycine 0 C--N 1.318 -0.469 0 O-C-N 123.505 0.503 . . . . 0.0 112.724 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.44 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -127.07 167.4 16.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.83 -34.95 76.34 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.31 120.67 4.77 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.245 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.6 t -76.08 103.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -86.83 137.02 32.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.224 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 60.5 mt -136.38 141.47 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 147.32 18.37 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.5 tp -95.76 124.12 39.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -118.97 170.1 9.32 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.697 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -117.21 125.99 52.05 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.577 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 16.0 t70 -69.56 132.54 89.26 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.9 -12.52 10.84 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.118 1.879 . . . . 0.0 114.185 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -97.48 -51.02 4.29 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.367 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 p -88.27 -37.28 16.16 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.899 0.479 . . . . 0.0 110.522 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -4.98 55.15 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.513 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -81.44 151.95 27.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.175 0.487 . . . . 0.0 111.641 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -89.63 125.33 35.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.184 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -127.25 140.66 52.07 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -101.4 136.6 40.96 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.63 143.82 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.47 139.54 51.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.79 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.67 174.78 3.53 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 25.1 Cg_exo -64.62 141.46 73.11 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 N-CA-C 108.183 -1.507 . . . . 0.0 108.183 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -26.05 68.39 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.226 0.536 . . . . 0.0 110.998 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.11 12.19 37.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.194 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.411 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 34.0 t80 -72.8 128.08 88.72 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.16 103.34 1.73 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.647 1.565 . . . . 0.0 113.397 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.739 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mtp . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -110.23 111.98 23.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 p -67.23 104.9 1.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.433 0.635 . . . . 0.0 111.413 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.52 -44.63 0.13 Allowed Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.376 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -73.07 132.24 43.09 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.566 0.698 . . . . 0.0 111.792 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -116.5 96.17 47.44 Favored Pre-proline 0 C--N 1.293 -1.875 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.153 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.32 143.65 14.03 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.407 2.072 . . . . 0.0 110.995 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.12 135.69 37.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -70.43 109.31 4.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -127.77 145.94 34.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.554 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 67.4 mttm -78.06 124.47 28.07 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -81.63 163.12 55.57 Favored Pre-proline 0 C--N 1.282 -2.333 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 -7.1 20.49 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.482 2.122 . . . . 0.0 111.404 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.89 -32.37 20.24 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.177 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.96 -39.44 1.66 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.808 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -71.67 164.91 25.06 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 120.844 0.354 . . . . 0.0 110.379 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 33.2 mt-10 -115.77 129.25 56.38 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.48 147.49 37.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.178 0.299 . . . . 0.0 110.209 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.53 105.26 11.64 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.61 138.14 51.65 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.948 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.39 122.08 63.72 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.86 146.41 77.96 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.89 2.393 . . . . 0.0 113.39 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -67.0 -45.94 76.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.45 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -149.63 152.55 35.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.598 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.68 151.14 33.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 123.576 0.547 . . . . 0.0 110.465 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -148.72 161.4 41.85 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.133 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.53 137.31 40.14 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.857 0.36 . . . . 0.0 111.289 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.47 119.98 41.09 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.12 90.91 47.7 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.21 105.55 2.1 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 122.708 2.272 . . . . 0.0 112.233 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 70.08 -64.08 0.37 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.682 1.593 . . . . 0.0 112.124 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.03 111.44 0.49 Allowed Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -159.95 163.8 33.9 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -79.3 -9.8 59.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.061 0.934 . . . . 0.0 108.712 176.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 100.12 108.14 2.96 Favored Glycine 0 N--CA 1.418 -2.563 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.834 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.99 112.44 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 60.0 mttp -99.1 136.3 39.26 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.847 -171.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -132.33 136.77 55.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.75 146.43 16.2 Favored Glycine 0 N--CA 1.422 -2.233 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.2 tp -96.6 123.68 40.35 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.79 174.17 6.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.664 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -132.41 127.56 35.65 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.0 t70 -86.93 116.34 65.69 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 11.3 Cg_exo -72.34 -8.68 23.11 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.006 2.471 . . . . 0.0 113.108 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.3 -53.57 4.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.507 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.3 p -84.68 -30.73 24.58 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.225 0.536 . . . . 0.0 111.1 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.71 30.62 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.177 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -123.53 152.0 42.26 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.789 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.22 135.51 33.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -137.06 139.86 41.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -99.37 129.57 45.58 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -134.37 147.48 50.53 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 38.7 ttmt -66.83 140.77 57.83 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mt -101.51 172.4 4.47 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -67.17 139.52 50.74 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.607 1.538 . . . . 0.0 109.641 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.45 -30.48 68.54 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.098 0.475 . . . . 0.0 110.539 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.31 -1.09 57.2 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.895 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -74.76 126.65 88.25 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 121.599 -0.688 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.86 120.99 6.01 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 112.581 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.131 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -55.08 112.1 0.99 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.237 0.615 . . . . 0.0 110.261 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -109.36 40.66 1.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.581 -175.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.2 29.53 5.57 Favored Glycine 0 C--O 1.236 0.256 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -139.09 -179.34 5.79 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -141.21 118.02 7.57 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.305 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 14.0 Cg_endo -72.35 141.91 36.24 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.597 1.532 . . . . 0.0 110.134 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 141.8 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.82 109.08 5.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.12 146.27 31.07 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.847 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -79.08 120.7 24.0 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.56 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.0 p -78.48 161.3 70.29 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.063 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.66 -15.99 37.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.487 2.125 . . . . 0.0 110.194 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.41 -51.28 24.84 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.893 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.8 -17.09 2.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.93 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -92.24 168.3 11.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -110.71 130.69 55.51 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.912 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.26 152.46 51.54 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.96 104.74 16.57 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.62 141.93 44.58 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.9 p -93.13 125.55 54.33 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.96 116.86 3.94 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 121.403 1.402 . . . . 0.0 110.525 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.81 -17.61 62.14 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.247 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -152.76 140.26 19.71 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.46 138.95 52.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 123.27 0.356 . . . . 0.0 110.421 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -152.24 154.32 35.51 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.4 137.92 54.04 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.495 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 5.2 mp -112.08 106.78 15.51 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.51 102.1 12.0 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 8.4 Cg_exo -73.94 154.46 48.01 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.024 1.816 . . . . 0.0 109.847 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -61.32 -44.59 96.95 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.81 26.72 20.14 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -136.07 -176.81 4.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -87.38 -56.43 3.36 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.393 0.616 . . . . 0.0 110.053 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 150.31 137.17 2.67 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.56 124.31 70.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.325 0.583 . . . . 0.0 109.998 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.83 128.27 43.62 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.247 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 47.4 mt -125.27 140.54 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.019 0.438 . . . . 0.0 109.99 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -128.05 149.92 18.26 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 tp -94.25 126.13 39.3 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.81 166.61 14.09 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.377 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.494 ' HZ3' ' HB3' ' A' ' 42' ' ' LYS . 6.3 ttpm? -126.93 122.68 35.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.56 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 18.2 t70 -65.83 129.57 94.32 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 -4.18 12.5 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.869 2.379 . . . . 0.0 113.095 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 16.6 tp10 -93.79 -51.46 4.89 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.329 0.585 . . . . 0.0 109.647 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 31.2 p -108.78 -22.01 12.41 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.72 11.99 69.89 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.538 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 ptpt -84.31 147.64 27.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.58 142.71 27.47 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.645 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -149.99 138.97 21.03 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -93.15 139.76 30.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -143.01 143.7 32.0 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.282 0.1 OUTLIER -74.46 140.19 44.45 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.604 179.529 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' A' ' 39' ' ' GLY . 17.8 mt -85.86 -177.22 0.89 Allowed Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -67.27 132.94 28.98 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 105.185 -2.659 . . . . 0.0 105.185 166.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.43 -7.97 54.74 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.921 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.34 -14.4 40.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.363 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -60.16 129.56 88.62 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.204 1.001 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.15 118.24 2.29 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.678 2.252 . . . . 0.0 112.757 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--N 1.293 -1.854 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.671 177.045 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 CA--C 1.509 -0.629 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 60.44 68.67 0.74 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.467 1.107 . . . . 0.0 111.367 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.5 m -90.53 -6.82 54.27 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.392 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.11 76.05 2.1 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -141.32 -174.19 3.96 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -152.1 131.41 6.75 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.67 136.4 45.8 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.913 1.742 . . . . 0.0 111.462 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.3 p -114.23 149.78 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.36 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -68.71 109.18 3.7 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.29 136.56 60.46 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.944 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 60.9 mttp -79.37 115.72 19.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -85.42 166.48 30.33 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.52 -18.69 64.76 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.556 2.171 . . . . 0.0 111.875 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.43 -14.82 62.27 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.94 50.11 4.51 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.017 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 22.1 ptmt -148.43 164.77 33.13 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.06 120.37 41.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.02 149.43 50.37 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -90.01 104.15 16.75 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -118.01 147.23 43.41 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.638 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.18 129.36 26.44 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.0 129.92 20.54 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.225 1.284 . . . . 0.0 111.645 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.25 -51.18 60.08 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.973 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -132.78 153.26 51.41 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.685 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.66 148.65 33.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 124.266 0.979 . . . . 0.0 109.429 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -157.18 163.97 38.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.47 132.91 39.84 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.127 0.489 . . . . 0.0 110.36 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 mp -97.99 92.11 5.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 100.31 52.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.12 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.46 -69.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.717 2.278 . . . . 0.0 112.426 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -168.62 -50.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.568 0.347 . . . . 0.0 111.893 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -128.58 40.37 1.73 Allowed Glycine 0 C--N 1.317 -0.507 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.809 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -129.36 25.98 5.42 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.55 -65.42 0.35 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.358 1.063 . . . . 0.0 112.514 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.44 118.82 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.31 116.67 37.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -89.16 131.04 35.48 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 66.8 mt -134.42 142.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.95 150.32 19.34 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.0 tp -94.63 124.29 38.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -117.62 170.66 8.59 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.076 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.82 125.87 45.45 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.06 119.99 79.53 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.46 -24.79 42.18 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.82 2.347 . . . . 0.0 114.164 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.22 -21.86 17.04 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.8 p -111.45 -18.73 12.8 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.672 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 9.74 85.27 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.522 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -100.22 156.97 16.92 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.515 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -94.82 146.99 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.49 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -147.57 139.47 24.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -94.49 133.46 38.08 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -141.38 149.53 41.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 21.5 ptmt -69.46 150.38 47.28 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.467 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . 43.6 mt -104.86 171.16 5.23 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.014 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' CD ' ' HB3' ' A' ' 54' ' ' LEU . 18.8 Cg_exo -67.34 148.72 80.28 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.922 2.415 . . . . 0.0 109.167 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.55 -23.53 63.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.84 4.62 53.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.369 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -73.12 122.66 88.2 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.7 101.45 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.813 2.342 . . . . 0.0 113.783 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 C--N 1.31 -1.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.91 175.82 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.8 mtmt . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -92.5 155.67 2.99 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 122.781 2.32 . . . . 0.0 114.761 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 11.9 p -130.96 152.0 36.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -76.54 110.92 11.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -132.71 144.71 35.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.508 0.67 . . . . 0.0 111.865 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 65.6 mttm -81.56 139.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.636 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 19.8 p -94.01 159.05 35.16 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 16.5 Cg_exo -67.18 -17.42 50.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.0 2.467 . . . . 0.0 111.479 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.06 -11.53 52.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.767 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.53 20.13 10.52 Favored Glycine 0 C--O 1.24 0.53 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.147 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.24 167.9 9.45 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 51.4 mt-10 -135.91 115.01 12.32 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 163.94 35.57 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.17 105.11 17.12 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.7 152.69 24.49 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.424 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.96 126.41 36.82 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.297 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 35.9 Cg_endo -70.07 130.5 19.06 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.833 1.689 . . . . 0.0 111.545 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 4.6 mm-40 -81.36 -27.43 34.9 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.534 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -144.22 131.11 20.34 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.04 138.66 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 O-C-N 123.364 0.415 . . . . 0.0 110.884 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -142.1 158.42 43.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.928 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 154.18 39.7 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.396 0.617 . . . . 0.0 111.526 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.0 mp -129.66 96.11 4.16 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.46 96.11 30.1 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 4.0 Cg_exo -82.22 139.44 10.53 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.653 2.235 . . . . 0.0 110.06 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.53 126.89 30.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.158 0.504 . . . . 0.0 110.92 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -2.3 75.91 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 33' ' ' ARG . 3.4 mmp_? -118.6 -167.54 1.39 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -107.89 150.12 27.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.65 90.56 1.36 Allowed Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.37 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.3 151.82 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -130.2 151.36 50.81 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 74.2 mt -136.82 135.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.79 147.33 16.47 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.5 tp -95.26 126.17 40.4 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.16 170.89 9.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.184 0.594 . . . . 0.0 109.894 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -113.64 128.94 56.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 16.0 t70 -80.58 121.77 81.66 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.74 -1.55 11.7 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 113.305 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.41 -50.62 4.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.376 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 41.3 p -94.44 -37.29 11.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.469 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.3 -6.04 34.0 Favored Glycine 0 N--CA 1.427 -1.948 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.139 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 19.2 ptpt -79.96 163.55 24.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.445 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 40' ' ' LEU . 74.2 m-85 -97.88 131.46 44.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -129.11 139.62 51.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -91.21 142.32 27.85 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -146.75 136.07 22.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 5.4 ptmt -64.26 135.35 56.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.441 0.639 . . . . 0.0 111.104 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.06 169.96 7.96 Favored Pre-proline 0 C--N 1.271 -2.843 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 19.5 Cg_exo -66.95 151.63 81.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.941 1.761 . . . . 0.0 109.477 175.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.04 -19.11 61.89 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.927 -0.483 . . . . 0.0 111.536 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.86 -1.82 54.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.541 0.686 . . . . 0.0 110.704 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 52.1 t80 -65.67 127.2 92.87 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.07 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.65 104.53 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.403 2.069 . . . . 0.0 113.652 -175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 60' ' ' ILE . 48.2 pt . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' ' CE1' ' A' ' 58' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 56.5 Cg_endo -84.27 174.85 7.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 121.902 1.735 . . . . 0.0 112.348 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.65 140.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 55.4 tttp -74.41 109.25 7.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.22 142.75 43.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.614 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -76.71 119.55 20.66 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.522 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 p -92.35 173.0 5.54 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.133 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.02 -14.56 38.66 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.003 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.34 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.938 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 1.69 49.32 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.628 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.87 156.56 18.56 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 41.0 tt0 -116.34 107.14 14.45 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.79 34.17 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.97 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 1.7 mp0 -80.55 108.99 14.65 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.363 0.601 . . . . 0.0 110.707 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.51 146.13 45.72 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.3 p -96.62 127.22 40.42 Favored Pre-proline 0 N--CA 1.419 -1.99 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.3 136.29 71.23 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.426 2.084 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.85 -42.33 81.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HG3' ' CZ3' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -147.64 150.19 33.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 ' HB ' ' A' ' 60' ' ' ILE . 32.2 m -124.36 150.57 29.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.409 ' CZ3' ' HG3' ' A' ' 24' ' ' LYS . 21.9 p90 -156.4 168.56 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.24 147.38 43.66 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.17 113.94 23.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.049 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.6 100.0 10.31 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.68 -67.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.298 1.999 . . . . 0.0 111.896 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -124.35 -142.53 0.31 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.93 84.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.28 0 O-C-N 122.997 0.186 . . . . 0.0 112.994 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -149.69 154.12 38.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 32.3 mmtp -42.6 -45.5 4.62 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.475 1.11 . . . . 0.0 113.216 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.45 90.27 2.01 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 m -74.46 115.96 16.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.881 0.848 . . . . 0.0 112.221 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 63.2 mttp -80.97 131.08 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.096 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.7 mt -134.45 142.11 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.25 149.24 18.53 Favored Glycine 0 N--CA 1.424 -2.1 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.44 125.62 43.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 90.0 m-85 -119.52 171.91 8.02 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.714 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -130.45 121.99 26.88 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.4 129.72 85.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.12 -31.5 29.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.145 1.897 . . . . 0.0 114.478 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -97.55 -34.96 10.78 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -88.44 -25.34 22.69 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.466 0.65 . . . . 0.0 109.688 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.56 -5.64 82.85 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.052 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -82.46 150.92 26.78 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 89.5 m-85 -95.09 126.47 40.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.612 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -130.55 139.17 50.47 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -96.08 128.3 42.86 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.51 144.06 47.81 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 62.3 tttt -60.27 139.26 57.7 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 124.039 0.837 . . . . 0.0 109.36 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 31.6 mt -96.99 168.51 10.17 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.98 141.76 65.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.569 1.513 . . . . 0.0 109.728 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.34 -41.87 52.11 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.966 0.906 . . . . 0.0 111.181 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.36 15.63 20.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.965 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 84.8 t80 -83.31 120.95 76.56 Favored Pre-proline 0 C--O 1.216 -0.66 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.47 114.35 4.01 Favored 'Trans proline' 0 C--O 1.248 1.001 0 C-N-CA 122.096 1.864 . . . . 0.0 112.587 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.4 ' HB ' HG21 ' A' ' 25' ' ' VAL . 37.6 pt . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 118.446 -0.787 . . . . 0.0 110.034 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.09 164.52 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.783 2.322 . . . . 0.0 113.409 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.1 p -139.27 151.31 22.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -67.84 109.11 3.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -130.3 146.72 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.48 130.73 35.03 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.578 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.7 p -89.9 161.48 38.32 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -71.77 -9.49 24.94 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.786 2.324 . . . . 0.0 109.85 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB1' ' HZ3' ' A' ' 16' ' ' LYS . . . -82.82 -5.93 59.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.093 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.75 -13.69 57.77 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 173.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HZ3' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -114.71 174.03 6.17 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.8 -0.823 . . . . 0.0 111.559 -178.121 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.73 153.77 20.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.163 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 152.19 27.53 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.2 mt-10 -89.46 104.43 16.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -112.96 147.98 35.99 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.72 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.38 123.14 63.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.57 132.81 28.08 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.964 1.776 . . . . 0.0 112.085 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -47.68 24.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -137.38 142.04 41.73 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.03 144.36 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.373 . . . . 0.0 110.46 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -151.71 164.2 37.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.26 39.63 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.705 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.37 102.8 12.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.63 105.54 45.67 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 13.1 Cg_exo -77.97 3.81 6.68 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.997 2.465 . . . . 0.0 112.831 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 71.67 107.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.042 1.337 . . . . 0.0 111.893 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.63 12.17 38.75 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 92.7 mtt180 -137.63 -166.7 1.99 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -80.34 154.37 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.58 103.87 2.92 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.59 98.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.18 130.03 34.69 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.105 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.39 140.54 47.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -130.11 149.02 18.77 Favored Glycine 0 N--CA 1.416 -2.636 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 tp -96.13 126.24 41.22 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 92.1 m-85 -121.25 170.34 9.68 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -122.25 119.5 31.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.578 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 17.8 t70 -64.86 135.36 96.36 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.85 -21.26 16.4 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.45 2.1 . . . . 0.0 114.575 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.32 -51.12 4.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.438 0.637 . . . . 0.0 111.61 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -86.65 -29.4 22.53 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.72 85.95 Favored Glycine 0 N--CA 1.431 -1.653 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.209 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.0 144.12 41.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.083 0.441 . . . . 0.0 110.995 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 56.5 m-85 -83.37 125.12 31.32 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -126.37 139.74 53.04 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.633 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -96.91 123.82 40.72 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -134.87 147.86 49.98 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 54.3 tttm -62.1 142.51 57.54 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 123.737 0.648 . . . . 0.0 110.122 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 30.7 mt -98.7 171.13 6.08 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.83 73.67 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.837 1.692 . . . . 0.0 109.368 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.42 -33.67 72.84 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 123.688 0.795 . . . . 0.0 110.536 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.19 5.15 51.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.309 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -77.45 123.53 86.82 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.63 120.17 6.31 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.66 2.24 . . . . 0.0 111.959 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.298 -1.655 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.157 178.338 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 39.9 pttt . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 120.948 0.404 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.71 124.64 4.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.391 2.061 . . . . 0.0 113.055 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.98 149.03 8.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.06 109.27 6.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -135.61 145.61 31.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.238 0.542 . . . . 0.0 110.534 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -89.3 134.66 33.97 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.076 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -83.63 169.09 18.4 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.541 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -70.99 -22.17 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.269 1.979 . . . . 0.0 109.095 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -51.99 66.29 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.423 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.0 -0.17 3.99 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.985 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.47 160.01 15.97 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.62 137.41 39.97 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 163.57 36.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.27 105.4 17.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.54 138.55 51.83 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.57 123.29 67.02 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.304 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.41 142.77 37.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.052 1.835 . . . . 0.0 111.65 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -69.38 -37.27 77.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.79 157.9 38.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.86 139.04 51.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 123.759 0.662 . . . . 0.0 110.054 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -141.94 154.23 44.91 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.32 124.45 32.35 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.012 0.434 . . . . 0.0 111.499 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.1 96.05 10.57 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.47 107.41 21.08 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.627 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.71 -69.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 121.792 1.662 . . . . 0.0 110.248 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -160.04 -63.9 0.07 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.26 82.96 0.8 Allowed Glycine 0 C--N 1.316 -0.559 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -170.58 154.16 4.45 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -57.82 -46.01 85.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.588 0.631 . . . . 0.0 109.366 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.18 112.8 2.66 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.99 98.43 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.99 126.98 32.59 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -129.48 137.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.93 148.16 16.68 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 tp -97.53 121.88 39.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.0 m-85 -118.72 169.57 9.72 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 123.541 0.736 . . . . 0.0 110.195 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -112.03 124.3 52.11 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 11.9 t70 -77.67 122.92 86.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.85 -2.04 12.1 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 113.844 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -97.53 -54.17 3.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.226 0.536 . . . . 0.0 110.153 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -94.72 -17.47 22.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.722 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.93 74.08 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.982 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -106.28 163.66 12.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 122.54 -0.388 . . . . 0.0 110.312 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.0 m-85 -94.62 132.05 39.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -130.82 140.5 50.27 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.012 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -139.22 150.11 45.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.42 141.61 58.47 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 123.669 0.605 . . . . 0.0 109.617 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.55 170.76 5.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -67.12 141.81 58.93 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.05 1.834 . . . . 0.0 108.77 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.21 -21.96 63.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.099 0.476 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.61 -1.67 57.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' OH ' ' HG3' ' A' ' 6' ' ' LYS . 91.8 t80 -81.35 123.24 81.45 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.8 Cg_endo -78.35 111.78 3.09 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.974 1.783 . . . . 0.0 109.888 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 C--N 1.296 -1.756 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.323 -179.054 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.0 Cg_endo -75.43 159.46 39.75 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.793 1.662 . . . . 0.0 112.586 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.4 146.87 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -69.06 109.84 4.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.34 139.16 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 121.727 0.775 . . . . 0.0 111.822 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 64.8 mttm -80.98 115.71 20.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.26 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -87.85 158.8 50.05 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.261 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 9.9 Cg_exo -71.03 -12.86 31.04 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.873 2.382 . . . . 0.0 110.702 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.91 64.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.516 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.9 9.42 24.52 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.601 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.26 26.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.706 177.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 48.2 mt-10 -94.31 121.48 35.87 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.34 138.73 52.51 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.93 105.54 14.02 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.27 151.29 39.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.381 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -100.55 127.61 32.28 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.59 143.31 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.008 1.805 . . . . 0.0 112.397 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.85 -37.55 64.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.42 149.01 28.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.91 149.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 123.57 0.544 . . . . 0.0 110.395 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -156.74 159.88 38.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.66 137.08 49.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.9 91.85 7.12 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.22 84.34 20.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.731 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -79.91 89.51 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 121.676 1.584 . . . . 0.0 111.443 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.279 19.2 ptpt 57.37 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 127.301 2.241 . . . . 0.0 116.256 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.0 70.76 0.29 Allowed Glycine 0 N--CA 1.432 -1.607 0 O-C-N 121.971 -0.456 . . . . 0.0 112.544 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -161.07 148.76 15.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.1 -39.18 91.62 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.385 0.428 . . . . 0.0 110.236 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.77 105.82 2.91 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.098 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.15 107.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.906 0.86 . . . . 0.0 109.116 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.46 131.35 34.67 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.753 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.84 140.47 48.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.94 149.49 18.83 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.32 123.47 41.15 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.0 m-85 -118.11 179.9 3.96 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.5 0.72 . . . . 0.0 110.563 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.7 tttp -128.96 113.44 15.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 10.1 t70 -65.94 133.21 94.82 Favored Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.031 0.932 . . . . 0.0 112.54 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.36 -31.37 62.53 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 123.375 2.717 . . . . 0.0 115.986 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.77 -30.69 12.64 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.615 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -104.21 -20.73 13.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.85 -2.68 67.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.661 -0.304 . . . . 0.0 113.524 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -78.35 160.74 27.65 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.934 0.397 . . . . 0.0 111.266 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 42.2 m-85 -93.0 120.63 33.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.334 176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.46 139.83 53.52 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -93.71 135.85 34.58 Favored 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.368 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -139.61 146.38 39.71 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.5 tttt -64.51 140.28 58.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 28.8 mt -96.51 176.06 2.34 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.93 140.04 53.55 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.663 1.575 . . . . 0.0 108.788 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.31 -24.11 67.12 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -108.28 15.02 24.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.112 -0.367 . . . . 0.0 111.595 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -68.8 128.81 92.76 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.27 108.0 1.28 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 123.341 2.694 . . . . 0.0 114.971 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 69.5 Cg_endo -93.85 -171.37 0.27 Allowed 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 123.117 2.545 . . . . 0.0 112.666 -175.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.45 146.0 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -71.73 110.6 6.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.37 143.07 42.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 120.836 0.35 . . . . 0.0 111.153 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 61.1 mttp -76.08 117.02 17.35 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.097 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 26.1 p -95.49 165.22 17.15 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.808 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 -23.08 73.95 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.34 2.693 . . . . 0.0 112.262 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.15 -17.05 64.68 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.31 49.38 4.98 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.557 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.22 159.99 44.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 41.6 mt-10 -106.2 111.76 24.5 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.28 150.83 41.79 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.65 104.57 15.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -115.49 138.12 51.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.527 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -90.77 123.58 64.61 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.25 139.89 62.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.087 1.858 . . . . 0.0 111.907 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -73.2 -49.46 27.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -134.94 143.73 47.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.718 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.62 145.17 31.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 O-C-N 123.505 0.503 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.32 151.92 31.48 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.49 124.32 44.14 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.194 0.521 . . . . 0.0 110.271 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.85 112.93 24.62 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.83 86.48 24.78 Favored Pre-proline 0 C--N 1.305 -1.369 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.783 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.51 149.19 23.92 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.657 2.238 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -71.49 100.53 2.25 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.24 -13.31 5.98 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.95 -176.14 3.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.89 -179.45 4.57 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.78 123.75 6.19 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.64 112.72 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 65.9 mttp -84.6 125.5 32.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.4 mt -131.09 142.14 44.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.0 148.29 18.43 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 49' ' ' TYR . 65.1 tp -98.07 126.32 43.45 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 91.2 m-85 -125.63 168.19 14.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.292 0.637 . . . . 0.0 110.567 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -120.13 114.81 22.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 15.3 t70 -58.14 132.36 84.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.893 0.877 . . . . 0.0 111.032 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.74 -19.83 30.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.935 2.423 . . . . 0.0 114.728 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.16 -54.08 3.18 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.67 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -82.71 -33.1 27.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.13 18.19 59.72 Favored Glycine 0 N--CA 1.426 -1.98 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.837 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.86 161.42 13.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.388 0.594 . . . . 0.0 110.755 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 61.9 m-85 -89.45 133.12 34.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.647 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.77 139.74 42.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -100.48 125.76 46.82 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -136.73 145.19 44.37 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.2 tttt -60.94 144.01 53.98 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.549 0.531 . . . . 0.0 109.958 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.3 mt -101.37 170.58 6.33 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.73 141.17 71.03 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.701 1.601 . . . . 0.0 109.319 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.43 -30.58 63.0 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.547 0.739 . . . . 0.0 112.37 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.71 18.7 21.53 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 77.3 t80 -78.84 128.31 77.2 Favored Pre-proline 0 C--N 1.316 -0.859 0 O-C-N 122.458 -0.151 . . . . 0.0 110.774 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.64 119.97 6.74 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 122.307 2.005 . . . . 0.0 111.442 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.727 179.646 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 95.6 mttt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -90.34 156.82 4.56 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.954 2.436 . . . . 0.0 112.507 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.4 154.92 22.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.18 115.83 14.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.11 138.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-O 121.17 0.51 . . . . 0.0 109.678 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -91.15 118.69 30.64 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.674 0.749 . . . . 0.0 109.16 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -69.5 161.02 76.86 Favored Pre-proline 0 C--N 1.281 -2.373 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.712 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.99 -19.49 57.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.76 2.307 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.86 -25.02 60.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.42 -13.42 12.2 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.5 -0.857 . . . . 0.0 114.715 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -88.7 147.28 24.58 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.155 0.977 . . . . 0.0 110.995 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.35 121.8 34.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.09 158.25 44.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -94.87 105.47 17.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.85 153.97 41.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.827 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -107.25 128.52 25.85 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.885 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 34.7 Cg_endo -68.18 137.84 41.65 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.804 1.669 . . . . 0.0 112.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.43 -44.5 44.11 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.293 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -137.51 146.69 44.49 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.38 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.11 144.65 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 O-C-N 123.654 0.596 . . . . 0.0 109.878 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -152.73 155.58 37.48 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.28 134.12 55.33 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.96 0.409 . . . . 0.0 111.35 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.49 120.67 41.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . . . -98.91 122.34 53.04 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.859 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 3.3 Cg_endo -86.13 61.77 4.95 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.752 2.302 . . . . 0.0 109.505 173.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 64.15 53.53 1.78 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.763 1.225 . . . . 0.0 110.462 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.07 -118.6 6.01 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.392 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 70.97 -66.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 110.734 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 179.55 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.79 132.5 4.14 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.99 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.62 118.6 33.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.03 125.41 41.46 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.9 mt -124.56 136.94 58.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.76 148.27 16.71 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 49' ' ' TYR . 57.3 tp -98.85 125.82 44.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 89.6 m-85 -120.25 168.85 10.82 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 123.201 0.601 . . . . 0.0 109.907 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -131.9 120.0 21.93 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.62 124.23 83.79 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 -14.75 25.03 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.772 2.315 . . . . 0.0 113.721 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.34 -46.83 7.18 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.734 0.302 . . . . 0.0 111.28 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 p -82.84 -36.8 25.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.485 0.66 . . . . 0.0 109.268 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 25.62 24.56 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.213 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -124.44 162.68 23.4 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.672 0.736 . . . . 0.0 111.491 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 40' ' ' LEU . 59.8 m-85 -91.64 142.99 27.02 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.212 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.93 139.92 25.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -94.92 141.53 28.54 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -146.95 149.0 32.32 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.264 0.0 OUTLIER -78.25 145.03 35.69 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.073 -179.966 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.6 mt -96.64 172.92 4.56 Favored Pre-proline 0 C--N 1.276 -2.598 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.51 142.88 66.86 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.449 1.433 . . . . 0.0 109.275 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.02 -24.32 67.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 0.0 111.288 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.32 -12.91 45.09 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.5 t80 -64.62 121.15 71.44 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.504 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 7.2 Cg_endo -79.08 107.78 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.157 1.904 . . . . 0.0 112.587 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 N--CA 1.426 -1.637 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.827 177.834 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 pttm . . . . . 0 C--O 1.236 0.383 0 CA-C-O 119.834 -0.127 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 12.1 Cg_endo -58.47 141.06 96.91 Favored 'Trans proline' 0 C--O 1.256 1.378 0 C-N-CA 122.957 2.438 . . . . 0.0 113.989 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.17 150.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.24 109.13 8.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.55 153.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.619 -173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 16.3 ptpt -88.22 134.22 33.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -102.2 172.61 4.2 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.664 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.79 -10.44 27.73 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.962 2.441 . . . . 0.0 111.841 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.48 -5.79 51.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.08 33.59 28.94 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.944 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.79 168.55 19.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 11' ' ' LYS . 42.6 mt-10 -120.26 130.75 54.64 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 165.11 32.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.38 110.7 21.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.204 0.526 . . . . 0.0 109.889 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 79.3 mt -122.16 152.21 40.18 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.721 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.34 124.5 42.74 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.23 131.69 21.09 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 121.779 1.653 . . . . 0.0 110.323 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.95 -34.34 66.46 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.801 0.81 . . . . 0.0 109.175 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -144.66 144.17 31.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 139.79 50.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.707 0.629 . . . . 0.0 109.798 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -147.28 148.01 30.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 110.861 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.21 129.99 53.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.891 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.08 89.49 3.08 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.82 84.41 25.44 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.837 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 33' ' ' ARG . 6.2 Cg_exo -75.68 125.68 9.03 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.115 1.877 . . . . 0.0 108.194 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.92 106.16 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.32 -12.75 8.42 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 mpt_? -105.45 -173.22 2.25 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.505 -0.409 . . . . 0.0 111.328 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -70.6 -50.05 41.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.14 103.42 1.6 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.24 165.07 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.188 0.518 . . . . 0.0 111.798 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -117.82 140.24 49.97 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -131.14 138.7 52.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.74 145.34 15.86 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 50.2 tp -94.2 121.95 36.24 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.1 m-85 -114.4 172.76 6.82 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -130.63 116.42 18.06 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.72 130.5 88.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.0 -24.76 28.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.436 2.091 . . . . 0.0 114.762 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -97.45 -37.85 9.83 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 34.7 p -87.03 -36.87 17.96 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.38 -0.54 71.52 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.471 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 21.8 ptmt -85.22 143.92 28.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.326 0.584 . . . . 0.0 111.607 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.8 m-85 -83.98 129.14 34.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.97 174.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -133.58 139.69 46.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 31.6 ptt180 -93.21 133.12 36.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -136.71 148.55 47.39 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.99 139.05 58.72 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 123.936 0.772 . . . . 0.0 109.675 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.2 mt -101.93 170.59 6.24 Favored Pre-proline 0 C--N 1.293 -1.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.34 147.19 77.54 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.515 2.144 . . . . 0.0 109.939 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.32 -33.33 75.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.129 0.49 . . . . 0.0 111.144 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 7.91 31.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.919 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -84.12 115.86 62.1 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.84 117.23 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.408 2.072 . . . . 0.0 113.115 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 C--N 1.3 -1.567 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.176 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttp . . . . . 0 N--CA 1.436 -1.157 0 CA-C-O 120.988 0.423 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 46.0 Cg_endo -73.53 158.73 47.33 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.938 1.759 . . . . 0.0 111.882 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.72 151.21 34.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.99 109.47 8.47 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.62 149.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.252 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -85.85 128.36 34.8 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.597 0.713 . . . . 0.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 170.57 14.55 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.592 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 23.9 Cg_exo -66.72 -16.79 51.39 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.618 2.212 . . . . 0.0 110.788 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.34 -21.02 58.7 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.393 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.04 12.75 48.48 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.685 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.26 166.62 11.65 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.82 137.81 31.98 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.461 0.476 . . . . 0.0 110.581 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.09 154.53 21.79 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 105.36 17.76 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.556 0.693 . . . . 0.0 109.179 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.1 139.18 43.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.42 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -91.8 118.22 68.17 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.26 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.29 136.47 24.28 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.962 2.442 . . . . 0.0 113.408 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.4 -41.23 18.38 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.576 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HB2' ' HZ3' ' A' ' 26' ' ' TRP . 28.9 mtpp -129.1 143.77 50.97 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.28 137.96 50.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.447 ' HZ3' ' HB2' ' A' ' 24' ' ' LYS . 27.2 p90 -151.29 164.42 36.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.74 132.71 35.19 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.134 0.492 . . . . 0.0 110.92 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.88 95.56 9.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.17 103.24 14.09 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.61 -56.44 1.01 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.386 2.057 . . . . 0.0 111.083 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -169.85 -64.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.57 47.86 2.33 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -141.65 152.92 44.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -64.61 -33.99 77.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.088 0.867 . . . . 0.0 110.18 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.9 130.85 6.75 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.457 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.28 105.91 16.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -83.59 132.37 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.2 mt -135.64 144.11 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.74 150.95 19.84 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.7 123.38 42.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.36 168.04 11.7 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.293 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -128.23 120.97 28.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 15.3 t70 -76.61 123.74 87.7 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 -20.53 21.58 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 C-N-CA 122.332 2.021 . . . . 0.0 113.742 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.55 -45.56 8.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.964 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -82.82 -31.12 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.433 0.635 . . . . 0.0 109.515 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.28 67.34 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.867 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -90.98 154.32 19.53 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -91.14 132.13 36.26 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.962 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -135.89 139.92 43.71 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -95.81 126.39 41.04 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -130.58 144.19 51.25 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -172.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -65.98 144.04 57.0 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.693 0.62 . . . . 0.0 109.448 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.97 168.66 8.49 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.05 145.03 72.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.592 2.195 . . . . 0.0 109.16 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.25 -41.92 72.8 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -88.96 5.31 44.75 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.54 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.5 t80 -73.88 125.18 90.51 Favored Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 121.844 -0.535 . . . . 0.0 110.047 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.2 Cg_exo -76.06 113.58 3.73 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 122.318 2.012 . . . . 0.0 110.363 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.296 -1.719 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.754 0.312 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -81.08 157.26 20.28 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 121.846 1.697 . . . . 0.0 111.609 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.2 p -141.69 148.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HG2' ' OE2' ' A' ' 19' ' ' GLU . 62.2 mttm -71.52 111.51 6.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.63 138.03 55.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 121.03 0.443 . . . . 0.0 109.817 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 123.69 29.87 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 p -92.91 165.69 18.18 Favored Pre-proline 0 N--CA 1.418 -2.054 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.32 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.3 -27.01 82.62 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.051 2.5 . . . . 0.0 112.445 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.27 -25.79 63.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.652 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.62 -12.29 8.33 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.113 -1.518 . . . . 0.0 115.085 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -100.66 154.44 18.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 118.253 1.026 . . . . 0.0 110.211 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.47 106.06 14.11 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.43 165.05 18.43 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.23 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.2 mp0 -82.82 104.77 13.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.118 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.22 157.12 20.47 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.86 129.03 24.39 Favored Pre-proline 0 N--CA 1.403 -2.818 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.071 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.13 123.56 7.9 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.775 1.65 . . . . 0.0 111.351 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.52 -35.22 65.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.35 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -134.52 136.92 43.44 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 139.05 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.36 0.412 . . . . 0.0 110.4 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.53 155.39 40.25 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.74 136.51 53.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.58 0.705 . . . . 0.0 111.057 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.6 mp -108.01 100.02 9.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.81 96.34 16.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 123.243 0.34 . . . . 0.0 110.676 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 6.2 Cg_exo -80.7 155.4 20.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.523 2.149 . . . . 0.0 109.848 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.85 127.86 33.79 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.064 0.459 . . . . 0.0 110.111 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' HD2' ' A' ' 33' ' ' ARG . . . 99.36 -15.48 60.1 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.231 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 32' ' ' GLY . 6.1 mpt_? -117.46 159.06 23.42 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.324 -0.515 . . . . 0.0 110.485 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.26 -33.3 73.03 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.467 0.479 . . . . 0.0 111.19 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.85 163.07 22.23 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.74 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.28 156.75 40.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.42 137.64 51.23 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 71.9 mt -134.04 141.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.83 150.65 19.38 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.8 tp -94.8 124.99 39.16 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.14 -179.86 4.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.246 1.018 . . . . 0.0 109.162 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 49' ' ' TYR . 84.0 tttt -134.05 132.09 39.61 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.76 121.34 82.26 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.99 -9.8 20.95 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.262 1.975 . . . . 0.0 114.851 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -99.13 -41.44 7.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.105 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -92.21 -25.95 18.42 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.982 0.42 . . . . 0.0 111.088 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.64 36.46 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.065 -0.516 . . . . 0.0 113.266 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -119.85 145.23 46.85 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.642 -0.328 . . . . 0.0 110.259 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 46.0 m-85 -80.55 138.53 36.51 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.3 140.2 33.78 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -93.54 137.82 32.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -142.51 147.03 35.34 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.5 ptpt -68.94 144.53 54.14 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.179 0.514 . . . . 0.0 110.428 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.66 169.16 7.86 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 24.6 Cg_exo -67.1 151.28 81.85 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.704 2.269 . . . . 0.0 109.895 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.22 -36.16 83.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.75 6.99 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.003 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.405 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 88.6 t80 -84.69 122.85 74.77 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.47 -0.769 . . . . 0.0 109.986 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.87 98.59 1.22 Allowed 'Trans proline' 0 N--CA 1.437 -1.794 0 C-N-CA 122.444 2.096 . . . . 0.0 111.916 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.2 pt . . . . . 0 N--CA 1.423 -1.79 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.002 179.463 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -78.81 141.95 17.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.945 1.764 . . . . 0.0 111.203 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 14.6 p -120.96 149.82 23.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 60.6 mttp -75.07 108.82 8.06 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.24 141.0 47.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.162 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -78.54 115.64 18.39 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.52 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.596 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 76.6 p -83.49 165.03 42.5 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.11 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.52 -17.4 57.21 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.436 2.091 . . . . 0.0 111.18 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.28 -17.97 61.26 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.674 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.4 31.24 6.55 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 114.772 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.64 38.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.601 0.701 . . . . 0.0 109.932 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 9' ' ' LYS . 36.7 tt0 -91.84 93.57 8.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.942 0.877 . . . . 0.0 109.563 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.29 160.28 14.82 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.535 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 52.3 mt-10 -92.29 105.61 17.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.462 0.649 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.1 mt -117.54 141.89 47.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.136 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.9 p -95.63 125.08 50.69 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 12.5 Cg_exo -66.6 141.17 59.53 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.145 1.896 . . . . 0.0 114.088 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.22 -47.12 65.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -142.26 144.32 33.25 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.527 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 m -124.99 152.73 31.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -157.36 153.48 27.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.074 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.96 125.05 42.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.239 0.542 . . . . 0.0 110.761 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 5.2 mp -89.43 87.16 6.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 98.85 8.96 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.43 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.77 -66.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.646 1.564 . . . . 0.0 108.501 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 175.39 148.19 0.09 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.26 -5.6 79.67 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -105.85 150.18 25.83 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -57.88 -39.1 77.03 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.298 0.374 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.48 95.34 2.21 Favored Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 28' ' ' LEU . 24.5 t -82.19 104.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -89.69 126.23 35.57 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.502 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.6 mt -129.19 142.72 43.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.86 147.66 18.49 Favored Glycine 0 N--CA 1.422 -2.294 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.35 125.37 40.8 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 95.0 m-85 -123.23 173.98 7.57 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 122.979 0.511 . . . . 0.0 109.972 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -125.34 125.3 43.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.596 ' OD2' ' HB ' ' A' ' 12' ' ' THR . 9.0 t70 -78.38 120.03 79.56 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.5 -12.37 27.06 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.728 2.285 . . . . 0.0 115.022 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.07 -34.38 10.8 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.907 -0.496 . . . . 0.0 112.053 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -93.77 -34.41 13.21 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.29 0.567 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.69 30.83 22.93 Favored Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.373 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.94 151.34 43.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.0 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 78.3 m-85 -87.83 129.81 35.08 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.971 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -134.59 139.33 45.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -95.23 131.68 41.02 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -139.07 149.96 45.19 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.22 142.02 57.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.5 mt -97.85 -179.82 0.95 Allowed Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.12 137.87 59.02 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.579 1.519 . . . . 0.0 108.162 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.11 -20.28 57.48 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.392 0.677 . . . . 0.0 112.625 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -112.26 11.62 20.2 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.632 0.73 . . . . 0.0 111.01 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 8' ' ' VAL . 13.8 t80 -67.09 127.72 93.6 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.35 92.36 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.308 2.005 . . . . 0.0 113.535 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.202 177.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tttp . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -80.01 159.63 23.97 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.514 1.476 . . . . 0.0 112.342 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.2 p -140.87 150.52 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -72.1 109.32 5.81 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -125.22 137.68 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 121.658 0.742 . . . . 0.0 109.859 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -83.6 119.81 25.2 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.4 p -92.18 155.64 42.64 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.8 -16.09 33.21 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.905 2.404 . . . . 0.0 110.476 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.24 72.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.343 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.3 -18.47 4.42 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.016 -1.087 . . . . 0.0 114.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 173.51 6.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 118.102 0.951 . . . . 0.0 112.141 -174.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.38 126.16 32.97 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.31 144.89 50.89 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.7 mt-10 -94.74 104.42 16.33 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.99 141.5 48.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.854 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -90.35 121.72 68.19 Favored Pre-proline 0 N--CA 1.416 -2.151 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.36 134.69 60.32 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.168 1.912 . . . . 0.0 111.448 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.62 -32.43 64.06 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.276 1.03 . . . . 0.0 108.633 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -153.02 138.74 17.89 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.74 144.86 31.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -153.9 160.66 42.23 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.68 130.62 30.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.25 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.11 97.05 8.21 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.76 97.71 32.56 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.79 -64.78 0.08 OUTLIER 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.612 2.208 . . . . 0.0 111.794 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.3 tttm 169.69 119.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.531 1.132 . . . . 0.0 108.963 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.26 43.73 89.31 Favored Glycine 0 C--O 1.246 0.886 0 CA-C-O 121.79 0.661 . . . . 0.0 111.93 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -140.21 176.2 8.96 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -70.21 107.83 3.88 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.55 89.84 0.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.63 100.47 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.252 1.025 . . . . 0.0 112.167 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.59 127.55 32.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.109 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 54.9 mt -128.86 139.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.95 145.75 15.93 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -93.9 126.18 38.96 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.31 178.46 4.52 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -129.71 125.44 35.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 11.0 t70 -63.66 127.78 91.89 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 124.074 0.859 . . . . 0.0 109.375 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 26.1 Cg_exo -63.31 -40.86 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.463 2.109 . . . . 0.0 114.183 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -88.44 -48.93 7.26 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -90.52 -19.93 23.24 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.06 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.95 0.54 89.72 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 115.003 0.761 . . . . 0.0 115.003 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -73.87 138.81 44.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 117.011 0.405 . . . . 0.0 111.272 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -81.45 121.29 26.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -126.32 139.44 53.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -96.02 134.03 39.54 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -137.33 139.95 41.17 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.21 139.19 52.24 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.035 178.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.71 173.12 6.83 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -66.61 140.0 55.23 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 N-CA-C 107.788 -1.658 . . . . 0.0 107.788 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.23 -28.31 68.63 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.34 -4.94 57.18 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.801 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -79.27 122.07 83.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -82.39 112.31 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.428 2.086 . . . . 0.0 111.658 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--N 1.298 -1.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.103 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.436 -1.165 0 CA-C-O 121.044 0.45 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.89 123.94 3.33 Favored 'Trans proline' 0 N--CA 1.425 -2.538 0 C-N-CA 121.585 1.524 . . . . 0.0 110.645 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -104.83 148.39 9.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -81.13 109.65 15.89 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.19 153.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 -172.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 54.1 mttp -86.09 135.47 33.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.032 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.7 p -88.75 170.45 11.08 Favored Pre-proline 0 N--CA 1.425 -1.676 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.06 -13.62 28.75 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.315 2.01 . . . . 0.0 112.526 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.65 -6.76 58.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.919 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.4 15.1 62.69 Favored Glycine 0 C--N 1.328 0.123 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 49.9 mtpt -98.02 163.92 12.56 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -129.41 125.64 37.0 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.727 -176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.77 164.58 36.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.32 121.57 28.25 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.35 137.89 52.89 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.22 126.15 61.61 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.99 141.02 68.67 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.11 1.873 . . . . 0.0 113.159 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG3' ' CE2' ' A' ' 49' ' ' TYR . 20.4 mm-40 -72.78 -45.61 57.64 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.919 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -139.63 148.7 42.83 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -131.83 143.5 40.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 O-C-N 123.406 0.441 . . . . 0.0 109.942 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -149.61 156.05 41.28 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.726 0.298 . . . . 0.0 110.62 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.67 125.2 33.36 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.676 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.78 92.84 7.31 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -137.6 87.74 17.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.083 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.19 -41.2 80.88 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.014 2.476 . . . . 0.0 110.685 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -171.68 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.29 92.98 0.31 Allowed Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -153.43 37.66 0.48 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 70.72 -55.04 0.64 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.017 1.727 . . . . 0.0 111.315 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 29' ' ' ALA . . . 103.96 72.74 0.91 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -74.69 114.44 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -96.89 130.7 44.15 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.8 mt -133.64 142.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.55 146.16 16.66 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp -96.19 128.14 42.83 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.74 169.54 10.02 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.977 0.418 . . . . 0.0 110.5 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -122.28 116.82 24.76 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.95 123.23 39.01 Favored Pre-proline 0 C--N 1.316 -0.881 0 C-N-CA 125.256 1.422 . . . . 0.0 109.689 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.79 -26.13 52.8 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.964 2.443 . . . . 0.0 114.087 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.05 -48.19 4.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -94.79 -13.14 25.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.405 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.25 18.67 79.12 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.862 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.97 148.04 22.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.886 0.343 . . . . 0.0 111.384 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.478 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 19.9 m-85 -87.86 128.4 35.35 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.14 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -136.47 140.45 43.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -97.88 132.34 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.246 0.546 . . . . 0.0 110.37 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -138.5 141.1 39.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.8 ptmt -70.89 149.24 46.96 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 118.01 -1.476 . . . . 0.0 109.86 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 28.9 mt -94.6 175.29 3.0 Favored Pre-proline 0 C--N 1.28 -2.431 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.96 141.65 59.16 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 N-CA-C 108.177 -1.509 . . . . 0.0 108.177 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -66.87 -23.06 65.97 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.482 0.658 . . . . 0.0 110.243 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -88.34 -5.25 58.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.413 1.485 . . . . 0.0 111.732 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.29 136.76 81.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.9 115.69 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.434 2.089 . . . . 0.0 114.538 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.925 173.271 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 88.0 tttt . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -75.49 131.85 14.17 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.453 1.435 . . . . 0.0 112.167 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.39 147.55 19.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.135 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -69.05 108.63 3.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 151.72 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 121.497 0.665 . . . . 0.0 111.624 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.46 141.17 28.89 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.252 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.0 p -93.14 171.69 6.97 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.67 -12.88 35.83 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.1 1.867 . . . . 0.0 111.581 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.16 -20.75 47.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.148 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.66 -16.7 36.96 Favored Glycine 0 C--O 1.242 0.635 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.906 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.76 158.14 21.85 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -112.17 145.04 40.56 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.48 154.87 32.5 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.47 104.88 17.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -117.04 148.23 41.67 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.498 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -96.18 125.97 45.98 Favored Pre-proline 0 N--CA 1.426 -1.66 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 56.9 Cg_endo -74.85 142.07 27.9 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.99 1.793 . . . . 0.0 111.871 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.33 -40.73 64.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.353 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -145.85 147.34 31.71 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.856 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.29 144.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -146.5 155.98 42.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.06 32.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.132 0.491 . . . . 0.0 110.719 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.81 85.85 2.47 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.7 94.85 24.43 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.12 136.62 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.721 1.614 . . . . 0.0 108.413 170.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -60.86 113.63 2.61 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.108 0.48 . . . . 0.0 111.933 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 2.01 56.07 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.138 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -116.47 -72.83 0.67 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -142.25 174.66 10.41 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 120.679 0.276 . . . . 0.0 111.15 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.54 42.28 0.89 Allowed Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.16 149.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.352 0.596 . . . . 0.0 110.826 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -127.65 144.58 51.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.8 mt -136.11 143.82 34.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.57 148.9 19.16 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.2 tp -98.22 122.72 41.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.53 173.41 6.85 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.038 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -134.64 125.77 27.82 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.54 128.5 77.3 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.54 -12.8 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.085 2.523 . . . . 0.0 114.254 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -97.68 -52.62 3.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.26 0.552 . . . . 0.0 111.69 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 45.0 p -82.79 -35.14 26.74 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.379 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.25 62.4 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.025 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.9 ptpt -88.29 150.0 23.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.265 0.555 . . . . 0.0 111.87 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -95.15 136.5 35.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -143.93 139.92 29.41 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.98 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -100.38 119.92 39.18 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 121.38 0.609 . . . . 0.0 109.77 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -127.49 144.28 51.08 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -68.58 141.48 55.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.611 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 mt -93.95 172.15 6.13 Favored Pre-proline 0 C--N 1.284 -2.272 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.92 140.48 55.15 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.526 1.484 . . . . 0.0 108.412 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.05 -26.72 68.97 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.36 0.6 . . . . 0.0 109.775 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.12 0.26 56.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.779 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 66.1 t80 -80.31 126.68 78.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.6 Cg_exo -76.96 107.88 2.53 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.145 1.897 . . . . 0.0 112.54 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.0 pt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 54.3 mtmt . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -84.55 120.03 2.38 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.328 2.019 . . . . 0.0 111.611 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.8 p -103.91 145.46 12.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.162 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.94 108.45 7.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -130.48 149.52 33.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.05 124.39 28.24 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.741 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.423 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 30.4 p -76.41 169.17 22.24 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.51 -24.38 36.22 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.266 1.978 . . . . 0.0 110.148 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.53 85.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.589 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.61 31.37 1.25 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.463 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.53 160.01 41.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.331 0.565 . . . . 0.0 109.772 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.202 0.525 . . . . 0.0 111.505 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.23 146.96 52.37 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -89.87 105.3 17.71 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.99 0.9 . . . . 0.0 108.952 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.01 141.74 48.42 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.535 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.97 121.87 68.39 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 30.8 Cg_endo -66.44 134.72 36.83 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.073 1.849 . . . . 0.0 112.28 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -61.27 -48.98 78.93 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -145.89 153.98 41.45 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.648 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.94 152.0 30.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 O-C-N 123.628 0.58 . . . . 0.0 110.544 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -155.53 168.37 27.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.256 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.56 139.79 36.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.006 0.431 . . . . 0.0 110.758 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 94.56 4.91 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 91.82 40.06 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.006 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.73 173.67 10.19 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.43 2.087 . . . . 0.0 108.621 172.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.39 139.62 51.92 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.682 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.21 32.4 25.87 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.741 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -156.37 154.12 30.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -69.93 -45.75 66.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.82 117.94 2.21 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.921 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.15 119.93 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 121.42 0.629 . . . . 0.0 110.078 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.04 136.5 35.29 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.4 mt -133.14 140.11 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.07 149.6 18.58 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 tp -96.14 125.51 40.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -122.88 175.07 6.76 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -133.4 122.93 24.47 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.3 t70 -78.74 125.72 83.75 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 3.2 Cg_exo -80.13 -8.34 14.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.247 1.965 . . . . 0.0 113.354 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.44 -40.74 8.54 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -90.29 -34.16 15.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.346 0.593 . . . . 0.0 109.577 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.79 22.78 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.704 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -118.89 144.24 46.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.912 0.356 . . . . 0.0 111.6 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.68 124.65 29.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.725 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -135.4 140.05 44.66 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -92.76 138.83 31.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -144.43 147.91 33.93 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.46 146.52 50.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.647 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.07 168.98 8.2 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.89 143.47 66.75 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.919 1.746 . . . . 0.0 108.908 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.05 -15.25 61.51 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.842 -0.536 . . . . 0.0 110.868 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.25 -1.82 57.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.597 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 89.0 t80 -81.7 133.83 51.68 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 122.761 0.424 . . . . 0.0 111.059 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.4 Cg_exo -78.95 106.19 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.572 2.182 . . . . 0.0 112.256 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.665 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 82.2 mttt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HB2' ' HG2' ' A' ' 19' ' ' GLU . 47.2 Cg_endo -71.67 138.91 32.9 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.104 1.869 . . . . 0.0 112.914 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.06 143.09 41.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 27.6 mtmm -74.43 108.51 7.25 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.15 144.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.112 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -75.52 115.67 15.43 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.297 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.2 p -83.85 162.75 51.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.957 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.47 -18.03 44.25 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.419 2.746 . . . . 0.0 114.782 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.04 -5.52 59.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.884 0.373 . . . . 0.0 111.803 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.41 9.54 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.568 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -140.33 166.25 25.2 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -113.65 147.51 37.99 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.212 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 146.7 28.67 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 7' ' ' PRO . 31.1 tt0 -92.32 105.89 18.0 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.56 145.56 48.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.296 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.82 128.37 46.25 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.09 144.7 93.07 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.453 2.102 . . . . 0.0 113.789 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.03 -42.51 23.64 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.726 1.211 . . . . 0.0 109.447 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -145.31 141.4 28.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.43 139.97 49.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 123.31 0.381 . . . . 0.0 110.009 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -146.33 158.2 43.86 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.95 125.78 38.22 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.3 mp -79.73 89.6 5.19 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.76 116.6 34.53 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.662 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.28 -48.85 12.33 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.695 1.597 . . . . 0.0 107.986 172.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp 177.92 -64.52 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.044 -1.435 . . . . 0.0 108.197 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.59 103.77 2.09 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.5 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -169.91 -79.23 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -172.11 -56.13 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.071 1.749 . . . . 0.0 106.693 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 112.56 2.34 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.564 -1.815 . . . . 0.0 108.564 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' A' ' 53' ' ' LYS . 59.4 t -75.33 105.42 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -80.68 125.93 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.534 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.0 mt -132.26 139.36 50.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.1 147.39 17.3 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 58.5 tp -94.9 130.01 41.68 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.5 m-85 -124.89 176.4 6.66 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 122.917 0.487 . . . . 0.0 110.084 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -130.58 115.84 17.31 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.61 126.02 92.01 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 -20.47 25.38 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 122.196 1.931 . . . . 0.0 113.39 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -60.46 2.1 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 39.8 p -82.52 -32.05 28.89 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.04 -3.88 62.45 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.113 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.3 ptpt -80.98 153.63 27.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 10.2 m-85 -90.9 125.37 35.74 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.138 177.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.69 139.78 47.83 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 39.4 ptt180 -94.06 138.3 32.29 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -143.99 144.51 31.71 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HE2' HG13 ' A' ' 36' ' ' VAL . 61.1 tttm -62.53 142.94 57.73 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.655 0.597 . . . . 0.0 109.761 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 25.5 mt -102.39 172.14 4.62 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -67.01 139.77 52.25 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.093 1.862 . . . . 0.0 107.708 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -74.84 -11.17 60.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.718 -0.614 . . . . 0.0 110.382 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -95.39 0.52 53.57 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.714 1.205 . . . . 0.0 110.448 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.423 ' OH ' ' HB2' ' A' ' 6' ' ' LYS . 77.4 t80 -80.75 119.49 76.33 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.36 104.71 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.487 2.125 . . . . 0.0 112.444 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.56 -179.728 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 7.9 tmtt? . . . . . 0 N--CA 1.414 -2.243 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -83.28 149.25 13.26 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.946 1.764 . . . . 0.0 112.373 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.0 p -121.52 144.92 29.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -73.57 108.39 6.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.8 p -121.28 141.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.05 -174.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.93 117.26 19.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 46.0 p -85.96 169.01 16.74 Favored Pre-proline 0 C--N 1.286 -2.191 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 31.2 Cg_exo -63.16 -22.26 72.82 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.143 2.562 . . . . 0.0 111.079 174.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.8 -14.75 62.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.51 4.74 62.12 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.17 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -115.64 161.09 19.16 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.496 -0.414 . . . . 0.0 110.049 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 52.6 mt-10 -102.29 135.57 43.66 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.132 0.492 . . . . 0.0 110.521 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.5 45.26 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.9 mt-10 -89.85 105.22 17.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.98 138.14 51.76 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.961 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.59 121.75 62.44 Favored Pre-proline 0 N--CA 1.415 -2.213 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.11 140.55 90.11 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.472 2.114 . . . . 0.0 113.013 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.2 -43.65 77.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.276 1.036 . . . . 0.0 109.005 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.32 138.34 38.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.201 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.06 144.41 32.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.191 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -152.2 161.84 42.02 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.57 128.16 32.69 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.248 0.547 . . . . 0.0 111.497 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -93.54 94.79 8.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.887 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.83 110.35 63.61 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.3 -69.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.19 1.926 . . . . 0.0 111.505 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -164.4 115.47 1.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.884 0.473 . . . . 0.0 110.153 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.16 45.34 96.24 Favored Glycine 0 C--N 1.318 -0.469 0 O-C-N 123.505 0.503 . . . . 0.0 112.724 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.536 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -127.07 167.4 16.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.83 -34.95 76.34 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.31 120.67 4.77 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.245 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.6 t -76.08 103.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -86.83 137.02 32.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.224 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 60.5 mt -136.38 141.47 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 147.32 18.37 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.5 tp -95.76 124.12 39.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -118.97 170.1 9.32 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.697 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -117.21 125.99 52.05 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.584 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 16.0 t70 -69.56 132.54 89.26 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.9 -12.52 10.84 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.118 1.879 . . . . 0.0 114.185 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -97.48 -51.02 4.29 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.367 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 p -88.27 -37.28 16.16 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.899 0.479 . . . . 0.0 110.522 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -4.98 55.15 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.513 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -81.44 151.95 27.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.175 0.487 . . . . 0.0 111.641 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -89.63 125.33 35.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.184 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -127.25 140.66 52.07 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -101.4 136.6 40.96 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.63 143.82 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.47 139.54 51.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.79 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.67 174.78 3.53 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.62 141.46 73.11 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 N-CA-C 108.183 -1.507 . . . . 0.0 108.183 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -26.05 68.39 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.226 0.536 . . . . 0.0 110.998 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.11 12.19 37.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.194 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -72.8 128.08 88.72 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.16 103.34 1.73 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.647 1.565 . . . . 0.0 113.397 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.739 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 pttp . . . . . 0 N--CA 1.431 -1.421 0 CA-C-O 121.441 0.639 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.32 143.65 14.03 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.407 2.072 . . . . 0.0 110.995 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.12 135.69 37.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -70.43 109.31 4.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -127.77 145.94 34.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.554 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 67.4 mttm -78.06 124.47 28.07 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -81.63 163.12 55.57 Favored Pre-proline 0 C--N 1.282 -2.333 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 -7.1 20.49 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.482 2.122 . . . . 0.0 111.404 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.89 -32.37 20.24 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.177 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.96 -39.44 1.66 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.808 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -71.67 164.91 25.06 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 120.844 0.354 . . . . 0.0 110.379 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 33.2 mt-10 -115.77 129.25 56.38 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.48 147.49 37.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.178 0.299 . . . . 0.0 110.209 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.53 105.26 11.64 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.61 138.14 51.65 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.948 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.39 122.08 63.72 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.86 146.41 77.96 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.89 2.393 . . . . 0.0 113.39 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -67.0 -45.94 76.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.45 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -149.63 152.55 35.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.598 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.68 151.14 33.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 123.576 0.547 . . . . 0.0 110.465 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -148.72 161.4 41.85 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.133 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.53 137.31 40.14 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.857 0.36 . . . . 0.0 111.289 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.47 119.98 41.09 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.12 90.91 47.7 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.21 105.55 2.1 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 122.708 2.272 . . . . 0.0 112.233 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 70.08 -64.08 0.37 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.682 1.593 . . . . 0.0 112.124 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.03 111.44 0.49 Allowed Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -159.95 163.8 33.9 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -79.3 -9.8 59.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.061 0.934 . . . . 0.0 108.712 176.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 100.12 108.14 2.96 Favored Glycine 0 N--CA 1.418 -2.563 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.834 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.99 112.44 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 60.0 mttp -99.1 136.3 39.26 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.847 -171.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -132.33 136.77 55.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.75 146.43 16.2 Favored Glycine 0 N--CA 1.422 -2.233 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.2 tp -96.6 123.68 40.35 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.79 174.17 6.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.664 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -132.41 127.56 35.65 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.0 t70 -86.93 116.34 65.69 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 11.3 Cg_exo -72.34 -8.68 23.11 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.006 2.471 . . . . 0.0 113.108 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.3 -53.57 4.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.507 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.3 p -84.68 -30.73 24.58 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.225 0.536 . . . . 0.0 111.1 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.71 30.62 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.177 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -123.53 152.0 42.26 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.789 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.22 135.51 33.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -137.06 139.86 41.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -99.37 129.57 45.58 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -134.37 147.48 50.53 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 38.7 ttmt -66.83 140.77 57.83 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mt -101.51 172.4 4.47 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -67.17 139.52 50.74 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.607 1.538 . . . . 0.0 109.641 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.45 -30.48 68.54 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.098 0.475 . . . . 0.0 110.539 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.31 -1.09 57.2 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.895 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -74.76 126.65 88.25 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 121.599 -0.688 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.86 120.99 6.01 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 112.581 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.131 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 tttp . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 14.0 Cg_endo -72.35 141.91 36.24 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.597 1.532 . . . . 0.0 110.134 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 141.8 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.82 109.08 5.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.12 146.27 31.07 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.847 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -79.08 120.7 24.0 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.573 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.0 p -78.48 161.3 70.29 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.063 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.66 -15.99 37.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.487 2.125 . . . . 0.0 110.194 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.41 -51.28 24.84 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.893 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.8 -17.09 2.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.93 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -92.24 168.3 11.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -110.71 130.69 55.51 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.912 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.26 152.46 51.54 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.96 104.74 16.57 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.62 141.93 44.58 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.9 p -93.13 125.55 54.33 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.96 116.86 3.94 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 121.403 1.402 . . . . 0.0 110.525 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.81 -17.61 62.14 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.247 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -152.76 140.26 19.71 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.46 138.95 52.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 123.27 0.356 . . . . 0.0 110.421 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -152.24 154.32 35.51 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.4 137.92 54.04 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 5.2 mp -112.08 106.78 15.51 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . . . -97.51 102.1 12.0 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.301 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 8.4 Cg_exo -73.94 154.46 48.01 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.024 1.816 . . . . 0.0 109.847 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -61.32 -44.59 96.95 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.81 26.72 20.14 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -136.07 -176.81 4.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -87.38 -56.43 3.36 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.393 0.616 . . . . 0.0 110.053 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 29' ' ' ALA . . . 150.31 137.17 2.67 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.56 124.31 70.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.325 0.583 . . . . 0.0 109.998 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.83 128.27 43.62 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.247 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 47.4 mt -125.27 140.54 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.019 0.438 . . . . 0.0 109.99 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -128.05 149.92 18.26 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 tp -94.25 126.13 39.3 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.81 166.61 14.09 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.377 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -126.93 122.68 35.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 18.2 t70 -65.83 129.57 94.32 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 -4.18 12.5 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.869 2.379 . . . . 0.0 113.095 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 16.6 tp10 -93.79 -51.46 4.89 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.329 0.585 . . . . 0.0 109.647 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.422 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 31.2 p -108.78 -22.01 12.41 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.72 11.99 69.89 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.538 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 ptpt -84.31 147.64 27.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.58 142.71 27.47 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.645 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -149.99 138.97 21.03 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -93.15 139.76 30.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -143.01 143.7 32.0 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.282 0.1 OUTLIER -74.46 140.19 44.45 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.604 179.529 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' A' ' 39' ' ' GLY . 17.8 mt -85.86 -177.22 0.89 Allowed Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -67.27 132.94 28.98 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 105.185 -2.659 . . . . 0.0 105.185 166.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.43 -7.97 54.74 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.921 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.34 -14.4 40.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.363 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -60.16 129.56 88.62 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.204 1.001 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.15 118.24 2.29 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.678 2.252 . . . . 0.0 112.757 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--N 1.293 -1.854 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.671 177.045 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 pttt . . . . . 0 N--CA 1.432 -1.333 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.67 136.4 45.8 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.913 1.742 . . . . 0.0 111.462 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.3 p -114.23 149.78 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.36 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -68.71 109.18 3.7 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.29 136.56 60.46 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.944 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 60.9 mttp -79.37 115.72 19.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -85.42 166.48 30.33 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.52 -18.69 64.76 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.556 2.171 . . . . 0.0 111.875 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.43 -14.82 62.27 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.94 50.11 4.51 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.017 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 22.1 ptmt -148.43 164.77 33.13 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 36.2 mt-10 -106.06 120.37 41.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.02 149.43 50.37 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -90.01 104.15 16.75 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -118.01 147.23 43.41 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.638 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.18 129.36 26.44 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.0 129.92 20.54 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.225 1.284 . . . . 0.0 111.645 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.25 -51.18 60.08 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.973 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -132.78 153.26 51.41 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.685 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.66 148.65 33.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 124.266 0.979 . . . . 0.0 109.429 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -157.18 163.97 38.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.47 132.91 39.84 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.127 0.489 . . . . 0.0 110.36 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 mp -97.99 92.11 5.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 100.31 52.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.12 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 34.5 Cg_exo -62.46 -69.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.717 2.278 . . . . 0.0 112.426 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -168.62 -50.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.568 0.347 . . . . 0.0 111.893 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -128.58 40.37 1.73 Allowed Glycine 0 C--N 1.317 -0.507 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.809 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 99.4 mtt180 -129.36 25.98 5.42 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.55 -65.42 0.35 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.358 1.063 . . . . 0.0 112.514 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.44 118.82 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.31 116.67 37.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -89.16 131.04 35.48 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 66.8 mt -134.42 142.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.95 150.32 19.34 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.0 tp -94.63 124.29 38.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -117.62 170.66 8.59 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.076 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.82 125.87 45.45 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.06 119.99 79.53 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.46 -24.79 42.18 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.82 2.347 . . . . 0.0 114.164 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.22 -21.86 17.04 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.8 p -111.45 -18.73 12.8 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.672 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 9.74 85.27 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.522 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -100.22 156.97 16.92 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.515 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -94.82 146.99 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.49 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -147.57 139.47 24.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -94.49 133.46 38.08 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -141.38 149.53 41.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 21.5 ptmt -69.46 150.38 47.28 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.467 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.86 171.16 5.23 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.014 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.34 148.72 80.28 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.922 2.415 . . . . 0.0 109.167 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.55 -23.53 63.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.84 4.62 53.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.369 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -73.12 122.66 88.2 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.7 101.45 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.813 2.342 . . . . 0.0 113.783 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 C--N 1.31 -1.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.91 175.82 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -70.24 137.62 50.99 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.976 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -83.57 120.18 25.63 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.043 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.03 -84.15 0.2 Allowed Glycine 0 N--CA 1.428 -1.878 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.02 167.17 13.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.8 mtmt -138.63 122.02 11.08 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -92.5 155.67 2.99 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 122.781 2.32 . . . . 0.0 114.761 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 11.9 p -130.96 152.0 36.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -76.54 110.92 11.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -132.71 144.71 35.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.508 0.67 . . . . 0.0 111.865 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 65.6 mttm -81.56 139.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.636 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 19.8 p -94.01 159.05 35.16 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 16.5 Cg_exo -67.18 -17.42 50.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.0 2.467 . . . . 0.0 111.479 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.06 -11.53 52.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.767 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.53 20.13 10.52 Favored Glycine 0 C--O 1.24 0.53 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.147 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.24 167.9 9.45 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 51.4 mt-10 -135.91 115.01 12.32 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 163.94 35.57 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.17 105.11 17.12 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.7 152.69 24.49 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.424 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.96 126.41 36.82 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.297 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 35.9 Cg_endo -70.07 130.5 19.06 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.833 1.689 . . . . 0.0 111.545 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 4.6 mm-40 -81.36 -27.43 34.9 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.534 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -144.22 131.11 20.34 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.04 138.66 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 O-C-N 123.364 0.415 . . . . 0.0 110.884 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -142.1 158.42 43.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.928 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 154.18 39.7 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.396 0.617 . . . . 0.0 111.526 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.0 mp -129.66 96.11 4.16 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.46 96.11 30.1 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 4.0 Cg_exo -82.22 139.44 10.53 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.653 2.235 . . . . 0.0 110.06 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.53 126.89 30.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.158 0.504 . . . . 0.0 110.92 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -2.3 75.91 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 33' ' ' ARG . 3.4 mmp_? -118.6 -167.54 1.39 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -107.89 150.12 27.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.65 90.56 1.36 Allowed Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.37 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.3 151.82 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -130.2 151.36 50.81 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 74.2 mt -136.82 135.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.79 147.33 16.47 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.5 tp -95.26 126.17 40.4 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.16 170.89 9.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.184 0.594 . . . . 0.0 109.894 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -113.64 128.94 56.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 16.0 t70 -80.58 121.77 81.66 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.74 -1.55 11.7 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 113.305 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.41 -50.62 4.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.376 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 41.3 p -94.44 -37.29 11.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.469 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.3 -6.04 34.0 Favored Glycine 0 N--CA 1.427 -1.948 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.139 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 19.2 ptpt -79.96 163.55 24.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.445 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 40' ' ' LEU . 74.2 m-85 -97.88 131.46 44.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -129.11 139.62 51.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -91.21 142.32 27.85 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -146.75 136.07 22.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 5.4 ptmt -64.26 135.35 56.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.441 0.639 . . . . 0.0 111.104 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.06 169.96 7.96 Favored Pre-proline 0 C--N 1.271 -2.843 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 19.5 Cg_exo -66.95 151.63 81.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.941 1.761 . . . . 0.0 109.477 175.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.04 -19.11 61.89 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.927 -0.483 . . . . 0.0 111.536 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.86 -1.82 54.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.541 0.686 . . . . 0.0 110.704 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 52.1 t80 -65.67 127.2 92.87 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.07 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.65 104.53 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.403 2.069 . . . . 0.0 113.652 -175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 60' ' ' ILE . 48.2 pt . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 m -87.85 78.79 8.27 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -87.45 87.49 7.42 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.515 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.73 -64.86 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.11 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -89.84 -173.28 3.85 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.999 0.52 . . . . 0.0 109.947 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' ' CE1' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -91.53 129.19 43.74 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 56.5 Cg_endo -84.27 174.85 7.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 121.902 1.735 . . . . 0.0 112.348 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.65 140.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 55.4 tttp -74.41 109.25 7.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.22 142.75 43.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.614 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -76.71 119.55 20.66 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.522 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 p -92.35 173.0 5.54 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.133 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.02 -14.56 38.66 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.003 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.34 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.938 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 1.69 49.32 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.628 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.87 156.56 18.56 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 41.0 tt0 -116.34 107.14 14.45 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.79 34.17 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.97 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 1.7 mp0 -80.55 108.99 14.65 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.363 0.601 . . . . 0.0 110.707 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.51 146.13 45.72 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.3 p -96.62 127.22 40.42 Favored Pre-proline 0 N--CA 1.419 -1.99 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.3 136.29 71.23 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.426 2.084 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.85 -42.33 81.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HG3' ' CZ3' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -147.64 150.19 33.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 ' HB ' ' A' ' 60' ' ' ILE . 32.2 m -124.36 150.57 29.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.409 ' CZ3' ' HG3' ' A' ' 24' ' ' LYS . 21.9 p90 -156.4 168.56 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.24 147.38 43.66 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.17 113.94 23.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.049 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.6 100.0 10.31 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.68 -67.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.298 1.999 . . . . 0.0 111.896 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -124.35 -142.53 0.31 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.93 84.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.28 0 O-C-N 122.997 0.186 . . . . 0.0 112.994 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -149.69 154.12 38.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 32.3 mmtp -42.6 -45.5 4.62 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.475 1.11 . . . . 0.0 113.216 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.45 90.27 2.01 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 m -74.46 115.96 16.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.881 0.848 . . . . 0.0 112.221 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 63.2 mttp -80.97 131.08 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.096 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.7 mt -134.45 142.11 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.25 149.24 18.53 Favored Glycine 0 N--CA 1.424 -2.1 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.44 125.62 43.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 90.0 m-85 -119.52 171.91 8.02 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.714 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -130.45 121.99 26.88 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.4 129.72 85.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.12 -31.5 29.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.145 1.897 . . . . 0.0 114.478 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -97.55 -34.96 10.78 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -88.44 -25.34 22.69 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.466 0.65 . . . . 0.0 109.688 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.56 -5.64 82.85 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.052 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -82.46 150.92 26.78 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 89.5 m-85 -95.09 126.47 40.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.612 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -130.55 139.17 50.47 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -96.08 128.3 42.86 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.51 144.06 47.81 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 62.3 tttt -60.27 139.26 57.7 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 124.039 0.837 . . . . 0.0 109.36 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 31.6 mt -96.99 168.51 10.17 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.98 141.76 65.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.569 1.513 . . . . 0.0 109.728 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.34 -41.87 52.11 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.966 0.906 . . . . 0.0 111.181 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.36 15.63 20.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.965 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 84.8 t80 -83.31 120.95 76.56 Favored Pre-proline 0 C--O 1.216 -0.66 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.47 114.35 4.01 Favored 'Trans proline' 0 C--O 1.248 1.001 0 C-N-CA 122.096 1.864 . . . . 0.0 112.587 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.4 ' HB ' HG21 ' A' ' 25' ' ' VAL . 37.6 pt . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 118.446 -0.787 . . . . 0.0 110.034 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 C--O 1.24 0.59 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 74.05 116.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.491 1.516 . . . . 0.0 111.722 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m -81.62 -24.48 36.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.451 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.1 -25.8 17.3 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -141.44 147.19 37.51 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 124.196 0.999 . . . . 0.0 108.484 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -149.39 90.2 4.67 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.09 164.52 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.783 2.322 . . . . 0.0 113.409 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.1 p -139.27 151.31 22.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -67.84 109.11 3.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -130.3 146.72 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.48 130.73 35.03 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.578 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.7 p -89.9 161.48 38.32 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -71.77 -9.49 24.94 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.786 2.324 . . . . 0.0 109.85 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB1' ' HZ3' ' A' ' 16' ' ' LYS . . . -82.82 -5.93 59.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.093 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.75 -13.69 57.77 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 173.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HZ3' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -114.71 174.03 6.17 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.8 -0.823 . . . . 0.0 111.559 -178.121 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.73 153.77 20.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.163 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 152.19 27.53 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.2 mt-10 -89.46 104.43 16.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -112.96 147.98 35.99 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.72 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.38 123.14 63.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.57 132.81 28.08 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.964 1.776 . . . . 0.0 112.085 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -47.68 24.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -137.38 142.04 41.73 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.03 144.36 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.373 . . . . 0.0 110.46 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -151.71 164.2 37.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.26 39.63 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.705 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.37 102.8 12.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.63 105.54 45.67 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 13.1 Cg_exo -77.97 3.81 6.68 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.997 2.465 . . . . 0.0 112.831 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 71.67 107.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.042 1.337 . . . . 0.0 111.893 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.63 12.17 38.75 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 92.7 mtt180 -137.63 -166.7 1.99 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -80.34 154.37 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.58 103.87 2.92 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.59 98.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.18 130.03 34.69 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.105 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.39 140.54 47.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -130.11 149.02 18.77 Favored Glycine 0 N--CA 1.416 -2.636 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 tp -96.13 126.24 41.22 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 92.1 m-85 -121.25 170.34 9.68 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -122.25 119.5 31.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.578 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 17.8 t70 -64.86 135.36 96.36 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.85 -21.26 16.4 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.45 2.1 . . . . 0.0 114.575 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.32 -51.12 4.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.438 0.637 . . . . 0.0 111.61 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -86.65 -29.4 22.53 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.72 85.95 Favored Glycine 0 N--CA 1.431 -1.653 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.209 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.0 144.12 41.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.083 0.441 . . . . 0.0 110.995 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 56.5 m-85 -83.37 125.12 31.32 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -126.37 139.74 53.04 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.633 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -96.91 123.82 40.72 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -134.87 147.86 49.98 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 54.3 tttm -62.1 142.51 57.54 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 123.737 0.648 . . . . 0.0 110.122 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 30.7 mt -98.7 171.13 6.08 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.83 73.67 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.837 1.692 . . . . 0.0 109.368 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.42 -33.67 72.84 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 123.688 0.795 . . . . 0.0 110.536 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.19 5.15 51.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.309 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -77.45 123.53 86.82 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.63 120.17 6.31 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.66 2.24 . . . . 0.0 111.959 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.298 -1.655 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.157 178.338 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 54.79 82.61 0.09 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.114 0.966 . . . . 0.0 111.573 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.4 m -147.05 92.98 2.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.047 -0.408 . . . . 0.0 110.11 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.63 -27.87 16.0 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.726 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -93.37 136.55 33.53 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 111.607 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 39.9 pttt -153.21 106.41 2.61 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.71 124.64 4.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.391 2.061 . . . . 0.0 113.055 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.98 149.03 8.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.06 109.27 6.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -135.61 145.61 31.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.238 0.542 . . . . 0.0 110.534 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -89.3 134.66 33.97 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.076 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -83.63 169.09 18.4 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.541 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -70.99 -22.17 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.269 1.979 . . . . 0.0 109.095 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -51.99 66.29 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.423 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.0 -0.17 3.99 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.985 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.47 160.01 15.97 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.62 137.41 39.97 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 163.57 36.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.27 105.4 17.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.54 138.55 51.83 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.57 123.29 67.02 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.304 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.41 142.77 37.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.052 1.835 . . . . 0.0 111.65 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -69.38 -37.27 77.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.79 157.9 38.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.86 139.04 51.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 123.759 0.662 . . . . 0.0 110.054 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -141.94 154.23 44.91 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.32 124.45 32.35 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.012 0.434 . . . . 0.0 111.499 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.1 96.05 10.57 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.47 107.41 21.08 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.627 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.71 -69.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 121.792 1.662 . . . . 0.0 110.248 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -160.04 -63.9 0.07 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.26 82.96 0.8 Allowed Glycine 0 C--N 1.316 -0.559 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -170.58 154.16 4.45 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -57.82 -46.01 85.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.588 0.631 . . . . 0.0 109.366 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.18 112.8 2.66 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.99 98.43 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.99 126.98 32.59 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -129.48 137.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.93 148.16 16.68 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 tp -97.53 121.88 39.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.0 m-85 -118.72 169.57 9.72 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 123.541 0.736 . . . . 0.0 110.195 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -112.03 124.3 52.11 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 11.9 t70 -77.67 122.92 86.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.85 -2.04 12.1 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 113.844 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -97.53 -54.17 3.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.226 0.536 . . . . 0.0 110.153 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -94.72 -17.47 22.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.722 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.93 74.08 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.982 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -106.28 163.66 12.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 122.54 -0.388 . . . . 0.0 110.312 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.0 m-85 -94.62 132.05 39.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -130.82 140.5 50.27 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.012 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -139.22 150.11 45.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.42 141.61 58.47 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 123.669 0.605 . . . . 0.0 109.617 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.55 170.76 5.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -67.12 141.81 58.93 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.05 1.834 . . . . 0.0 108.77 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.21 -21.96 63.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.099 0.476 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.61 -1.67 57.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' OH ' ' HG3' ' A' ' 6' ' ' LYS . 91.8 t80 -81.35 123.24 81.45 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.8 Cg_endo -78.35 111.78 3.09 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.974 1.783 . . . . 0.0 109.888 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 C--N 1.296 -1.756 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.323 -179.054 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.763 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -90.29 82.45 5.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 121.772 0.796 . . . . 0.0 111.547 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 t -110.85 -66.79 1.04 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.93 -70.88 1.45 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.814 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -106.26 146.39 30.41 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 146.27 22.76 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.0 Cg_endo -75.43 159.46 39.75 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.793 1.662 . . . . 0.0 112.586 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.4 146.87 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -69.06 109.84 4.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.34 139.16 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 121.727 0.775 . . . . 0.0 111.822 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 64.8 mttm -80.98 115.71 20.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.26 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -87.85 158.8 50.05 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.261 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 9.9 Cg_exo -71.03 -12.86 31.04 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.873 2.382 . . . . 0.0 110.702 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.91 64.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.516 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.9 9.42 24.52 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.601 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.26 26.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.706 177.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 48.2 mt-10 -94.31 121.48 35.87 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.34 138.73 52.51 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.93 105.54 14.02 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.27 151.29 39.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.381 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -100.55 127.61 32.28 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.59 143.31 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.008 1.805 . . . . 0.0 112.397 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.85 -37.55 64.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.42 149.01 28.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.91 149.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 123.57 0.544 . . . . 0.0 110.395 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -156.74 159.88 38.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.66 137.08 49.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.9 91.85 7.12 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.22 84.34 20.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.731 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -79.91 89.51 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 121.676 1.584 . . . . 0.0 111.443 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.279 19.2 ptpt 57.37 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 127.301 2.241 . . . . 0.0 116.256 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.0 70.76 0.29 Allowed Glycine 0 N--CA 1.432 -1.607 0 O-C-N 121.971 -0.456 . . . . 0.0 112.544 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -161.07 148.76 15.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.1 -39.18 91.62 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.385 0.428 . . . . 0.0 110.236 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.77 105.82 2.91 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.098 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.15 107.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.906 0.86 . . . . 0.0 109.116 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.46 131.35 34.67 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.753 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.84 140.47 48.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.94 149.49 18.83 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.32 123.47 41.15 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.0 m-85 -118.11 179.9 3.96 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.5 0.72 . . . . 0.0 110.563 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.7 tttp -128.96 113.44 15.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 10.1 t70 -65.94 133.21 94.82 Favored Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.031 0.932 . . . . 0.0 112.54 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.36 -31.37 62.53 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 123.375 2.717 . . . . 0.0 115.986 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.77 -30.69 12.64 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.615 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -104.21 -20.73 13.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.85 -2.68 67.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.661 -0.304 . . . . 0.0 113.524 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -78.35 160.74 27.65 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.934 0.397 . . . . 0.0 111.266 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 42.2 m-85 -93.0 120.63 33.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.334 176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.46 139.83 53.52 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -93.71 135.85 34.58 Favored 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.368 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -139.61 146.38 39.71 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.5 tttt -64.51 140.28 58.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 28.8 mt -96.51 176.06 2.34 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.93 140.04 53.55 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.663 1.575 . . . . 0.0 108.788 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.31 -24.11 67.12 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -108.28 15.02 24.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.112 -0.367 . . . . 0.0 111.595 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -68.8 128.81 92.76 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.27 108.0 1.28 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 123.341 2.694 . . . . 0.0 114.971 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -59.24 113.02 1.94 Allowed 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.496 0.497 . . . . 0.0 110.27 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 p -149.68 157.13 42.95 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.716 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.56 -33.31 2.78 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -132.59 173.32 11.45 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -131.8 84.34 54.67 Favored Pre-proline 0 C--N 1.264 -3.137 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 69.5 Cg_endo -93.85 -171.37 0.27 Allowed 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 123.117 2.545 . . . . 0.0 112.666 -175.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.45 146.0 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -71.73 110.6 6.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.37 143.07 42.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 120.836 0.35 . . . . 0.0 111.153 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 61.1 mttp -76.08 117.02 17.35 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.097 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 26.1 p -95.49 165.22 17.15 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.808 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 -23.08 73.95 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.34 2.693 . . . . 0.0 112.262 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.15 -17.05 64.68 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.31 49.38 4.98 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.557 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.22 159.99 44.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 41.6 mt-10 -106.2 111.76 24.5 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.28 150.83 41.79 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.65 104.57 15.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -115.49 138.12 51.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.527 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -90.77 123.58 64.61 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.25 139.89 62.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.087 1.858 . . . . 0.0 111.907 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -73.2 -49.46 27.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -134.94 143.73 47.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.718 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.62 145.17 31.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 O-C-N 123.505 0.503 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.32 151.92 31.48 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.49 124.32 44.14 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.194 0.521 . . . . 0.0 110.271 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.85 112.93 24.62 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.83 86.48 24.78 Favored Pre-proline 0 C--N 1.305 -1.369 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.783 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.51 149.19 23.92 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.657 2.238 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -71.49 100.53 2.25 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.24 -13.31 5.98 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.95 -176.14 3.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.89 -179.45 4.57 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.78 123.75 6.19 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.64 112.72 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 65.9 mttp -84.6 125.5 32.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.4 mt -131.09 142.14 44.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.0 148.29 18.43 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 49' ' ' TYR . 65.1 tp -98.07 126.32 43.45 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 91.2 m-85 -125.63 168.19 14.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.292 0.637 . . . . 0.0 110.567 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -120.13 114.81 22.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 15.3 t70 -58.14 132.36 84.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.893 0.877 . . . . 0.0 111.032 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.74 -19.83 30.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.935 2.423 . . . . 0.0 114.728 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.16 -54.08 3.18 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.67 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -82.71 -33.1 27.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.13 18.19 59.72 Favored Glycine 0 N--CA 1.426 -1.98 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.837 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.86 161.42 13.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.388 0.594 . . . . 0.0 110.755 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 61.9 m-85 -89.45 133.12 34.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.647 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.77 139.74 42.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -100.48 125.76 46.82 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -136.73 145.19 44.37 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.2 tttt -60.94 144.01 53.98 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.549 0.531 . . . . 0.0 109.958 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.3 mt -101.37 170.58 6.33 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.73 141.17 71.03 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.701 1.601 . . . . 0.0 109.319 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.43 -30.58 63.0 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.547 0.739 . . . . 0.0 112.37 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.71 18.7 21.53 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 77.3 t80 -78.84 128.31 77.2 Favored Pre-proline 0 C--N 1.316 -0.859 0 O-C-N 122.458 -0.151 . . . . 0.0 110.774 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.64 119.97 6.74 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 122.307 2.005 . . . . 0.0 111.442 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.727 179.646 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ptp . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -155.1 -54.93 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 m -110.17 138.11 46.99 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.93 -62.13 0.29 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' HB2' HG21 ' A' ' 21' ' ' VAL . 51.2 mtmt 57.37 -162.18 0.21 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.792 0.837 . . . . 0.0 110.95 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 95.6 mttt -104.99 112.79 65.24 Favored Pre-proline 0 C--N 1.309 -1.194 0 O-C-N 122.067 -0.396 . . . . 0.0 110.062 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -90.34 156.82 4.56 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.954 2.436 . . . . 0.0 112.507 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.4 154.92 22.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.18 115.83 14.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.11 138.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-O 121.17 0.51 . . . . 0.0 109.678 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -91.15 118.69 30.64 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.674 0.749 . . . . 0.0 109.16 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -69.5 161.02 76.86 Favored Pre-proline 0 C--N 1.281 -2.373 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.712 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.99 -19.49 57.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.76 2.307 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.86 -25.02 60.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.42 -13.42 12.2 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.5 -0.857 . . . . 0.0 114.715 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -88.7 147.28 24.58 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.155 0.977 . . . . 0.0 110.995 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.35 121.8 34.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.09 158.25 44.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -94.87 105.47 17.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.85 153.97 41.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.827 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 5' ' ' LYS . 14.5 p -107.25 128.52 25.85 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.885 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 34.7 Cg_endo -68.18 137.84 41.65 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.804 1.669 . . . . 0.0 112.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.43 -44.5 44.11 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.293 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -137.51 146.69 44.49 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.38 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.11 144.65 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 O-C-N 123.654 0.596 . . . . 0.0 109.878 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -152.73 155.58 37.48 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.28 134.12 55.33 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.96 0.409 . . . . 0.0 111.35 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.49 120.67 41.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . . . -98.91 122.34 53.04 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.859 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 3.3 Cg_endo -86.13 61.77 4.95 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.752 2.302 . . . . 0.0 109.505 173.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 64.15 53.53 1.78 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.763 1.225 . . . . 0.0 110.462 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.07 -118.6 6.01 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.392 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 70.97 -66.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 110.734 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 179.55 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.79 132.5 4.14 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.99 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.62 118.6 33.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.03 125.41 41.46 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.9 mt -124.56 136.94 58.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.76 148.27 16.71 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 49' ' ' TYR . 57.3 tp -98.85 125.82 44.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 89.6 m-85 -120.25 168.85 10.82 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 123.201 0.601 . . . . 0.0 109.907 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -131.9 120.0 21.93 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.62 124.23 83.79 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 -14.75 25.03 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.772 2.315 . . . . 0.0 113.721 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.34 -46.83 7.18 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.734 0.302 . . . . 0.0 111.28 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 p -82.84 -36.8 25.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.485 0.66 . . . . 0.0 109.268 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 25.62 24.56 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.213 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -124.44 162.68 23.4 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.672 0.736 . . . . 0.0 111.491 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 40' ' ' LEU . 59.8 m-85 -91.64 142.99 27.02 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.212 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.93 139.92 25.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -94.92 141.53 28.54 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -146.95 149.0 32.32 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.264 0.0 OUTLIER -78.25 145.03 35.69 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.073 -179.966 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.6 mt -96.64 172.92 4.56 Favored Pre-proline 0 C--N 1.276 -2.598 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.51 142.88 66.86 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.449 1.433 . . . . 0.0 109.275 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.02 -24.32 67.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 0.0 111.288 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.32 -12.91 45.09 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.5 t80 -64.62 121.15 71.44 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.504 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 7.2 Cg_endo -79.08 107.78 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.157 1.904 . . . . 0.0 112.587 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 N--CA 1.426 -1.637 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.827 177.834 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 CA--C 1.496 -1.1 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -104.35 132.44 50.6 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.08 0.467 . . . . 0.0 110.79 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.8 m -146.29 44.48 1.23 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.34 -66.87 3.81 Favored Glycine 0 C--O 1.247 0.963 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -84.93 151.14 24.46 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 113.389 -1.406 . . . . 0.0 107.617 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -153.12 137.77 11.01 Favored Pre-proline 0 C--N 1.294 -1.839 0 C-N-CA 122.87 0.468 . . . . 0.0 111.04 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 12.1 Cg_endo -58.47 141.06 96.91 Favored 'Trans proline' 0 C--O 1.256 1.378 0 C-N-CA 122.957 2.438 . . . . 0.0 113.989 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.17 150.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.24 109.13 8.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.55 153.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.619 -173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 16.3 ptpt -88.22 134.22 33.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -102.2 172.61 4.2 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.664 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.79 -10.44 27.73 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.962 2.441 . . . . 0.0 111.841 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.48 -5.79 51.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.08 33.59 28.94 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.944 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.79 168.55 19.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 11' ' ' LYS . 42.6 mt-10 -120.26 130.75 54.64 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 165.11 32.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.38 110.7 21.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.204 0.526 . . . . 0.0 109.889 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 79.3 mt -122.16 152.21 40.18 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.721 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.34 124.5 42.74 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.23 131.69 21.09 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 121.779 1.653 . . . . 0.0 110.323 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.95 -34.34 66.46 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.801 0.81 . . . . 0.0 109.175 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -144.66 144.17 31.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 139.79 50.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.707 0.629 . . . . 0.0 109.798 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -147.28 148.01 30.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 110.861 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.21 129.99 53.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.891 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.08 89.49 3.08 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.82 84.41 25.44 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.837 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 33' ' ' ARG . 6.2 Cg_exo -75.68 125.68 9.03 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.115 1.877 . . . . 0.0 108.194 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.92 106.16 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.32 -12.75 8.42 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 mpt_? -105.45 -173.22 2.25 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.505 -0.409 . . . . 0.0 111.328 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -70.6 -50.05 41.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.14 103.42 1.6 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.24 165.07 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.188 0.518 . . . . 0.0 111.798 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -117.82 140.24 49.97 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -131.14 138.7 52.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.74 145.34 15.86 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 50.2 tp -94.2 121.95 36.24 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.1 m-85 -114.4 172.76 6.82 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -130.63 116.42 18.06 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.72 130.5 88.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.0 -24.76 28.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.436 2.091 . . . . 0.0 114.762 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -97.45 -37.85 9.83 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 34.7 p -87.03 -36.87 17.96 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.38 -0.54 71.52 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.471 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 21.8 ptmt -85.22 143.92 28.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.326 0.584 . . . . 0.0 111.607 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.8 m-85 -83.98 129.14 34.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.97 174.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -133.58 139.69 46.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 31.6 ptt180 -93.21 133.12 36.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -136.71 148.55 47.39 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.99 139.05 58.72 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 123.936 0.772 . . . . 0.0 109.675 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.2 mt -101.93 170.59 6.24 Favored Pre-proline 0 C--N 1.293 -1.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.34 147.19 77.54 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.515 2.144 . . . . 0.0 109.939 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.32 -33.33 75.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.129 0.49 . . . . 0.0 111.144 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 7.91 31.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.919 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -84.12 115.86 62.1 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.84 117.23 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.408 2.072 . . . . 0.0 113.115 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 C--N 1.3 -1.567 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.176 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.378 0.132 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 m -88.73 -5.58 58.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.239 0.542 . . . . 0.0 109.688 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -56.03 121.6 9.72 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 124.733 1.213 . . . . 0.0 110.122 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.02 -36.05 4.61 Favored Glycine 0 C--N 1.302 -1.358 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 89.8 mttt 61.19 -162.2 0.28 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.845 1.658 . . . . 0.0 111.065 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -128.74 107.66 18.59 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 46.0 Cg_endo -73.53 158.73 47.33 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.938 1.759 . . . . 0.0 111.882 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.72 151.21 34.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.99 109.47 8.47 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.62 149.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.252 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -85.85 128.36 34.8 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.597 0.713 . . . . 0.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 170.57 14.55 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.592 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 23.9 Cg_exo -66.72 -16.79 51.39 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.618 2.212 . . . . 0.0 110.788 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.34 -21.02 58.7 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.393 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.04 12.75 48.48 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.685 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.26 166.62 11.65 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.82 137.81 31.98 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.461 0.476 . . . . 0.0 110.581 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.09 154.53 21.79 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 105.36 17.76 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.556 0.693 . . . . 0.0 109.179 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.1 139.18 43.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.42 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 5' ' ' LYS . 7.2 p -91.8 118.22 68.17 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.26 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.29 136.47 24.28 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.962 2.442 . . . . 0.0 113.408 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.4 -41.23 18.38 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.576 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HB2' ' HZ3' ' A' ' 26' ' ' TRP . 28.9 mtpp -129.1 143.77 50.97 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.28 137.96 50.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.447 ' HZ3' ' HB2' ' A' ' 24' ' ' LYS . 27.2 p90 -151.29 164.42 36.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.74 132.71 35.19 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.134 0.492 . . . . 0.0 110.92 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.88 95.56 9.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.17 103.24 14.09 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.61 -56.44 1.01 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.386 2.057 . . . . 0.0 111.083 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -169.85 -64.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.57 47.86 2.33 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -141.65 152.92 44.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -64.61 -33.99 77.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.088 0.867 . . . . 0.0 110.18 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.9 130.85 6.75 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.457 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.28 105.91 16.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -83.59 132.37 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.2 mt -135.64 144.11 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.74 150.95 19.84 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.7 123.38 42.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.36 168.04 11.7 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.293 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -128.23 120.97 28.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 15.3 t70 -76.61 123.74 87.7 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 -20.53 21.58 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 C-N-CA 122.332 2.021 . . . . 0.0 113.742 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.55 -45.56 8.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.964 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -82.82 -31.12 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.433 0.635 . . . . 0.0 109.515 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.28 67.34 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.867 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -90.98 154.32 19.53 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -91.14 132.13 36.26 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.962 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -135.89 139.92 43.71 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -95.81 126.39 41.04 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -130.58 144.19 51.25 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -172.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -65.98 144.04 57.0 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.693 0.62 . . . . 0.0 109.448 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.97 168.66 8.49 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.05 145.03 72.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.592 2.195 . . . . 0.0 109.16 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.25 -41.92 72.8 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -88.96 5.31 44.75 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.54 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.5 t80 -73.88 125.18 90.51 Favored Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 121.844 -0.535 . . . . 0.0 110.047 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.2 Cg_exo -76.06 113.58 3.73 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 122.318 2.012 . . . . 0.0 110.363 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.296 -1.719 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -139.41 20.1 2.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.507 0.67 . . . . 0.0 110.238 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -80.19 -30.43 38.76 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.459 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.22 -125.25 8.2 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.2 mttm 67.62 -178.9 0.22 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.874 0.87 . . . . 0.0 111.418 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -128.47 105.88 19.24 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-O 120.754 0.312 . . . . 0.0 110.988 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -81.08 157.26 20.28 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 121.846 1.697 . . . . 0.0 111.609 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.2 p -141.69 148.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HG2' ' OE2' ' A' ' 19' ' ' GLU . 62.2 mttm -71.52 111.51 6.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.63 138.03 55.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 121.03 0.443 . . . . 0.0 109.817 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 123.69 29.87 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 p -92.91 165.69 18.18 Favored Pre-proline 0 N--CA 1.418 -2.054 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.32 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.3 -27.01 82.62 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.051 2.5 . . . . 0.0 112.445 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.27 -25.79 63.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.652 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.62 -12.29 8.33 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.113 -1.518 . . . . 0.0 115.085 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -100.66 154.44 18.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 118.253 1.026 . . . . 0.0 110.211 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.47 106.06 14.11 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.43 165.05 18.43 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.23 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.2 mp0 -82.82 104.77 13.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.118 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.22 157.12 20.47 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.86 129.03 24.39 Favored Pre-proline 0 N--CA 1.403 -2.818 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.071 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.13 123.56 7.9 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.775 1.65 . . . . 0.0 111.351 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.52 -35.22 65.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.35 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -134.52 136.92 43.44 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 139.05 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.36 0.412 . . . . 0.0 110.4 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.53 155.39 40.25 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.74 136.51 53.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.58 0.705 . . . . 0.0 111.057 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.6 mp -108.01 100.02 9.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.81 96.34 16.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 123.243 0.34 . . . . 0.0 110.676 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 6.2 Cg_exo -80.7 155.4 20.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.523 2.149 . . . . 0.0 109.848 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.85 127.86 33.79 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.064 0.459 . . . . 0.0 110.111 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' HD2' ' A' ' 33' ' ' ARG . . . 99.36 -15.48 60.1 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.231 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 32' ' ' GLY . 6.1 mpt_? -117.46 159.06 23.42 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.324 -0.515 . . . . 0.0 110.485 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.26 -33.3 73.03 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.467 0.479 . . . . 0.0 111.19 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.85 163.07 22.23 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.74 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.28 156.75 40.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.42 137.64 51.23 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 71.9 mt -134.04 141.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.83 150.65 19.38 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.8 tp -94.8 124.99 39.16 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.14 -179.86 4.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.246 1.018 . . . . 0.0 109.162 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 49' ' ' TYR . 84.0 tttt -134.05 132.09 39.61 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.76 121.34 82.26 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.99 -9.8 20.95 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.262 1.975 . . . . 0.0 114.851 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -99.13 -41.44 7.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.105 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -92.21 -25.95 18.42 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.982 0.42 . . . . 0.0 111.088 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.64 36.46 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.065 -0.516 . . . . 0.0 113.266 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -119.85 145.23 46.85 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.642 -0.328 . . . . 0.0 110.259 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 46.0 m-85 -80.55 138.53 36.51 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.3 140.2 33.78 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -93.54 137.82 32.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -142.51 147.03 35.34 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.5 ptpt -68.94 144.53 54.14 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.179 0.514 . . . . 0.0 110.428 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.66 169.16 7.86 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 24.6 Cg_exo -67.1 151.28 81.85 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.704 2.269 . . . . 0.0 109.895 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.22 -36.16 83.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.75 6.99 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.003 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.405 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 88.6 t80 -84.69 122.85 74.77 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.47 -0.769 . . . . 0.0 109.986 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.87 98.59 1.22 Allowed 'Trans proline' 0 N--CA 1.437 -1.794 0 C-N-CA 122.444 2.096 . . . . 0.0 111.916 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.2 pt . . . . . 0 N--CA 1.423 -1.79 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.002 179.463 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.307 0.099 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 62.41 74.44 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.415 1.086 . . . . 0.0 111.827 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.7 m -141.36 70.04 1.34 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.062 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.36 53.49 2.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.0 -172.95 3.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.03 134.93 9.05 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -78.81 141.95 17.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.945 1.764 . . . . 0.0 111.203 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 14.6 p -120.96 149.82 23.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 60.6 mttp -75.07 108.82 8.06 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.24 141.0 47.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.162 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -78.54 115.64 18.39 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.52 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.596 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 76.6 p -83.49 165.03 42.5 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.11 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.52 -17.4 57.21 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.436 2.091 . . . . 0.0 111.18 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.28 -17.97 61.26 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.674 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.4 31.24 6.55 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 114.772 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.64 38.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.601 0.701 . . . . 0.0 109.932 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 9' ' ' LYS . 36.7 tt0 -91.84 93.57 8.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.942 0.877 . . . . 0.0 109.563 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.29 160.28 14.82 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.535 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 52.3 mt-10 -92.29 105.61 17.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.462 0.649 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.1 mt -117.54 141.89 47.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.136 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.9 p -95.63 125.08 50.69 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 12.5 Cg_exo -66.6 141.17 59.53 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.145 1.896 . . . . 0.0 114.088 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.22 -47.12 65.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -142.26 144.32 33.25 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.527 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 m -124.99 152.73 31.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -157.36 153.48 27.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.074 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.96 125.05 42.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.239 0.542 . . . . 0.0 110.761 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 5.2 mp -89.43 87.16 6.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 98.85 8.96 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.43 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.77 -66.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.646 1.564 . . . . 0.0 108.501 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 175.39 148.19 0.09 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.26 -5.6 79.67 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -105.85 150.18 25.83 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -57.88 -39.1 77.03 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.298 0.374 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.48 95.34 2.21 Favored Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 28' ' ' LEU . 24.5 t -82.19 104.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -89.69 126.23 35.57 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.502 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.6 mt -129.19 142.72 43.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.86 147.66 18.49 Favored Glycine 0 N--CA 1.422 -2.294 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.35 125.37 40.8 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 95.0 m-85 -123.23 173.98 7.57 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 122.979 0.511 . . . . 0.0 109.972 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -125.34 125.3 43.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.596 ' OD2' ' HB ' ' A' ' 12' ' ' THR . 9.0 t70 -78.38 120.03 79.56 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.5 -12.37 27.06 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.728 2.285 . . . . 0.0 115.022 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.07 -34.38 10.8 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.907 -0.496 . . . . 0.0 112.053 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -93.77 -34.41 13.21 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.29 0.567 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.69 30.83 22.93 Favored Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.373 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.94 151.34 43.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.0 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 78.3 m-85 -87.83 129.81 35.08 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.971 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -134.59 139.33 45.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -95.23 131.68 41.02 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -139.07 149.96 45.19 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.22 142.02 57.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.5 mt -97.85 -179.82 0.95 Allowed Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.12 137.87 59.02 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.579 1.519 . . . . 0.0 108.162 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.11 -20.28 57.48 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.392 0.677 . . . . 0.0 112.625 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -112.26 11.62 20.2 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.632 0.73 . . . . 0.0 111.01 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 8' ' ' VAL . 13.8 t80 -67.09 127.72 93.6 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.35 92.36 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.308 2.005 . . . . 0.0 113.535 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.202 177.944 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -139.81 169.66 17.32 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.805 0.336 . . . . 0.0 111.591 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -151.91 79.92 1.26 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.062 0.945 . . . . 0.0 108.725 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.73 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.797 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -85.17 83.07 8.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.578 0.704 . . . . 0.0 109.654 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -127.16 115.82 21.75 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -80.01 159.63 23.97 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.514 1.476 . . . . 0.0 112.342 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.2 p -140.87 150.52 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -72.1 109.32 5.81 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -125.22 137.68 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 121.658 0.742 . . . . 0.0 109.859 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -83.6 119.81 25.2 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.4 p -92.18 155.64 42.64 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.8 -16.09 33.21 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.905 2.404 . . . . 0.0 110.476 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.24 72.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.343 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.3 -18.47 4.42 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.016 -1.087 . . . . 0.0 114.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 173.51 6.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 118.102 0.951 . . . . 0.0 112.141 -174.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.38 126.16 32.97 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.31 144.89 50.89 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.7 mt-10 -94.74 104.42 16.33 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.99 141.5 48.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.854 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -90.35 121.72 68.19 Favored Pre-proline 0 N--CA 1.416 -2.151 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.36 134.69 60.32 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.168 1.912 . . . . 0.0 111.448 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.62 -32.43 64.06 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.276 1.03 . . . . 0.0 108.633 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -153.02 138.74 17.89 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.74 144.86 31.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -153.9 160.66 42.23 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.68 130.62 30.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.25 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.11 97.05 8.21 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.76 97.71 32.56 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.79 -64.78 0.08 OUTLIER 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.612 2.208 . . . . 0.0 111.794 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.3 tttm 169.69 119.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.531 1.132 . . . . 0.0 108.963 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.26 43.73 89.31 Favored Glycine 0 C--O 1.246 0.886 0 CA-C-O 121.79 0.661 . . . . 0.0 111.93 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -140.21 176.2 8.96 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -70.21 107.83 3.88 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.55 89.84 0.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.63 100.47 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.252 1.025 . . . . 0.0 112.167 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.59 127.55 32.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.109 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 54.9 mt -128.86 139.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.95 145.75 15.93 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -93.9 126.18 38.96 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.31 178.46 4.52 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -129.71 125.44 35.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 11.0 t70 -63.66 127.78 91.89 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 124.074 0.859 . . . . 0.0 109.375 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 26.1 Cg_exo -63.31 -40.86 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.463 2.109 . . . . 0.0 114.183 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -88.44 -48.93 7.26 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -90.52 -19.93 23.24 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.06 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.95 0.54 89.72 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 115.003 0.761 . . . . 0.0 115.003 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -73.87 138.81 44.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 117.011 0.405 . . . . 0.0 111.272 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -81.45 121.29 26.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -126.32 139.44 53.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -96.02 134.03 39.54 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -137.33 139.95 41.17 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.21 139.19 52.24 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.035 178.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.71 173.12 6.83 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -66.61 140.0 55.23 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 N-CA-C 107.788 -1.658 . . . . 0.0 107.788 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.23 -28.31 68.63 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.34 -4.94 57.18 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.801 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -79.27 122.07 83.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -82.39 112.31 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.428 2.086 . . . . 0.0 111.658 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--N 1.298 -1.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.103 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tmm? . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -95.11 -40.71 9.48 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.355 0.598 . . . . 0.0 110.455 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -124.76 107.33 10.82 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-O 121.321 0.581 . . . . 0.0 109.885 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.92 46.0 1.23 Allowed Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -72.97 82.05 1.21 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.013 -0.594 . . . . 0.0 111.959 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.36 78.59 67.52 Favored Pre-proline 0 C--N 1.296 -1.736 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.427 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.89 123.94 3.33 Favored 'Trans proline' 0 N--CA 1.425 -2.538 0 C-N-CA 121.585 1.524 . . . . 0.0 110.645 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -104.83 148.39 9.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -81.13 109.65 15.89 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.19 153.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 -172.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 54.1 mttp -86.09 135.47 33.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.032 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.7 p -88.75 170.45 11.08 Favored Pre-proline 0 N--CA 1.425 -1.676 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.06 -13.62 28.75 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.315 2.01 . . . . 0.0 112.526 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.65 -6.76 58.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.919 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.4 15.1 62.69 Favored Glycine 0 C--N 1.328 0.123 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 49.9 mtpt -98.02 163.92 12.56 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -129.41 125.64 37.0 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.727 -176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.77 164.58 36.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.32 121.57 28.25 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.35 137.89 52.89 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.22 126.15 61.61 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.99 141.02 68.67 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.11 1.873 . . . . 0.0 113.159 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG3' ' CE2' ' A' ' 49' ' ' TYR . 20.4 mm-40 -72.78 -45.61 57.64 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.919 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -139.63 148.7 42.83 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -131.83 143.5 40.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 O-C-N 123.406 0.441 . . . . 0.0 109.942 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -149.61 156.05 41.28 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.726 0.298 . . . . 0.0 110.62 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.67 125.2 33.36 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.676 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.78 92.84 7.31 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -137.6 87.74 17.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.083 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.19 -41.2 80.88 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.014 2.476 . . . . 0.0 110.685 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -171.68 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.29 92.98 0.31 Allowed Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -153.43 37.66 0.48 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 70.72 -55.04 0.64 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.017 1.727 . . . . 0.0 111.315 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 29' ' ' ALA . . . 103.96 72.74 0.91 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -74.69 114.44 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -96.89 130.7 44.15 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.8 mt -133.64 142.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.55 146.16 16.66 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp -96.19 128.14 42.83 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.74 169.54 10.02 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.977 0.418 . . . . 0.0 110.5 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -122.28 116.82 24.76 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.95 123.23 39.01 Favored Pre-proline 0 C--N 1.316 -0.881 0 C-N-CA 125.256 1.422 . . . . 0.0 109.689 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.79 -26.13 52.8 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.964 2.443 . . . . 0.0 114.087 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.05 -48.19 4.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -94.79 -13.14 25.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.405 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.25 18.67 79.12 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.862 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.97 148.04 22.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.886 0.343 . . . . 0.0 111.384 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.478 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 19.9 m-85 -87.86 128.4 35.35 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.14 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -136.47 140.45 43.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -97.88 132.34 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.246 0.546 . . . . 0.0 110.37 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -138.5 141.1 39.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.8 ptmt -70.89 149.24 46.96 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 118.01 -1.476 . . . . 0.0 109.86 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 28.9 mt -94.6 175.29 3.0 Favored Pre-proline 0 C--N 1.28 -2.431 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.96 141.65 59.16 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 N-CA-C 108.177 -1.509 . . . . 0.0 108.177 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -66.87 -23.06 65.97 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.482 0.658 . . . . 0.0 110.243 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -88.34 -5.25 58.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.413 1.485 . . . . 0.0 111.732 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.29 136.76 81.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.9 115.69 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.434 2.089 . . . . 0.0 114.538 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.925 173.271 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tmm? . . . . . 0 C--O 1.243 0.72 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.7 m 64.86 88.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.782 1.233 . . . . 0.0 111.5 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 t -94.79 -2.22 51.35 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.232 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.53 -60.11 0.6 Allowed Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 99.0 mttt -104.69 151.99 23.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 88.0 tttt -142.4 135.18 13.81 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -75.49 131.85 14.17 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.453 1.435 . . . . 0.0 112.167 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.39 147.55 19.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.135 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -69.05 108.63 3.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 151.72 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 121.497 0.665 . . . . 0.0 111.624 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.46 141.17 28.89 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.252 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.0 p -93.14 171.69 6.97 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.67 -12.88 35.83 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.1 1.867 . . . . 0.0 111.581 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.16 -20.75 47.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.148 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.66 -16.7 36.96 Favored Glycine 0 C--O 1.242 0.635 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.906 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.76 158.14 21.85 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -112.17 145.04 40.56 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.48 154.87 32.5 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.47 104.88 17.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -117.04 148.23 41.67 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.498 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG2' ' HB3' ' A' ' 5' ' ' LYS . 14.6 p -96.18 125.97 45.98 Favored Pre-proline 0 N--CA 1.426 -1.66 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 56.9 Cg_endo -74.85 142.07 27.9 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.99 1.793 . . . . 0.0 111.871 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.33 -40.73 64.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.353 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -145.85 147.34 31.71 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.856 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.29 144.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -146.5 155.98 42.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.06 32.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.132 0.491 . . . . 0.0 110.719 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.81 85.85 2.47 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.7 94.85 24.43 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.12 136.62 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.721 1.614 . . . . 0.0 108.413 170.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -60.86 113.63 2.61 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.108 0.48 . . . . 0.0 111.933 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 2.01 56.07 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.138 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -116.47 -72.83 0.67 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -142.25 174.66 10.41 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 120.679 0.276 . . . . 0.0 111.15 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.54 42.28 0.89 Allowed Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.16 149.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.352 0.596 . . . . 0.0 110.826 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -127.65 144.58 51.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.8 mt -136.11 143.82 34.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.57 148.9 19.16 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.2 tp -98.22 122.72 41.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.53 173.41 6.85 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.038 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -134.64 125.77 27.82 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.54 128.5 77.3 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.54 -12.8 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.085 2.523 . . . . 0.0 114.254 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -97.68 -52.62 3.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.26 0.552 . . . . 0.0 111.69 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 45.0 p -82.79 -35.14 26.74 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.379 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.25 62.4 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.025 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.9 ptpt -88.29 150.0 23.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.265 0.555 . . . . 0.0 111.87 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -95.15 136.5 35.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -143.93 139.92 29.41 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.98 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -100.38 119.92 39.18 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 121.38 0.609 . . . . 0.0 109.77 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -127.49 144.28 51.08 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -68.58 141.48 55.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.611 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 mt -93.95 172.15 6.13 Favored Pre-proline 0 C--N 1.284 -2.272 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.92 140.48 55.15 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.526 1.484 . . . . 0.0 108.412 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.05 -26.72 68.97 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.36 0.6 . . . . 0.0 109.775 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.12 0.26 56.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.779 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 66.1 t80 -80.31 126.68 78.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.6 Cg_exo -76.96 107.88 2.53 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.145 1.897 . . . . 0.0 112.54 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.0 pt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.479 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -92.99 95.38 9.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.299 0.571 . . . . 0.0 110.847 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -95.33 86.3 4.49 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.573 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 -143.33 17.87 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.578 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -89.63 138.33 31.56 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.571 0.701 . . . . 0.0 112.829 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 54.3 mtmt -139.39 94.17 9.66 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -84.55 120.03 2.38 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.328 2.019 . . . . 0.0 111.611 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.8 p -103.91 145.46 12.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.162 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.94 108.45 7.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -130.48 149.52 33.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.05 124.39 28.24 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.741 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.423 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 30.4 p -76.41 169.17 22.24 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.51 -24.38 36.22 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.266 1.978 . . . . 0.0 110.148 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.53 85.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.589 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.61 31.37 1.25 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.463 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.53 160.01 41.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.331 0.565 . . . . 0.0 109.772 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.202 0.525 . . . . 0.0 111.505 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.23 146.96 52.37 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -89.87 105.3 17.71 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.99 0.9 . . . . 0.0 108.952 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.01 141.74 48.42 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.535 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.97 121.87 68.39 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 30.8 Cg_endo -66.44 134.72 36.83 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.073 1.849 . . . . 0.0 112.28 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -61.27 -48.98 78.93 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -145.89 153.98 41.45 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.648 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.94 152.0 30.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 O-C-N 123.628 0.58 . . . . 0.0 110.544 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -155.53 168.37 27.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.256 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.56 139.79 36.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.006 0.431 . . . . 0.0 110.758 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 94.56 4.91 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 91.82 40.06 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.006 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.73 173.67 10.19 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.43 2.087 . . . . 0.0 108.621 172.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.39 139.62 51.92 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.682 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.21 32.4 25.87 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.741 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -156.37 154.12 30.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -69.93 -45.75 66.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.82 117.94 2.21 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.921 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.15 119.93 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 121.42 0.629 . . . . 0.0 110.078 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.04 136.5 35.29 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.4 mt -133.14 140.11 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.07 149.6 18.58 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 tp -96.14 125.51 40.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -122.88 175.07 6.76 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -133.4 122.93 24.47 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.3 t70 -78.74 125.72 83.75 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 3.2 Cg_exo -80.13 -8.34 14.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.247 1.965 . . . . 0.0 113.354 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.44 -40.74 8.54 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -90.29 -34.16 15.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.346 0.593 . . . . 0.0 109.577 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.79 22.78 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.704 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -118.89 144.24 46.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.912 0.356 . . . . 0.0 111.6 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.68 124.65 29.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.725 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -135.4 140.05 44.66 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -92.76 138.83 31.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -144.43 147.91 33.93 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.46 146.52 50.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.647 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.07 168.98 8.2 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.89 143.47 66.75 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.919 1.746 . . . . 0.0 108.908 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.05 -15.25 61.51 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.842 -0.536 . . . . 0.0 110.868 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.25 -1.82 57.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.597 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 89.0 t80 -81.7 133.83 51.68 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 122.761 0.424 . . . . 0.0 111.059 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.4 Cg_exo -78.95 106.19 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.572 2.182 . . . . 0.0 112.256 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.665 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 t 62.67 -158.64 0.32 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -139.59 111.59 7.43 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.49 -82.99 1.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 55.68 73.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.433 1.093 . . . . 0.0 111.517 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 82.2 mttt -121.81 99.4 44.49 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.622 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HB2' ' HG2' ' A' ' 19' ' ' GLU . 47.2 Cg_endo -71.67 138.91 32.9 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.104 1.869 . . . . 0.0 112.914 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.06 143.09 41.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 27.6 mtmm -74.43 108.51 7.25 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.15 144.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.112 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -75.52 115.67 15.43 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.297 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.2 p -83.85 162.75 51.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.957 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.47 -18.03 44.25 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.419 2.746 . . . . 0.0 114.782 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.04 -5.52 59.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.884 0.373 . . . . 0.0 111.803 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.41 9.54 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.568 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -140.33 166.25 25.2 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -113.65 147.51 37.99 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.212 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 146.7 28.67 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 7' ' ' PRO . 31.1 tt0 -92.32 105.89 18.0 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.56 145.56 48.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.296 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.82 128.37 46.25 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.09 144.7 93.07 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.453 2.102 . . . . 0.0 113.789 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.03 -42.51 23.64 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.726 1.211 . . . . 0.0 109.447 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -145.31 141.4 28.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.43 139.97 49.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 123.31 0.381 . . . . 0.0 110.009 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -146.33 158.2 43.86 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.95 125.78 38.22 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.3 mp -79.73 89.6 5.19 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.76 116.6 34.53 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.662 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.28 -48.85 12.33 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.695 1.597 . . . . 0.0 107.986 172.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp 177.92 -64.52 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.044 -1.435 . . . . 0.0 108.197 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.59 103.77 2.09 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.5 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -169.91 -79.23 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -172.11 -56.13 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.071 1.749 . . . . 0.0 106.693 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 112.56 2.34 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.564 -1.815 . . . . 0.0 108.564 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' A' ' 53' ' ' LYS . 59.4 t -75.33 105.42 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -80.68 125.93 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.534 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.0 mt -132.26 139.36 50.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.1 147.39 17.3 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 58.5 tp -94.9 130.01 41.68 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.5 m-85 -124.89 176.4 6.66 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 122.917 0.487 . . . . 0.0 110.084 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -130.58 115.84 17.31 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.61 126.02 92.01 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 -20.47 25.38 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 122.196 1.931 . . . . 0.0 113.39 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -60.46 2.1 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 39.8 p -82.52 -32.05 28.89 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.04 -3.88 62.45 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.113 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.3 ptpt -80.98 153.63 27.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 10.2 m-85 -90.9 125.37 35.74 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.138 177.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.69 139.78 47.83 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 39.4 ptt180 -94.06 138.3 32.29 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -143.99 144.51 31.71 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HE2' HG13 ' A' ' 36' ' ' VAL . 61.1 tttm -62.53 142.94 57.73 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.655 0.597 . . . . 0.0 109.761 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 25.5 mt -102.39 172.14 4.62 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -67.01 139.77 52.25 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.093 1.862 . . . . 0.0 107.708 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -74.84 -11.17 60.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.718 -0.614 . . . . 0.0 110.382 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -95.39 0.52 53.57 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.714 1.205 . . . . 0.0 110.448 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' OH ' ' HB2' ' A' ' 6' ' ' LYS . 77.4 t80 -80.75 119.49 76.33 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.36 104.71 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.487 2.125 . . . . 0.0 112.444 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.56 -179.728 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 C--O 1.217 -0.616 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -57.9 113.59 1.94 Allowed 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 111.806 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m 63.75 44.56 4.93 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.289 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.88 92.99 1.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.184 -1.967 . . . . 0.0 108.184 173.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 21' ' ' VAL . 22.1 pttm -92.13 147.37 22.99 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.119 0.962 . . . . 0.0 113.576 -170.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 7.9 tmtt? -150.19 104.6 3.15 Favored Pre-proline 0 N--CA 1.414 -2.243 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 168.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -83.28 149.25 13.26 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.946 1.764 . . . . 0.0 112.373 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.0 p -121.52 144.92 29.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -73.57 108.39 6.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.8 p -121.28 141.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.05 -174.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.93 117.26 19.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 46.0 p -85.96 169.01 16.74 Favored Pre-proline 0 C--N 1.286 -2.191 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 31.2 Cg_exo -63.16 -22.26 72.82 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.143 2.562 . . . . 0.0 111.079 174.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.8 -14.75 62.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.51 4.74 62.12 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.17 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -115.64 161.09 19.16 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.496 -0.414 . . . . 0.0 110.049 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 52.6 mt-10 -102.29 135.57 43.66 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.132 0.492 . . . . 0.0 110.521 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.5 45.26 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.9 mt-10 -89.85 105.22 17.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.98 138.14 51.76 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.961 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 5' ' ' LYS . 6.9 p -94.59 121.75 62.44 Favored Pre-proline 0 N--CA 1.415 -2.213 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.11 140.55 90.11 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.472 2.114 . . . . 0.0 113.013 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.2 -43.65 77.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.276 1.036 . . . . 0.0 109.005 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.32 138.34 38.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.201 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.06 144.41 32.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.191 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -152.2 161.84 42.02 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.57 128.16 32.69 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.248 0.547 . . . . 0.0 111.497 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -93.54 94.79 8.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.887 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.83 110.35 63.61 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.3 -69.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.19 1.926 . . . . 0.0 111.505 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -164.4 115.47 1.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.884 0.473 . . . . 0.0 110.153 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.16 45.34 96.24 Favored Glycine 0 C--N 1.318 -0.469 0 O-C-N 123.505 0.503 . . . . 0.0 112.724 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.536 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -127.07 167.4 16.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.83 -34.95 76.34 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.31 120.67 4.77 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.245 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.6 t -76.08 103.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -86.83 137.02 32.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.224 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 60.5 mt -136.38 141.47 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 147.32 18.37 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.5 tp -95.76 124.12 39.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -118.97 170.1 9.32 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.697 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -117.21 125.99 52.05 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.584 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 16.0 t70 -69.56 132.54 89.26 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.9 -12.52 10.84 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.118 1.879 . . . . 0.0 114.185 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -97.48 -51.02 4.29 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.367 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 p -88.27 -37.28 16.16 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.899 0.479 . . . . 0.0 110.522 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -4.98 55.15 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.513 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -81.44 151.95 27.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.175 0.487 . . . . 0.0 111.641 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -89.63 125.33 35.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.184 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -127.25 140.66 52.07 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -101.4 136.6 40.96 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.63 143.82 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.47 139.54 51.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.79 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.67 174.78 3.53 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.62 141.46 73.11 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 N-CA-C 108.183 -1.507 . . . . 0.0 108.183 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -26.05 68.39 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.226 0.536 . . . . 0.0 110.998 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.11 12.19 37.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.194 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -72.8 128.08 88.72 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.16 103.34 1.73 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.647 1.565 . . . . 0.0 113.397 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.739 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mtp . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -110.23 111.98 23.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 p -67.23 104.9 1.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.433 0.635 . . . . 0.0 111.413 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.52 -44.63 0.13 Allowed Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.376 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -73.07 132.24 43.09 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.566 0.698 . . . . 0.0 111.792 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -116.5 96.17 47.44 Favored Pre-proline 0 C--N 1.293 -1.875 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.153 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.32 143.65 14.03 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.407 2.072 . . . . 0.0 110.995 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.12 135.69 37.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -70.43 109.31 4.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -127.77 145.94 34.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.554 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 67.4 mttm -78.06 124.47 28.07 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -81.63 163.12 55.57 Favored Pre-proline 0 C--N 1.282 -2.333 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 -7.1 20.49 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.482 2.122 . . . . 0.0 111.404 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.89 -32.37 20.24 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.177 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.96 -39.44 1.66 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.808 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -71.67 164.91 25.06 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 120.844 0.354 . . . . 0.0 110.379 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 33.2 mt-10 -115.77 129.25 56.38 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.48 147.49 37.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.178 0.299 . . . . 0.0 110.209 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.53 105.26 11.64 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.61 138.14 51.65 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.948 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.39 122.08 63.72 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.86 146.41 77.96 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.89 2.393 . . . . 0.0 113.39 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -67.0 -45.94 76.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.45 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -149.63 152.55 35.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.598 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.68 151.14 33.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 123.576 0.547 . . . . 0.0 110.465 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -148.72 161.4 41.85 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.133 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.53 137.31 40.14 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.857 0.36 . . . . 0.0 111.289 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.47 119.98 41.09 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.12 90.91 47.7 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.21 105.55 2.1 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 122.708 2.272 . . . . 0.0 112.233 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 70.08 -64.08 0.37 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.682 1.593 . . . . 0.0 112.124 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.03 111.44 0.49 Allowed Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -159.95 163.8 33.9 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -79.3 -9.8 59.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.061 0.934 . . . . 0.0 108.712 176.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 100.12 108.14 2.96 Favored Glycine 0 N--CA 1.418 -2.563 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.834 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.99 112.44 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 60.0 mttp -99.1 136.3 39.26 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.847 -171.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -132.33 136.77 55.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.75 146.43 16.2 Favored Glycine 0 N--CA 1.422 -2.233 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.2 tp -96.6 123.68 40.35 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.79 174.17 6.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.664 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -132.41 127.56 35.65 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.0 t70 -86.93 116.34 65.69 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 11.3 Cg_exo -72.34 -8.68 23.11 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.006 2.471 . . . . 0.0 113.108 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.3 -53.57 4.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.507 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.3 p -84.68 -30.73 24.58 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.225 0.536 . . . . 0.0 111.1 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.71 30.62 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.177 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -123.53 152.0 42.26 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.789 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.22 135.51 33.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -137.06 139.86 41.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -99.37 129.57 45.58 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -134.37 147.48 50.53 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 38.7 ttmt -66.83 140.77 57.83 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mt -101.51 172.4 4.47 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -67.17 139.52 50.74 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.607 1.538 . . . . 0.0 109.641 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.45 -30.48 68.54 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.098 0.475 . . . . 0.0 110.539 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.31 -1.09 57.2 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.895 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -74.76 126.65 88.25 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 121.599 -0.688 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.86 120.99 6.01 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 112.581 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.131 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -55.08 112.1 0.99 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.237 0.615 . . . . 0.0 110.261 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -109.36 40.66 1.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.581 -175.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.2 29.53 5.57 Favored Glycine 0 C--O 1.236 0.256 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -139.09 -179.34 5.79 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -141.21 118.02 7.57 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.305 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 14.0 Cg_endo -72.35 141.91 36.24 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.597 1.532 . . . . 0.0 110.134 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 141.8 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.82 109.08 5.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.12 146.27 31.07 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.847 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -79.08 120.7 24.0 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.573 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.0 p -78.48 161.3 70.29 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.063 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.66 -15.99 37.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.487 2.125 . . . . 0.0 110.194 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.41 -51.28 24.84 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.893 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.8 -17.09 2.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.93 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -92.24 168.3 11.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -110.71 130.69 55.51 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.912 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.26 152.46 51.54 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.96 104.74 16.57 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.62 141.93 44.58 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.9 p -93.13 125.55 54.33 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.96 116.86 3.94 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 121.403 1.402 . . . . 0.0 110.525 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.81 -17.61 62.14 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.247 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -152.76 140.26 19.71 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.46 138.95 52.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 123.27 0.356 . . . . 0.0 110.421 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -152.24 154.32 35.51 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.4 137.92 54.04 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 5.2 mp -112.08 106.78 15.51 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . . . -97.51 102.1 12.0 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.301 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 8.4 Cg_exo -73.94 154.46 48.01 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.024 1.816 . . . . 0.0 109.847 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -61.32 -44.59 96.95 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.81 26.72 20.14 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -136.07 -176.81 4.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -87.38 -56.43 3.36 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.393 0.616 . . . . 0.0 110.053 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 29' ' ' ALA . . . 150.31 137.17 2.67 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.56 124.31 70.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.325 0.583 . . . . 0.0 109.998 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.83 128.27 43.62 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.247 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 47.4 mt -125.27 140.54 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.019 0.438 . . . . 0.0 109.99 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -128.05 149.92 18.26 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 tp -94.25 126.13 39.3 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.81 166.61 14.09 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.377 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -126.93 122.68 35.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 18.2 t70 -65.83 129.57 94.32 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 -4.18 12.5 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.869 2.379 . . . . 0.0 113.095 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 16.6 tp10 -93.79 -51.46 4.89 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.329 0.585 . . . . 0.0 109.647 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.422 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 31.2 p -108.78 -22.01 12.41 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.72 11.99 69.89 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.538 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 ptpt -84.31 147.64 27.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.58 142.71 27.47 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.645 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -149.99 138.97 21.03 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -93.15 139.76 30.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -143.01 143.7 32.0 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.282 0.1 OUTLIER -74.46 140.19 44.45 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.604 179.529 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' A' ' 39' ' ' GLY . 17.8 mt -85.86 -177.22 0.89 Allowed Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -67.27 132.94 28.98 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 105.185 -2.659 . . . . 0.0 105.185 166.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.43 -7.97 54.74 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.921 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.34 -14.4 40.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.363 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -60.16 129.56 88.62 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.204 1.001 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.15 118.24 2.29 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.678 2.252 . . . . 0.0 112.757 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--N 1.293 -1.854 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.671 177.045 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 CA--C 1.509 -0.629 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 60.44 68.67 0.74 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.467 1.107 . . . . 0.0 111.367 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.5 m -90.53 -6.82 54.27 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.392 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.11 76.05 2.1 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -141.32 -174.19 3.96 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -152.1 131.41 6.75 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.67 136.4 45.8 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.913 1.742 . . . . 0.0 111.462 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.3 p -114.23 149.78 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.36 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -68.71 109.18 3.7 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.29 136.56 60.46 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.944 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 60.9 mttp -79.37 115.72 19.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -85.42 166.48 30.33 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.52 -18.69 64.76 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.556 2.171 . . . . 0.0 111.875 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.43 -14.82 62.27 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.94 50.11 4.51 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.017 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 22.1 ptmt -148.43 164.77 33.13 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 36.2 mt-10 -106.06 120.37 41.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.02 149.43 50.37 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -90.01 104.15 16.75 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -118.01 147.23 43.41 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.638 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.18 129.36 26.44 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.0 129.92 20.54 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.225 1.284 . . . . 0.0 111.645 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.25 -51.18 60.08 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.973 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -132.78 153.26 51.41 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.685 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.66 148.65 33.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 124.266 0.979 . . . . 0.0 109.429 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -157.18 163.97 38.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.47 132.91 39.84 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.127 0.489 . . . . 0.0 110.36 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 mp -97.99 92.11 5.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 100.31 52.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.12 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 34.5 Cg_exo -62.46 -69.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.717 2.278 . . . . 0.0 112.426 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -168.62 -50.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.568 0.347 . . . . 0.0 111.893 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -128.58 40.37 1.73 Allowed Glycine 0 C--N 1.317 -0.507 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.809 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 99.4 mtt180 -129.36 25.98 5.42 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.55 -65.42 0.35 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.358 1.063 . . . . 0.0 112.514 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.44 118.82 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.31 116.67 37.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -89.16 131.04 35.48 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 66.8 mt -134.42 142.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.95 150.32 19.34 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.0 tp -94.63 124.29 38.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -117.62 170.66 8.59 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.076 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.82 125.87 45.45 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.06 119.99 79.53 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.46 -24.79 42.18 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.82 2.347 . . . . 0.0 114.164 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.22 -21.86 17.04 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.8 p -111.45 -18.73 12.8 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.672 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 9.74 85.27 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.522 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -100.22 156.97 16.92 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.515 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -94.82 146.99 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.49 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -147.57 139.47 24.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -94.49 133.46 38.08 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -141.38 149.53 41.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 21.5 ptmt -69.46 150.38 47.28 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.467 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.86 171.16 5.23 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.014 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.34 148.72 80.28 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.922 2.415 . . . . 0.0 109.167 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.55 -23.53 63.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.84 4.62 53.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.369 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -73.12 122.66 88.2 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.7 101.45 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.813 2.342 . . . . 0.0 113.783 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 C--N 1.31 -1.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.91 175.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.8 mtmt . . . . . 0 C--O 1.216 -0.692 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -92.5 155.67 2.99 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 122.781 2.32 . . . . 0.0 114.761 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 11.9 p -130.96 152.0 36.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -76.54 110.92 11.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -132.71 144.71 35.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.508 0.67 . . . . 0.0 111.865 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 65.6 mttm -81.56 139.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.636 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 19.8 p -94.01 159.05 35.16 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 16.5 Cg_exo -67.18 -17.42 50.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.0 2.467 . . . . 0.0 111.479 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.06 -11.53 52.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.767 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.53 20.13 10.52 Favored Glycine 0 C--O 1.24 0.53 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.147 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.24 167.9 9.45 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 51.4 mt-10 -135.91 115.01 12.32 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 163.94 35.57 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.17 105.11 17.12 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.7 152.69 24.49 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.424 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.96 126.41 36.82 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.297 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 35.9 Cg_endo -70.07 130.5 19.06 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.833 1.689 . . . . 0.0 111.545 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 4.6 mm-40 -81.36 -27.43 34.9 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.534 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -144.22 131.11 20.34 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.04 138.66 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 O-C-N 123.364 0.415 . . . . 0.0 110.884 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -142.1 158.42 43.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.928 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 154.18 39.7 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.396 0.617 . . . . 0.0 111.526 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.0 mp -129.66 96.11 4.16 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.46 96.11 30.1 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 4.0 Cg_exo -82.22 139.44 10.53 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.653 2.235 . . . . 0.0 110.06 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.53 126.89 30.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.158 0.504 . . . . 0.0 110.92 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -2.3 75.91 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 33' ' ' ARG . 3.4 mmp_? -118.6 -167.54 1.39 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -107.89 150.12 27.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.65 90.56 1.36 Allowed Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.37 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.3 151.82 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -130.2 151.36 50.81 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 74.2 mt -136.82 135.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.79 147.33 16.47 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.5 tp -95.26 126.17 40.4 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.16 170.89 9.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.184 0.594 . . . . 0.0 109.894 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -113.64 128.94 56.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 16.0 t70 -80.58 121.77 81.66 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.74 -1.55 11.7 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 113.305 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.41 -50.62 4.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.376 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 41.3 p -94.44 -37.29 11.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.469 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.3 -6.04 34.0 Favored Glycine 0 N--CA 1.427 -1.948 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.139 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 19.2 ptpt -79.96 163.55 24.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.445 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 40' ' ' LEU . 74.2 m-85 -97.88 131.46 44.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -129.11 139.62 51.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -91.21 142.32 27.85 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -146.75 136.07 22.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 5.4 ptmt -64.26 135.35 56.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.441 0.639 . . . . 0.0 111.104 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.06 169.96 7.96 Favored Pre-proline 0 C--N 1.271 -2.843 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 19.5 Cg_exo -66.95 151.63 81.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.941 1.761 . . . . 0.0 109.477 175.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.04 -19.11 61.89 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.927 -0.483 . . . . 0.0 111.536 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.86 -1.82 54.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.541 0.686 . . . . 0.0 110.704 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 52.1 t80 -65.67 127.2 92.87 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.07 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.65 104.53 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.403 2.069 . . . . 0.0 113.652 -175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 60' ' ' ILE . 48.2 pt . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' ' CE1' ' A' ' 58' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.108 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 56.5 Cg_endo -84.27 174.85 7.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 121.902 1.735 . . . . 0.0 112.348 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.65 140.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 55.4 tttp -74.41 109.25 7.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.22 142.75 43.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.614 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -76.71 119.55 20.66 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.522 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 p -92.35 173.0 5.54 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.133 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.02 -14.56 38.66 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.003 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.34 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.938 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 1.69 49.32 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.628 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.87 156.56 18.56 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 41.0 tt0 -116.34 107.14 14.45 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.79 34.17 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.97 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 1.7 mp0 -80.55 108.99 14.65 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.363 0.601 . . . . 0.0 110.707 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.51 146.13 45.72 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.3 p -96.62 127.22 40.42 Favored Pre-proline 0 N--CA 1.419 -1.99 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.3 136.29 71.23 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.426 2.084 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.85 -42.33 81.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HG3' ' CZ3' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -147.64 150.19 33.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 ' HB ' ' A' ' 60' ' ' ILE . 32.2 m -124.36 150.57 29.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.409 ' CZ3' ' HG3' ' A' ' 24' ' ' LYS . 21.9 p90 -156.4 168.56 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.24 147.38 43.66 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.17 113.94 23.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.049 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.6 100.0 10.31 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.68 -67.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.298 1.999 . . . . 0.0 111.896 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -124.35 -142.53 0.31 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.93 84.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.28 0 O-C-N 122.997 0.186 . . . . 0.0 112.994 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -149.69 154.12 38.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 32.3 mmtp -42.6 -45.5 4.62 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.475 1.11 . . . . 0.0 113.216 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.45 90.27 2.01 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 m -74.46 115.96 16.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.881 0.848 . . . . 0.0 112.221 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 63.2 mttp -80.97 131.08 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.096 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.7 mt -134.45 142.11 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.25 149.24 18.53 Favored Glycine 0 N--CA 1.424 -2.1 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.44 125.62 43.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 90.0 m-85 -119.52 171.91 8.02 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.714 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -130.45 121.99 26.88 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.4 129.72 85.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.12 -31.5 29.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.145 1.897 . . . . 0.0 114.478 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -97.55 -34.96 10.78 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -88.44 -25.34 22.69 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.466 0.65 . . . . 0.0 109.688 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.56 -5.64 82.85 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.052 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -82.46 150.92 26.78 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 89.5 m-85 -95.09 126.47 40.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.612 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -130.55 139.17 50.47 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -96.08 128.3 42.86 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.51 144.06 47.81 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 62.3 tttt -60.27 139.26 57.7 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 124.039 0.837 . . . . 0.0 109.36 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 31.6 mt -96.99 168.51 10.17 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.98 141.76 65.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.569 1.513 . . . . 0.0 109.728 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.34 -41.87 52.11 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.966 0.906 . . . . 0.0 111.181 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.36 15.63 20.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.965 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 84.8 t80 -83.31 120.95 76.56 Favored Pre-proline 0 C--O 1.216 -0.66 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.47 114.35 4.01 Favored 'Trans proline' 0 C--O 1.248 1.001 0 C-N-CA 122.096 1.864 . . . . 0.0 112.587 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.4 ' HB ' HG21 ' A' ' 25' ' ' VAL . 37.6 pt . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 118.446 -0.787 . . . . 0.0 110.034 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.09 164.52 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.783 2.322 . . . . 0.0 113.409 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.1 p -139.27 151.31 22.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -67.84 109.11 3.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -130.3 146.72 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.48 130.73 35.03 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.578 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.7 p -89.9 161.48 38.32 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -71.77 -9.49 24.94 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.786 2.324 . . . . 0.0 109.85 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB1' ' HZ3' ' A' ' 16' ' ' LYS . . . -82.82 -5.93 59.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.093 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.75 -13.69 57.77 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 173.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HZ3' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -114.71 174.03 6.17 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.8 -0.823 . . . . 0.0 111.559 -178.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.73 153.77 20.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.163 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 152.19 27.53 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.2 mt-10 -89.46 104.43 16.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -112.96 147.98 35.99 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.72 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.38 123.14 63.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.57 132.81 28.08 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.964 1.776 . . . . 0.0 112.085 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -47.68 24.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -137.38 142.04 41.73 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.03 144.36 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.373 . . . . 0.0 110.46 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -151.71 164.2 37.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.26 39.63 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.705 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.37 102.8 12.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.63 105.54 45.67 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 13.1 Cg_exo -77.97 3.81 6.68 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.997 2.465 . . . . 0.0 112.831 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 71.67 107.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.042 1.337 . . . . 0.0 111.893 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.63 12.17 38.75 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 92.7 mtt180 -137.63 -166.7 1.99 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -80.34 154.37 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.58 103.87 2.92 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.59 98.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.18 130.03 34.69 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.105 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.39 140.54 47.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -130.11 149.02 18.77 Favored Glycine 0 N--CA 1.416 -2.636 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 tp -96.13 126.24 41.22 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 92.1 m-85 -121.25 170.34 9.68 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -122.25 119.5 31.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.578 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 17.8 t70 -64.86 135.36 96.36 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.85 -21.26 16.4 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.45 2.1 . . . . 0.0 114.575 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.32 -51.12 4.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.438 0.637 . . . . 0.0 111.61 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -86.65 -29.4 22.53 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.72 85.95 Favored Glycine 0 N--CA 1.431 -1.653 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.209 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.0 144.12 41.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.083 0.441 . . . . 0.0 110.995 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 56.5 m-85 -83.37 125.12 31.32 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -126.37 139.74 53.04 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.633 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -96.91 123.82 40.72 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -134.87 147.86 49.98 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 54.3 tttm -62.1 142.51 57.54 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 123.737 0.648 . . . . 0.0 110.122 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 30.7 mt -98.7 171.13 6.08 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.83 73.67 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.837 1.692 . . . . 0.0 109.368 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.42 -33.67 72.84 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 123.688 0.795 . . . . 0.0 110.536 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.19 5.15 51.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.309 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -77.45 123.53 86.82 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.63 120.17 6.31 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.66 2.24 . . . . 0.0 111.959 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.298 -1.655 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.157 178.338 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 39.9 pttt . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 120.948 0.404 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.71 124.64 4.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.391 2.061 . . . . 0.0 113.055 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.98 149.03 8.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.06 109.27 6.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -135.61 145.61 31.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.238 0.542 . . . . 0.0 110.534 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -89.3 134.66 33.97 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.076 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -83.63 169.09 18.4 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.541 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -70.99 -22.17 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.269 1.979 . . . . 0.0 109.095 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -51.99 66.29 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.423 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.0 -0.17 3.99 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.985 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.47 160.01 15.97 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.62 137.41 39.97 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 163.57 36.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.27 105.4 17.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.54 138.55 51.83 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.57 123.29 67.02 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.304 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.41 142.77 37.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.052 1.835 . . . . 0.0 111.65 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -69.38 -37.27 77.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.79 157.9 38.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.86 139.04 51.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 123.759 0.662 . . . . 0.0 110.054 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -141.94 154.23 44.91 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.32 124.45 32.35 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.012 0.434 . . . . 0.0 111.499 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.1 96.05 10.57 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.47 107.41 21.08 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.627 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.71 -69.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 121.792 1.662 . . . . 0.0 110.248 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -160.04 -63.9 0.07 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.26 82.96 0.8 Allowed Glycine 0 C--N 1.316 -0.559 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -170.58 154.16 4.45 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -57.82 -46.01 85.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.588 0.631 . . . . 0.0 109.366 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.18 112.8 2.66 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.99 98.43 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.99 126.98 32.59 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -129.48 137.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.93 148.16 16.68 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 tp -97.53 121.88 39.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.0 m-85 -118.72 169.57 9.72 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 123.541 0.736 . . . . 0.0 110.195 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -112.03 124.3 52.11 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 11.9 t70 -77.67 122.92 86.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.85 -2.04 12.1 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 113.844 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -97.53 -54.17 3.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.226 0.536 . . . . 0.0 110.153 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -94.72 -17.47 22.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.722 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.93 74.08 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.982 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -106.28 163.66 12.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 122.54 -0.388 . . . . 0.0 110.312 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.0 m-85 -94.62 132.05 39.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -130.82 140.5 50.27 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.012 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -139.22 150.11 45.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.42 141.61 58.47 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 123.669 0.605 . . . . 0.0 109.617 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.55 170.76 5.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -67.12 141.81 58.93 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.05 1.834 . . . . 0.0 108.77 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.21 -21.96 63.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.099 0.476 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.61 -1.67 57.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' OH ' ' HG3' ' A' ' 6' ' ' LYS . 91.8 t80 -81.35 123.24 81.45 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.8 Cg_endo -78.35 111.78 3.09 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.974 1.783 . . . . 0.0 109.888 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 C--N 1.296 -1.756 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.323 -179.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.0 Cg_endo -75.43 159.46 39.75 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.793 1.662 . . . . 0.0 112.586 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.4 146.87 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -69.06 109.84 4.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.34 139.16 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 121.727 0.775 . . . . 0.0 111.822 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 64.8 mttm -80.98 115.71 20.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.26 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -87.85 158.8 50.05 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.261 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 9.9 Cg_exo -71.03 -12.86 31.04 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.873 2.382 . . . . 0.0 110.702 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.91 64.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.516 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.9 9.42 24.52 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.601 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.26 26.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.706 177.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 48.2 mt-10 -94.31 121.48 35.87 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.34 138.73 52.51 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.93 105.54 14.02 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.27 151.29 39.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.381 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -100.55 127.61 32.28 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.59 143.31 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.008 1.805 . . . . 0.0 112.397 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.85 -37.55 64.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.42 149.01 28.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.91 149.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 123.57 0.544 . . . . 0.0 110.395 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -156.74 159.88 38.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.66 137.08 49.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.9 91.85 7.12 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.22 84.34 20.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.731 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -79.91 89.51 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 121.676 1.584 . . . . 0.0 111.443 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.279 19.2 ptpt 57.37 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 127.301 2.241 . . . . 0.0 116.256 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.0 70.76 0.29 Allowed Glycine 0 N--CA 1.432 -1.607 0 O-C-N 121.971 -0.456 . . . . 0.0 112.544 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -161.07 148.76 15.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.1 -39.18 91.62 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.385 0.428 . . . . 0.0 110.236 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.77 105.82 2.91 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.098 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.15 107.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.906 0.86 . . . . 0.0 109.116 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.46 131.35 34.67 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.753 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.84 140.47 48.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.94 149.49 18.83 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.32 123.47 41.15 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.0 m-85 -118.11 179.9 3.96 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.5 0.72 . . . . 0.0 110.563 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.7 tttp -128.96 113.44 15.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 10.1 t70 -65.94 133.21 94.82 Favored Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.031 0.932 . . . . 0.0 112.54 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.36 -31.37 62.53 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 123.375 2.717 . . . . 0.0 115.986 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.77 -30.69 12.64 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.615 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -104.21 -20.73 13.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.85 -2.68 67.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.661 -0.304 . . . . 0.0 113.524 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -78.35 160.74 27.65 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.934 0.397 . . . . 0.0 111.266 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 42.2 m-85 -93.0 120.63 33.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.334 176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.46 139.83 53.52 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -93.71 135.85 34.58 Favored 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.368 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -139.61 146.38 39.71 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.5 tttt -64.51 140.28 58.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 28.8 mt -96.51 176.06 2.34 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.93 140.04 53.55 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.663 1.575 . . . . 0.0 108.788 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.31 -24.11 67.12 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -108.28 15.02 24.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.112 -0.367 . . . . 0.0 111.595 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -68.8 128.81 92.76 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.27 108.0 1.28 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 123.341 2.694 . . . . 0.0 114.971 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.424 -1.727 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 69.5 Cg_endo -93.85 -171.37 0.27 Allowed 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 123.117 2.545 . . . . 0.0 112.666 -175.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.45 146.0 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -71.73 110.6 6.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.37 143.07 42.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 120.836 0.35 . . . . 0.0 111.153 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 61.1 mttp -76.08 117.02 17.35 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.097 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 26.1 p -95.49 165.22 17.15 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.808 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 -23.08 73.95 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.34 2.693 . . . . 0.0 112.262 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.15 -17.05 64.68 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.31 49.38 4.98 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.557 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.22 159.99 44.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 41.6 mt-10 -106.2 111.76 24.5 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.28 150.83 41.79 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.65 104.57 15.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -115.49 138.12 51.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.527 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -90.77 123.58 64.61 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.25 139.89 62.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.087 1.858 . . . . 0.0 111.907 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -73.2 -49.46 27.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -134.94 143.73 47.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.718 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.62 145.17 31.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 O-C-N 123.505 0.503 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.32 151.92 31.48 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.49 124.32 44.14 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.194 0.521 . . . . 0.0 110.271 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.85 112.93 24.62 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.83 86.48 24.78 Favored Pre-proline 0 C--N 1.305 -1.369 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.783 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.51 149.19 23.92 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.657 2.238 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -71.49 100.53 2.25 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.24 -13.31 5.98 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.95 -176.14 3.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.89 -179.45 4.57 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.78 123.75 6.19 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.64 112.72 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 65.9 mttp -84.6 125.5 32.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.4 mt -131.09 142.14 44.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.0 148.29 18.43 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 49' ' ' TYR . 65.1 tp -98.07 126.32 43.45 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 91.2 m-85 -125.63 168.19 14.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.292 0.637 . . . . 0.0 110.567 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -120.13 114.81 22.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 15.3 t70 -58.14 132.36 84.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.893 0.877 . . . . 0.0 111.032 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.74 -19.83 30.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.935 2.423 . . . . 0.0 114.728 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.16 -54.08 3.18 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.67 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -82.71 -33.1 27.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.13 18.19 59.72 Favored Glycine 0 N--CA 1.426 -1.98 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.837 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.86 161.42 13.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.388 0.594 . . . . 0.0 110.755 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 61.9 m-85 -89.45 133.12 34.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.647 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.77 139.74 42.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -100.48 125.76 46.82 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -136.73 145.19 44.37 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.2 tttt -60.94 144.01 53.98 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.549 0.531 . . . . 0.0 109.958 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.3 mt -101.37 170.58 6.33 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.73 141.17 71.03 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.701 1.601 . . . . 0.0 109.319 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.43 -30.58 63.0 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.547 0.739 . . . . 0.0 112.37 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.71 18.7 21.53 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 77.3 t80 -78.84 128.31 77.2 Favored Pre-proline 0 C--N 1.316 -0.859 0 O-C-N 122.458 -0.151 . . . . 0.0 110.774 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.64 119.97 6.74 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 122.307 2.005 . . . . 0.0 111.442 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.727 179.646 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 95.6 mttt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-O 119.294 -0.384 . . . . 0.0 110.062 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -90.34 156.82 4.56 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.954 2.436 . . . . 0.0 112.507 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.4 154.92 22.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.18 115.83 14.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.11 138.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-O 121.17 0.51 . . . . 0.0 109.678 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -91.15 118.69 30.64 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.674 0.749 . . . . 0.0 109.16 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -69.5 161.02 76.86 Favored Pre-proline 0 C--N 1.281 -2.373 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.712 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.99 -19.49 57.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.76 2.307 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.86 -25.02 60.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.42 -13.42 12.2 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.5 -0.857 . . . . 0.0 114.715 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -88.7 147.28 24.58 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.155 0.977 . . . . 0.0 110.995 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.35 121.8 34.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.09 158.25 44.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -94.87 105.47 17.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.85 153.97 41.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.827 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -107.25 128.52 25.85 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.885 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 34.7 Cg_endo -68.18 137.84 41.65 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.804 1.669 . . . . 0.0 112.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.43 -44.5 44.11 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.293 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -137.51 146.69 44.49 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.38 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.11 144.65 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 O-C-N 123.654 0.596 . . . . 0.0 109.878 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -152.73 155.58 37.48 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.28 134.12 55.33 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.96 0.409 . . . . 0.0 111.35 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.49 120.67 41.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . . . -98.91 122.34 53.04 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.859 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 3.3 Cg_endo -86.13 61.77 4.95 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.752 2.302 . . . . 0.0 109.505 173.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 64.15 53.53 1.78 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.763 1.225 . . . . 0.0 110.462 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.07 -118.6 6.01 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.392 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 70.97 -66.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 110.734 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 179.55 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.79 132.5 4.14 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.99 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.62 118.6 33.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.03 125.41 41.46 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.9 mt -124.56 136.94 58.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.76 148.27 16.71 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 49' ' ' TYR . 57.3 tp -98.85 125.82 44.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 89.6 m-85 -120.25 168.85 10.82 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 123.201 0.601 . . . . 0.0 109.907 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -131.9 120.0 21.93 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.62 124.23 83.79 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 -14.75 25.03 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.772 2.315 . . . . 0.0 113.721 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.34 -46.83 7.18 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.734 0.302 . . . . 0.0 111.28 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 p -82.84 -36.8 25.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.485 0.66 . . . . 0.0 109.268 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 25.62 24.56 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.213 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -124.44 162.68 23.4 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.672 0.736 . . . . 0.0 111.491 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 40' ' ' LEU . 59.8 m-85 -91.64 142.99 27.02 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.212 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.93 139.92 25.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -94.92 141.53 28.54 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -146.95 149.0 32.32 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.264 0.0 OUTLIER -78.25 145.03 35.69 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.073 -179.966 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.6 mt -96.64 172.92 4.56 Favored Pre-proline 0 C--N 1.276 -2.598 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.51 142.88 66.86 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.449 1.433 . . . . 0.0 109.275 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.02 -24.32 67.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 0.0 111.288 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.32 -12.91 45.09 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.5 t80 -64.62 121.15 71.44 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.504 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 7.2 Cg_endo -79.08 107.78 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.157 1.904 . . . . 0.0 112.587 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 N--CA 1.426 -1.637 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.827 177.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 pttm . . . . . 0 C--O 1.236 0.383 0 CA-C-O 119.834 -0.127 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 12.1 Cg_endo -58.47 141.06 96.91 Favored 'Trans proline' 0 C--O 1.256 1.378 0 C-N-CA 122.957 2.438 . . . . 0.0 113.989 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.17 150.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.24 109.13 8.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.55 153.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.619 -173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 16.3 ptpt -88.22 134.22 33.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -102.2 172.61 4.2 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.664 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.79 -10.44 27.73 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.962 2.441 . . . . 0.0 111.841 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.48 -5.79 51.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.08 33.59 28.94 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.944 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.79 168.55 19.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 11' ' ' LYS . 42.6 mt-10 -120.26 130.75 54.64 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 165.11 32.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.38 110.7 21.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.204 0.526 . . . . 0.0 109.889 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 79.3 mt -122.16 152.21 40.18 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.721 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.34 124.5 42.74 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.23 131.69 21.09 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 121.779 1.653 . . . . 0.0 110.323 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.95 -34.34 66.46 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.801 0.81 . . . . 0.0 109.175 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -144.66 144.17 31.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 139.79 50.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.707 0.629 . . . . 0.0 109.798 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -147.28 148.01 30.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 110.861 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.21 129.99 53.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.891 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.08 89.49 3.08 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.82 84.41 25.44 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.837 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 33' ' ' ARG . 6.2 Cg_exo -75.68 125.68 9.03 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.115 1.877 . . . . 0.0 108.194 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.92 106.16 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.32 -12.75 8.42 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 mpt_? -105.45 -173.22 2.25 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.505 -0.409 . . . . 0.0 111.328 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -70.6 -50.05 41.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.14 103.42 1.6 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.24 165.07 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.188 0.518 . . . . 0.0 111.798 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -117.82 140.24 49.97 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -131.14 138.7 52.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.74 145.34 15.86 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 50.2 tp -94.2 121.95 36.24 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.1 m-85 -114.4 172.76 6.82 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -130.63 116.42 18.06 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.72 130.5 88.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.0 -24.76 28.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.436 2.091 . . . . 0.0 114.762 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -97.45 -37.85 9.83 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 34.7 p -87.03 -36.87 17.96 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.38 -0.54 71.52 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.471 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 21.8 ptmt -85.22 143.92 28.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.326 0.584 . . . . 0.0 111.607 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.8 m-85 -83.98 129.14 34.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.97 174.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -133.58 139.69 46.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 31.6 ptt180 -93.21 133.12 36.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -136.71 148.55 47.39 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.99 139.05 58.72 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 123.936 0.772 . . . . 0.0 109.675 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.2 mt -101.93 170.59 6.24 Favored Pre-proline 0 C--N 1.293 -1.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.34 147.19 77.54 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.515 2.144 . . . . 0.0 109.939 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.32 -33.33 75.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.129 0.49 . . . . 0.0 111.144 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 7.91 31.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.919 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -84.12 115.86 62.1 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.84 117.23 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.408 2.072 . . . . 0.0 113.115 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 C--N 1.3 -1.567 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.176 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttp . . . . . 0 N--CA 1.436 -1.157 0 CA-C-O 120.988 0.423 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 46.0 Cg_endo -73.53 158.73 47.33 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.938 1.759 . . . . 0.0 111.882 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.72 151.21 34.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.99 109.47 8.47 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.62 149.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.252 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -85.85 128.36 34.8 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.597 0.713 . . . . 0.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 170.57 14.55 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.592 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 23.9 Cg_exo -66.72 -16.79 51.39 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.618 2.212 . . . . 0.0 110.788 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.34 -21.02 58.7 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.393 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.04 12.75 48.48 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.685 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.26 166.62 11.65 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.82 137.81 31.98 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.461 0.476 . . . . 0.0 110.581 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.09 154.53 21.79 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 105.36 17.76 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.556 0.693 . . . . 0.0 109.179 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.1 139.18 43.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.42 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -91.8 118.22 68.17 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.26 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.29 136.47 24.28 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.962 2.442 . . . . 0.0 113.408 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.4 -41.23 18.38 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.576 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HB2' ' HZ3' ' A' ' 26' ' ' TRP . 28.9 mtpp -129.1 143.77 50.97 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.28 137.96 50.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.447 ' HZ3' ' HB2' ' A' ' 24' ' ' LYS . 27.2 p90 -151.29 164.42 36.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.74 132.71 35.19 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.134 0.492 . . . . 0.0 110.92 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.88 95.56 9.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.17 103.24 14.09 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.61 -56.44 1.01 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.386 2.057 . . . . 0.0 111.083 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -169.85 -64.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.57 47.86 2.33 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -141.65 152.92 44.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -64.61 -33.99 77.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.088 0.867 . . . . 0.0 110.18 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.9 130.85 6.75 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.457 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.28 105.91 16.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -83.59 132.37 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.2 mt -135.64 144.11 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.74 150.95 19.84 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.7 123.38 42.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.36 168.04 11.7 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.293 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -128.23 120.97 28.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 15.3 t70 -76.61 123.74 87.7 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 -20.53 21.58 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 C-N-CA 122.332 2.021 . . . . 0.0 113.742 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.55 -45.56 8.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.964 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -82.82 -31.12 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.433 0.635 . . . . 0.0 109.515 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.28 67.34 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.867 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -90.98 154.32 19.53 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -91.14 132.13 36.26 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.962 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -135.89 139.92 43.71 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -95.81 126.39 41.04 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -130.58 144.19 51.25 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -172.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -65.98 144.04 57.0 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.693 0.62 . . . . 0.0 109.448 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.97 168.66 8.49 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.05 145.03 72.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.592 2.195 . . . . 0.0 109.16 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.25 -41.92 72.8 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -88.96 5.31 44.75 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.54 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.5 t80 -73.88 125.18 90.51 Favored Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 121.844 -0.535 . . . . 0.0 110.047 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.2 Cg_exo -76.06 113.58 3.73 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 122.318 2.012 . . . . 0.0 110.363 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.296 -1.719 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.754 0.312 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -81.08 157.26 20.28 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 121.846 1.697 . . . . 0.0 111.609 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.2 p -141.69 148.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HG2' ' OE2' ' A' ' 19' ' ' GLU . 62.2 mttm -71.52 111.51 6.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.63 138.03 55.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 121.03 0.443 . . . . 0.0 109.817 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 123.69 29.87 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 p -92.91 165.69 18.18 Favored Pre-proline 0 N--CA 1.418 -2.054 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.32 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.3 -27.01 82.62 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.051 2.5 . . . . 0.0 112.445 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.27 -25.79 63.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.652 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.62 -12.29 8.33 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.113 -1.518 . . . . 0.0 115.085 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -100.66 154.44 18.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 118.253 1.026 . . . . 0.0 110.211 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.47 106.06 14.11 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.43 165.05 18.43 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.23 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.2 mp0 -82.82 104.77 13.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.118 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.22 157.12 20.47 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.86 129.03 24.39 Favored Pre-proline 0 N--CA 1.403 -2.818 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.071 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.13 123.56 7.9 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.775 1.65 . . . . 0.0 111.351 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.52 -35.22 65.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.35 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -134.52 136.92 43.44 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 139.05 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.36 0.412 . . . . 0.0 110.4 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.53 155.39 40.25 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.74 136.51 53.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.58 0.705 . . . . 0.0 111.057 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.6 mp -108.01 100.02 9.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.81 96.34 16.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 123.243 0.34 . . . . 0.0 110.676 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 6.2 Cg_exo -80.7 155.4 20.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.523 2.149 . . . . 0.0 109.848 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.85 127.86 33.79 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.064 0.459 . . . . 0.0 110.111 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' HD2' ' A' ' 33' ' ' ARG . . . 99.36 -15.48 60.1 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.231 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 32' ' ' GLY . 6.1 mpt_? -117.46 159.06 23.42 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.324 -0.515 . . . . 0.0 110.485 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.26 -33.3 73.03 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.467 0.479 . . . . 0.0 111.19 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.85 163.07 22.23 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.74 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.28 156.75 40.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.42 137.64 51.23 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 71.9 mt -134.04 141.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.83 150.65 19.38 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.8 tp -94.8 124.99 39.16 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.14 -179.86 4.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.246 1.018 . . . . 0.0 109.162 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 49' ' ' TYR . 84.0 tttt -134.05 132.09 39.61 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.76 121.34 82.26 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.99 -9.8 20.95 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.262 1.975 . . . . 0.0 114.851 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -99.13 -41.44 7.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.105 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -92.21 -25.95 18.42 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.982 0.42 . . . . 0.0 111.088 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.64 36.46 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.065 -0.516 . . . . 0.0 113.266 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -119.85 145.23 46.85 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.642 -0.328 . . . . 0.0 110.259 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 46.0 m-85 -80.55 138.53 36.51 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.3 140.2 33.78 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -93.54 137.82 32.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -142.51 147.03 35.34 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.5 ptpt -68.94 144.53 54.14 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.179 0.514 . . . . 0.0 110.428 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.66 169.16 7.86 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 24.6 Cg_exo -67.1 151.28 81.85 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.704 2.269 . . . . 0.0 109.895 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.22 -36.16 83.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.75 6.99 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.003 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.405 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 88.6 t80 -84.69 122.85 74.77 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.47 -0.769 . . . . 0.0 109.986 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.87 98.59 1.22 Allowed 'Trans proline' 0 N--CA 1.437 -1.794 0 C-N-CA 122.444 2.096 . . . . 0.0 111.916 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.2 pt . . . . . 0 N--CA 1.423 -1.79 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.002 179.463 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -78.81 141.95 17.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.945 1.764 . . . . 0.0 111.203 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 14.6 p -120.96 149.82 23.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 60.6 mttp -75.07 108.82 8.06 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.24 141.0 47.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.162 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -78.54 115.64 18.39 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.52 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.596 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 76.6 p -83.49 165.03 42.5 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.11 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.52 -17.4 57.21 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.436 2.091 . . . . 0.0 111.18 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.28 -17.97 61.26 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.674 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.4 31.24 6.55 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 114.772 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.64 38.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.601 0.701 . . . . 0.0 109.932 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 9' ' ' LYS . 36.7 tt0 -91.84 93.57 8.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.942 0.877 . . . . 0.0 109.563 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.29 160.28 14.82 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.535 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 52.3 mt-10 -92.29 105.61 17.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.462 0.649 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.1 mt -117.54 141.89 47.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.136 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.9 p -95.63 125.08 50.69 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 12.5 Cg_exo -66.6 141.17 59.53 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.145 1.896 . . . . 0.0 114.088 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.22 -47.12 65.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -142.26 144.32 33.25 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.527 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 m -124.99 152.73 31.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -157.36 153.48 27.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.074 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.96 125.05 42.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.239 0.542 . . . . 0.0 110.761 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 5.2 mp -89.43 87.16 6.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 98.85 8.96 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.43 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.77 -66.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.646 1.564 . . . . 0.0 108.501 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 175.39 148.19 0.09 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.26 -5.6 79.67 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -105.85 150.18 25.83 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -57.88 -39.1 77.03 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.298 0.374 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.48 95.34 2.21 Favored Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 28' ' ' LEU . 24.5 t -82.19 104.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -89.69 126.23 35.57 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.502 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.6 mt -129.19 142.72 43.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.86 147.66 18.49 Favored Glycine 0 N--CA 1.422 -2.294 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.35 125.37 40.8 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 95.0 m-85 -123.23 173.98 7.57 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 122.979 0.511 . . . . 0.0 109.972 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -125.34 125.3 43.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.596 ' OD2' ' HB ' ' A' ' 12' ' ' THR . 9.0 t70 -78.38 120.03 79.56 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.5 -12.37 27.06 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.728 2.285 . . . . 0.0 115.022 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.07 -34.38 10.8 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.907 -0.496 . . . . 0.0 112.053 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -93.77 -34.41 13.21 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.29 0.567 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.69 30.83 22.93 Favored Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.373 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.94 151.34 43.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.0 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 78.3 m-85 -87.83 129.81 35.08 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.971 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -134.59 139.33 45.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -95.23 131.68 41.02 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -139.07 149.96 45.19 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.22 142.02 57.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.5 mt -97.85 -179.82 0.95 Allowed Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.12 137.87 59.02 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.579 1.519 . . . . 0.0 108.162 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.11 -20.28 57.48 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.392 0.677 . . . . 0.0 112.625 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -112.26 11.62 20.2 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.632 0.73 . . . . 0.0 111.01 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 8' ' ' VAL . 13.8 t80 -67.09 127.72 93.6 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.35 92.36 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.308 2.005 . . . . 0.0 113.535 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.202 177.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tttp . . . . . 0 N--CA 1.428 -1.573 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -80.01 159.63 23.97 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.514 1.476 . . . . 0.0 112.342 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.2 p -140.87 150.52 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -72.1 109.32 5.81 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -125.22 137.68 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 121.658 0.742 . . . . 0.0 109.859 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -83.6 119.81 25.2 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.4 p -92.18 155.64 42.64 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.8 -16.09 33.21 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.905 2.404 . . . . 0.0 110.476 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.24 72.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.343 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.3 -18.47 4.42 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.016 -1.087 . . . . 0.0 114.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 173.51 6.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 118.102 0.951 . . . . 0.0 112.141 -174.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.38 126.16 32.97 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.31 144.89 50.89 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.7 mt-10 -94.74 104.42 16.33 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.99 141.5 48.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.854 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -90.35 121.72 68.19 Favored Pre-proline 0 N--CA 1.416 -2.151 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.36 134.69 60.32 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.168 1.912 . . . . 0.0 111.448 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.62 -32.43 64.06 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.276 1.03 . . . . 0.0 108.633 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -153.02 138.74 17.89 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.74 144.86 31.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -153.9 160.66 42.23 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.68 130.62 30.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.25 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.11 97.05 8.21 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.76 97.71 32.56 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.79 -64.78 0.08 OUTLIER 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.612 2.208 . . . . 0.0 111.794 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.3 tttm 169.69 119.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.531 1.132 . . . . 0.0 108.963 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.26 43.73 89.31 Favored Glycine 0 C--O 1.246 0.886 0 CA-C-O 121.79 0.661 . . . . 0.0 111.93 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -140.21 176.2 8.96 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -70.21 107.83 3.88 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.55 89.84 0.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.63 100.47 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.252 1.025 . . . . 0.0 112.167 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.59 127.55 32.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.109 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 54.9 mt -128.86 139.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.95 145.75 15.93 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -93.9 126.18 38.96 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.31 178.46 4.52 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -129.71 125.44 35.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 11.0 t70 -63.66 127.78 91.89 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 124.074 0.859 . . . . 0.0 109.375 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 26.1 Cg_exo -63.31 -40.86 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.463 2.109 . . . . 0.0 114.183 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -88.44 -48.93 7.26 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -90.52 -19.93 23.24 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.06 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.95 0.54 89.72 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 115.003 0.761 . . . . 0.0 115.003 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -73.87 138.81 44.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 117.011 0.405 . . . . 0.0 111.272 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -81.45 121.29 26.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -126.32 139.44 53.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -96.02 134.03 39.54 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -137.33 139.95 41.17 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.21 139.19 52.24 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.035 178.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.71 173.12 6.83 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -66.61 140.0 55.23 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 N-CA-C 107.788 -1.658 . . . . 0.0 107.788 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.23 -28.31 68.63 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.34 -4.94 57.18 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.801 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -79.27 122.07 83.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -82.39 112.31 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.428 2.086 . . . . 0.0 111.658 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--N 1.298 -1.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.103 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.436 -1.165 0 CA-C-O 121.044 0.45 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.89 123.94 3.33 Favored 'Trans proline' 0 N--CA 1.425 -2.538 0 C-N-CA 121.585 1.524 . . . . 0.0 110.645 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -104.83 148.39 9.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -81.13 109.65 15.89 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.19 153.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 -172.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 54.1 mttp -86.09 135.47 33.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.032 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.7 p -88.75 170.45 11.08 Favored Pre-proline 0 N--CA 1.425 -1.676 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.06 -13.62 28.75 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.315 2.01 . . . . 0.0 112.526 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.65 -6.76 58.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.919 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.4 15.1 62.69 Favored Glycine 0 C--N 1.328 0.123 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 49.9 mtpt -98.02 163.92 12.56 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -129.41 125.64 37.0 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.727 -176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.77 164.58 36.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.32 121.57 28.25 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.35 137.89 52.89 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.22 126.15 61.61 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.99 141.02 68.67 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.11 1.873 . . . . 0.0 113.159 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG3' ' CE2' ' A' ' 49' ' ' TYR . 20.4 mm-40 -72.78 -45.61 57.64 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.919 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -139.63 148.7 42.83 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -131.83 143.5 40.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 O-C-N 123.406 0.441 . . . . 0.0 109.942 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -149.61 156.05 41.28 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.726 0.298 . . . . 0.0 110.62 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.67 125.2 33.36 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.676 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.78 92.84 7.31 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -137.6 87.74 17.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.083 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.19 -41.2 80.88 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.014 2.476 . . . . 0.0 110.685 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -171.68 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.29 92.98 0.31 Allowed Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -153.43 37.66 0.48 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 70.72 -55.04 0.64 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.017 1.727 . . . . 0.0 111.315 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 29' ' ' ALA . . . 103.96 72.74 0.91 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -74.69 114.44 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -96.89 130.7 44.15 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.8 mt -133.64 142.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.55 146.16 16.66 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp -96.19 128.14 42.83 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.74 169.54 10.02 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.977 0.418 . . . . 0.0 110.5 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -122.28 116.82 24.76 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.95 123.23 39.01 Favored Pre-proline 0 C--N 1.316 -0.881 0 C-N-CA 125.256 1.422 . . . . 0.0 109.689 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.79 -26.13 52.8 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.964 2.443 . . . . 0.0 114.087 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.05 -48.19 4.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -94.79 -13.14 25.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.405 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.25 18.67 79.12 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.862 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.97 148.04 22.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.886 0.343 . . . . 0.0 111.384 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.478 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 19.9 m-85 -87.86 128.4 35.35 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.14 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -136.47 140.45 43.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -97.88 132.34 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.246 0.546 . . . . 0.0 110.37 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -138.5 141.1 39.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.8 ptmt -70.89 149.24 46.96 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 118.01 -1.476 . . . . 0.0 109.86 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 28.9 mt -94.6 175.29 3.0 Favored Pre-proline 0 C--N 1.28 -2.431 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.96 141.65 59.16 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 N-CA-C 108.177 -1.509 . . . . 0.0 108.177 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -66.87 -23.06 65.97 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.482 0.658 . . . . 0.0 110.243 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -88.34 -5.25 58.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.413 1.485 . . . . 0.0 111.732 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.29 136.76 81.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.9 115.69 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.434 2.089 . . . . 0.0 114.538 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.925 173.271 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 88.0 tttt . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -75.49 131.85 14.17 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.453 1.435 . . . . 0.0 112.167 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.39 147.55 19.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.135 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -69.05 108.63 3.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 151.72 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 121.497 0.665 . . . . 0.0 111.624 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.46 141.17 28.89 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.252 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.0 p -93.14 171.69 6.97 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.67 -12.88 35.83 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.1 1.867 . . . . 0.0 111.581 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.16 -20.75 47.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.148 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.66 -16.7 36.96 Favored Glycine 0 C--O 1.242 0.635 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.906 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.76 158.14 21.85 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -112.17 145.04 40.56 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.48 154.87 32.5 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.47 104.88 17.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -117.04 148.23 41.67 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.498 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -96.18 125.97 45.98 Favored Pre-proline 0 N--CA 1.426 -1.66 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 56.9 Cg_endo -74.85 142.07 27.9 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.99 1.793 . . . . 0.0 111.871 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.33 -40.73 64.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.353 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -145.85 147.34 31.71 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.856 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.29 144.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -146.5 155.98 42.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.06 32.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.132 0.491 . . . . 0.0 110.719 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.81 85.85 2.47 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.7 94.85 24.43 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.12 136.62 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.721 1.614 . . . . 0.0 108.413 170.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -60.86 113.63 2.61 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.108 0.48 . . . . 0.0 111.933 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 2.01 56.07 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.138 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -116.47 -72.83 0.67 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -142.25 174.66 10.41 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 120.679 0.276 . . . . 0.0 111.15 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.54 42.28 0.89 Allowed Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.16 149.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.352 0.596 . . . . 0.0 110.826 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -127.65 144.58 51.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.8 mt -136.11 143.82 34.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.57 148.9 19.16 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.2 tp -98.22 122.72 41.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.53 173.41 6.85 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.038 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -134.64 125.77 27.82 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.54 128.5 77.3 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.54 -12.8 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.085 2.523 . . . . 0.0 114.254 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -97.68 -52.62 3.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.26 0.552 . . . . 0.0 111.69 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 45.0 p -82.79 -35.14 26.74 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.379 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.25 62.4 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.025 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.9 ptpt -88.29 150.0 23.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.265 0.555 . . . . 0.0 111.87 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -95.15 136.5 35.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -143.93 139.92 29.41 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.98 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -100.38 119.92 39.18 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 121.38 0.609 . . . . 0.0 109.77 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -127.49 144.28 51.08 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -68.58 141.48 55.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.611 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 mt -93.95 172.15 6.13 Favored Pre-proline 0 C--N 1.284 -2.272 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.92 140.48 55.15 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.526 1.484 . . . . 0.0 108.412 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.05 -26.72 68.97 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.36 0.6 . . . . 0.0 109.775 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.12 0.26 56.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.779 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 66.1 t80 -80.31 126.68 78.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.6 Cg_exo -76.96 107.88 2.53 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.145 1.897 . . . . 0.0 112.54 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.0 pt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 54.3 mtmt . . . . . 0 N--CA 1.433 -1.317 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -84.55 120.03 2.38 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.328 2.019 . . . . 0.0 111.611 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.8 p -103.91 145.46 12.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.162 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.94 108.45 7.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -130.48 149.52 33.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.05 124.39 28.24 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.741 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.423 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 30.4 p -76.41 169.17 22.24 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.51 -24.38 36.22 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.266 1.978 . . . . 0.0 110.148 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.53 85.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.589 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.61 31.37 1.25 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.463 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.53 160.01 41.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.331 0.565 . . . . 0.0 109.772 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.202 0.525 . . . . 0.0 111.505 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.23 146.96 52.37 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -89.87 105.3 17.71 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.99 0.9 . . . . 0.0 108.952 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.01 141.74 48.42 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.535 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.97 121.87 68.39 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 30.8 Cg_endo -66.44 134.72 36.83 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.073 1.849 . . . . 0.0 112.28 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -61.27 -48.98 78.93 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -145.89 153.98 41.45 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.648 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.94 152.0 30.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 O-C-N 123.628 0.58 . . . . 0.0 110.544 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -155.53 168.37 27.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.256 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.56 139.79 36.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.006 0.431 . . . . 0.0 110.758 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 94.56 4.91 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 91.82 40.06 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.006 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.73 173.67 10.19 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.43 2.087 . . . . 0.0 108.621 172.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.39 139.62 51.92 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.682 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.21 32.4 25.87 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.741 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -156.37 154.12 30.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -69.93 -45.75 66.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.82 117.94 2.21 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.921 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.15 119.93 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 121.42 0.629 . . . . 0.0 110.078 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.04 136.5 35.29 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.4 mt -133.14 140.11 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.07 149.6 18.58 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 tp -96.14 125.51 40.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -122.88 175.07 6.76 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -133.4 122.93 24.47 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.3 t70 -78.74 125.72 83.75 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 3.2 Cg_exo -80.13 -8.34 14.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.247 1.965 . . . . 0.0 113.354 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.44 -40.74 8.54 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -90.29 -34.16 15.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.346 0.593 . . . . 0.0 109.577 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.79 22.78 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.704 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -118.89 144.24 46.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.912 0.356 . . . . 0.0 111.6 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.68 124.65 29.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.725 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -135.4 140.05 44.66 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -92.76 138.83 31.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -144.43 147.91 33.93 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.46 146.52 50.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.647 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.07 168.98 8.2 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.89 143.47 66.75 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.919 1.746 . . . . 0.0 108.908 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.05 -15.25 61.51 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.842 -0.536 . . . . 0.0 110.868 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.25 -1.82 57.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.597 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 89.0 t80 -81.7 133.83 51.68 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 122.761 0.424 . . . . 0.0 111.059 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.4 Cg_exo -78.95 106.19 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.572 2.182 . . . . 0.0 112.256 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.665 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 82.2 mttt . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HB2' ' HG2' ' A' ' 19' ' ' GLU . 47.2 Cg_endo -71.67 138.91 32.9 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.104 1.869 . . . . 0.0 112.914 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.06 143.09 41.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 27.6 mtmm -74.43 108.51 7.25 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.15 144.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.112 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -75.52 115.67 15.43 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.297 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.2 p -83.85 162.75 51.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.957 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.47 -18.03 44.25 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.419 2.746 . . . . 0.0 114.782 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.04 -5.52 59.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.884 0.373 . . . . 0.0 111.803 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.41 9.54 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.568 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -140.33 166.25 25.2 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -113.65 147.51 37.99 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.212 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 146.7 28.67 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 7' ' ' PRO . 31.1 tt0 -92.32 105.89 18.0 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.56 145.56 48.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.296 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.82 128.37 46.25 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.09 144.7 93.07 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.453 2.102 . . . . 0.0 113.789 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.03 -42.51 23.64 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.726 1.211 . . . . 0.0 109.447 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -145.31 141.4 28.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.43 139.97 49.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 123.31 0.381 . . . . 0.0 110.009 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -146.33 158.2 43.86 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.95 125.78 38.22 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.3 mp -79.73 89.6 5.19 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.76 116.6 34.53 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.662 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.28 -48.85 12.33 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.695 1.597 . . . . 0.0 107.986 172.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp 177.92 -64.52 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.044 -1.435 . . . . 0.0 108.197 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.59 103.77 2.09 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.5 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -169.91 -79.23 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -172.11 -56.13 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.071 1.749 . . . . 0.0 106.693 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 112.56 2.34 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.564 -1.815 . . . . 0.0 108.564 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' A' ' 53' ' ' LYS . 59.4 t -75.33 105.42 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -80.68 125.93 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.534 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.0 mt -132.26 139.36 50.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.1 147.39 17.3 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 58.5 tp -94.9 130.01 41.68 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.5 m-85 -124.89 176.4 6.66 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 122.917 0.487 . . . . 0.0 110.084 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -130.58 115.84 17.31 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.61 126.02 92.01 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 -20.47 25.38 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 122.196 1.931 . . . . 0.0 113.39 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -60.46 2.1 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 39.8 p -82.52 -32.05 28.89 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.04 -3.88 62.45 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.113 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.3 ptpt -80.98 153.63 27.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 10.2 m-85 -90.9 125.37 35.74 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.138 177.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.69 139.78 47.83 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 39.4 ptt180 -94.06 138.3 32.29 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -143.99 144.51 31.71 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HE2' HG13 ' A' ' 36' ' ' VAL . 61.1 tttm -62.53 142.94 57.73 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.655 0.597 . . . . 0.0 109.761 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 25.5 mt -102.39 172.14 4.62 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -67.01 139.77 52.25 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.093 1.862 . . . . 0.0 107.708 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -74.84 -11.17 60.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.718 -0.614 . . . . 0.0 110.382 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -95.39 0.52 53.57 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.714 1.205 . . . . 0.0 110.448 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.423 ' OH ' ' HB2' ' A' ' 6' ' ' LYS . 77.4 t80 -80.75 119.49 76.33 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.36 104.71 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.487 2.125 . . . . 0.0 112.444 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.56 -179.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 7.9 tmtt? . . . . . 0 N--CA 1.414 -2.243 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -83.28 149.25 13.26 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.946 1.764 . . . . 0.0 112.373 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.0 p -121.52 144.92 29.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -73.57 108.39 6.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.8 p -121.28 141.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.05 -174.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.93 117.26 19.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 46.0 p -85.96 169.01 16.74 Favored Pre-proline 0 C--N 1.286 -2.191 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 31.2 Cg_exo -63.16 -22.26 72.82 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.143 2.562 . . . . 0.0 111.079 174.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.8 -14.75 62.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.51 4.74 62.12 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.17 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -115.64 161.09 19.16 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.496 -0.414 . . . . 0.0 110.049 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 52.6 mt-10 -102.29 135.57 43.66 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.132 0.492 . . . . 0.0 110.521 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.5 45.26 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.9 mt-10 -89.85 105.22 17.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.98 138.14 51.76 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.961 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -94.59 121.75 62.44 Favored Pre-proline 0 N--CA 1.415 -2.213 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.11 140.55 90.11 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.472 2.114 . . . . 0.0 113.013 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.2 -43.65 77.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.276 1.036 . . . . 0.0 109.005 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.32 138.34 38.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.201 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.06 144.41 32.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.191 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -152.2 161.84 42.02 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.57 128.16 32.69 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.248 0.547 . . . . 0.0 111.497 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -93.54 94.79 8.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.887 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.83 110.35 63.61 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.3 -69.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.19 1.926 . . . . 0.0 111.505 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -164.4 115.47 1.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.884 0.473 . . . . 0.0 110.153 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.16 45.34 96.24 Favored Glycine 0 C--N 1.318 -0.469 0 O-C-N 123.505 0.503 . . . . 0.0 112.724 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.536 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -127.07 167.4 16.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.83 -34.95 76.34 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.31 120.67 4.77 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.245 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.6 t -76.08 103.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -86.83 137.02 32.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.224 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 60.5 mt -136.38 141.47 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 147.32 18.37 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.5 tp -95.76 124.12 39.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -118.97 170.1 9.32 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.697 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -117.21 125.99 52.05 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.584 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 16.0 t70 -69.56 132.54 89.26 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.9 -12.52 10.84 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.118 1.879 . . . . 0.0 114.185 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -97.48 -51.02 4.29 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.367 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 p -88.27 -37.28 16.16 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.899 0.479 . . . . 0.0 110.522 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -4.98 55.15 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.513 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -81.44 151.95 27.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.175 0.487 . . . . 0.0 111.641 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -89.63 125.33 35.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.184 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -127.25 140.66 52.07 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -101.4 136.6 40.96 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.63 143.82 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.47 139.54 51.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.79 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.67 174.78 3.53 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.62 141.46 73.11 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 N-CA-C 108.183 -1.507 . . . . 0.0 108.183 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -26.05 68.39 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.226 0.536 . . . . 0.0 110.998 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.11 12.19 37.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.194 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -72.8 128.08 88.72 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.16 103.34 1.73 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.647 1.565 . . . . 0.0 113.397 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.739 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 pttp . . . . . 0 N--CA 1.431 -1.421 0 CA-C-O 121.441 0.639 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.32 143.65 14.03 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.407 2.072 . . . . 0.0 110.995 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.12 135.69 37.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -70.43 109.31 4.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -127.77 145.94 34.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.554 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 67.4 mttm -78.06 124.47 28.07 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -81.63 163.12 55.57 Favored Pre-proline 0 C--N 1.282 -2.333 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 -7.1 20.49 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.482 2.122 . . . . 0.0 111.404 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.89 -32.37 20.24 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.177 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.96 -39.44 1.66 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.808 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -71.67 164.91 25.06 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 120.844 0.354 . . . . 0.0 110.379 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 33.2 mt-10 -115.77 129.25 56.38 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.48 147.49 37.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.178 0.299 . . . . 0.0 110.209 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.53 105.26 11.64 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.61 138.14 51.65 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.948 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.39 122.08 63.72 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.86 146.41 77.96 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.89 2.393 . . . . 0.0 113.39 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -67.0 -45.94 76.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.45 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -149.63 152.55 35.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.598 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.68 151.14 33.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 123.576 0.547 . . . . 0.0 110.465 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -148.72 161.4 41.85 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.133 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.53 137.31 40.14 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.857 0.36 . . . . 0.0 111.289 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.47 119.98 41.09 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.12 90.91 47.7 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.21 105.55 2.1 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 122.708 2.272 . . . . 0.0 112.233 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 70.08 -64.08 0.37 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.682 1.593 . . . . 0.0 112.124 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.03 111.44 0.49 Allowed Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -159.95 163.8 33.9 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -79.3 -9.8 59.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.061 0.934 . . . . 0.0 108.712 176.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 100.12 108.14 2.96 Favored Glycine 0 N--CA 1.418 -2.563 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.834 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.99 112.44 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 60.0 mttp -99.1 136.3 39.26 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.847 -171.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -132.33 136.77 55.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.75 146.43 16.2 Favored Glycine 0 N--CA 1.422 -2.233 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.2 tp -96.6 123.68 40.35 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.79 174.17 6.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.664 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -132.41 127.56 35.65 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.0 t70 -86.93 116.34 65.69 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 11.3 Cg_exo -72.34 -8.68 23.11 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.006 2.471 . . . . 0.0 113.108 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.3 -53.57 4.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.507 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.3 p -84.68 -30.73 24.58 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.225 0.536 . . . . 0.0 111.1 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.71 30.62 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.177 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -123.53 152.0 42.26 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.789 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.22 135.51 33.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -137.06 139.86 41.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -99.37 129.57 45.58 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -134.37 147.48 50.53 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 38.7 ttmt -66.83 140.77 57.83 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mt -101.51 172.4 4.47 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -67.17 139.52 50.74 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.607 1.538 . . . . 0.0 109.641 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.45 -30.48 68.54 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.098 0.475 . . . . 0.0 110.539 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.31 -1.09 57.2 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.895 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -74.76 126.65 88.25 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 121.599 -0.688 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.86 120.99 6.01 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 112.581 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.131 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 tttp . . . . . 0 N--CA 1.44 -0.936 0 CA-C-O 120.556 0.217 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 14.0 Cg_endo -72.35 141.91 36.24 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.597 1.532 . . . . 0.0 110.134 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 141.8 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.82 109.08 5.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.12 146.27 31.07 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.847 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -79.08 120.7 24.0 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.573 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.0 p -78.48 161.3 70.29 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.063 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.66 -15.99 37.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.487 2.125 . . . . 0.0 110.194 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.41 -51.28 24.84 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.893 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.8 -17.09 2.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.93 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -92.24 168.3 11.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -110.71 130.69 55.51 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.912 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.26 152.46 51.54 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.96 104.74 16.57 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.62 141.93 44.58 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.9 p -93.13 125.55 54.33 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.96 116.86 3.94 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 121.403 1.402 . . . . 0.0 110.525 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.81 -17.61 62.14 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.247 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -152.76 140.26 19.71 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.46 138.95 52.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 123.27 0.356 . . . . 0.0 110.421 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -152.24 154.32 35.51 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.4 137.92 54.04 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 5.2 mp -112.08 106.78 15.51 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . . . -97.51 102.1 12.0 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.301 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 8.4 Cg_exo -73.94 154.46 48.01 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.024 1.816 . . . . 0.0 109.847 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -61.32 -44.59 96.95 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.81 26.72 20.14 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -136.07 -176.81 4.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -87.38 -56.43 3.36 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.393 0.616 . . . . 0.0 110.053 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 29' ' ' ALA . . . 150.31 137.17 2.67 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.56 124.31 70.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.325 0.583 . . . . 0.0 109.998 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.83 128.27 43.62 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.247 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 47.4 mt -125.27 140.54 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.019 0.438 . . . . 0.0 109.99 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -128.05 149.92 18.26 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 tp -94.25 126.13 39.3 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.81 166.61 14.09 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.377 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -126.93 122.68 35.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 18.2 t70 -65.83 129.57 94.32 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 -4.18 12.5 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.869 2.379 . . . . 0.0 113.095 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 16.6 tp10 -93.79 -51.46 4.89 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.329 0.585 . . . . 0.0 109.647 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.422 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 31.2 p -108.78 -22.01 12.41 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.72 11.99 69.89 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.538 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 ptpt -84.31 147.64 27.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.58 142.71 27.47 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.645 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -149.99 138.97 21.03 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -93.15 139.76 30.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -143.01 143.7 32.0 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.282 0.1 OUTLIER -74.46 140.19 44.45 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.604 179.529 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' A' ' 39' ' ' GLY . 17.8 mt -85.86 -177.22 0.89 Allowed Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -67.27 132.94 28.98 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 105.185 -2.659 . . . . 0.0 105.185 166.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.43 -7.97 54.74 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.921 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.34 -14.4 40.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.363 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -60.16 129.56 88.62 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.204 1.001 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.15 118.24 2.29 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.678 2.252 . . . . 0.0 112.757 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--N 1.293 -1.854 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.671 177.045 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 pttt . . . . . 0 N--CA 1.432 -1.333 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.67 136.4 45.8 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.913 1.742 . . . . 0.0 111.462 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.3 p -114.23 149.78 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.36 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -68.71 109.18 3.7 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.29 136.56 60.46 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.944 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 60.9 mttp -79.37 115.72 19.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -85.42 166.48 30.33 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.52 -18.69 64.76 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.556 2.171 . . . . 0.0 111.875 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.43 -14.82 62.27 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.94 50.11 4.51 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.017 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 22.1 ptmt -148.43 164.77 33.13 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 36.2 mt-10 -106.06 120.37 41.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.02 149.43 50.37 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -90.01 104.15 16.75 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -118.01 147.23 43.41 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.638 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.18 129.36 26.44 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.0 129.92 20.54 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.225 1.284 . . . . 0.0 111.645 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.25 -51.18 60.08 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.973 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -132.78 153.26 51.41 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.685 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.66 148.65 33.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 124.266 0.979 . . . . 0.0 109.429 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -157.18 163.97 38.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.47 132.91 39.84 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.127 0.489 . . . . 0.0 110.36 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 mp -97.99 92.11 5.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 100.31 52.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.12 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 34.5 Cg_exo -62.46 -69.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.717 2.278 . . . . 0.0 112.426 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -168.62 -50.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.568 0.347 . . . . 0.0 111.893 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -128.58 40.37 1.73 Allowed Glycine 0 C--N 1.317 -0.507 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.809 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 99.4 mtt180 -129.36 25.98 5.42 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.55 -65.42 0.35 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.358 1.063 . . . . 0.0 112.514 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.44 118.82 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.31 116.67 37.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -89.16 131.04 35.48 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 66.8 mt -134.42 142.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.95 150.32 19.34 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.0 tp -94.63 124.29 38.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -117.62 170.66 8.59 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.076 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.82 125.87 45.45 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.06 119.99 79.53 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.46 -24.79 42.18 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.82 2.347 . . . . 0.0 114.164 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.22 -21.86 17.04 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.8 p -111.45 -18.73 12.8 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.672 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 9.74 85.27 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.522 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -100.22 156.97 16.92 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.515 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -94.82 146.99 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.49 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -147.57 139.47 24.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -94.49 133.46 38.08 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -141.38 149.53 41.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 21.5 ptmt -69.46 150.38 47.28 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.467 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.86 171.16 5.23 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.014 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.34 148.72 80.28 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.922 2.415 . . . . 0.0 109.167 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.55 -23.53 63.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.84 4.62 53.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.369 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -73.12 122.66 88.2 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.7 101.45 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.813 2.342 . . . . 0.0 113.783 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 C--N 1.31 -1.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.91 175.82 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mtp . . . . . 0 CA--C 1.509 -0.616 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -70.24 137.62 50.99 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.992 0.517 . . . . 0.0 109.976 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.6 m -83.57 120.18 25.63 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.043 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.03 -84.15 0.2 Allowed Glycine 0 N--CA 1.428 -1.878 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.575 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -123.02 167.17 13.96 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 22.8 mtmt -138.63 122.02 11.08 Favored Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -92.5 155.67 2.99 Favored 'Trans proline' 0 C--O 1.253 1.228 0 C-N-CA 122.781 2.32 . . . . 0.0 114.761 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 58' ' ' TYR . 11.9 p -130.96 152.0 36.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.899 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -76.54 110.92 11.49 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -132.71 144.71 35.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.508 0.67 . . . . 0.0 111.865 -173.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 65.6 mttm -81.56 139.1 35.28 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.636 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 19.8 p -94.01 159.05 35.16 Favored Pre-proline 0 C--N 1.294 -1.841 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 16.5 Cg_exo -67.18 -17.42 50.36 Favored 'Trans proline' 0 C--O 1.239 0.551 0 C-N-CA 123.0 2.467 . . . . 0.0 111.479 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.06 -11.53 52.56 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.767 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.53 20.13 10.52 Favored Glycine 0 C--O 1.24 0.53 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.147 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -104.24 167.9 9.45 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 51.4 mt-10 -135.91 115.01 12.32 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 163.94 35.57 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.17 105.11 17.12 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.7 152.69 24.49 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.424 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.96 126.41 36.82 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.297 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 35.9 Cg_endo -70.07 130.5 19.06 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 C-N-CA 121.833 1.689 . . . . 0.0 111.545 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 4.6 mm-40 -81.36 -27.43 34.9 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.823 -1.081 . . . . 0.0 112.534 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -144.22 131.11 20.34 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.04 138.66 52.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 O-C-N 123.364 0.415 . . . . 0.0 110.884 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -142.1 158.42 43.76 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.928 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 154.18 39.7 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.396 0.617 . . . . 0.0 111.526 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.0 mp -129.66 96.11 4.16 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.46 96.11 30.1 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 4.0 Cg_exo -82.22 139.44 10.53 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.653 2.235 . . . . 0.0 110.06 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.53 126.89 30.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.158 0.504 . . . . 0.0 110.92 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.9 -2.3 75.91 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 33' ' ' ARG . 3.4 mmp_? -118.6 -167.54 1.39 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -107.89 150.12 27.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.65 90.56 1.36 Allowed Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.37 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.1 m -75.3 151.82 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -130.2 151.36 50.81 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -173.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 74.2 mt -136.82 135.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.79 147.33 16.47 Favored Glycine 0 N--CA 1.416 -2.657 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.5 tp -95.26 126.17 40.4 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.16 170.89 9.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.184 0.594 . . . . 0.0 109.894 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -113.64 128.94 56.62 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.636 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 16.0 t70 -80.58 121.77 81.66 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -78.74 -1.55 11.7 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 113.305 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -97.41 -50.62 4.46 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.376 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 41.3 p -94.44 -37.29 11.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.469 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.3 -6.04 34.0 Favored Glycine 0 N--CA 1.427 -1.948 0 C-N-CA 120.978 -0.629 . . . . 0.0 113.139 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 19.2 ptpt -79.96 163.55 24.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.917 0.389 . . . . 0.0 111.445 -175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 40' ' ' LEU . 74.2 m-85 -97.88 131.46 44.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -129.11 139.62 51.9 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -91.21 142.32 27.85 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -146.75 136.07 22.75 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 5.4 ptmt -64.26 135.35 56.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.441 0.639 . . . . 0.0 111.104 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.6 mt -97.06 169.96 7.96 Favored Pre-proline 0 C--N 1.271 -2.843 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 19.5 Cg_exo -66.95 151.63 81.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 121.941 1.761 . . . . 0.0 109.477 175.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.04 -19.11 61.89 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.927 -0.483 . . . . 0.0 111.536 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -93.86 -1.82 54.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.541 0.686 . . . . 0.0 110.704 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CE1' ' HB ' ' A' ' 8' ' ' VAL . 52.1 t80 -65.67 127.2 92.87 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.07 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.65 104.53 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.403 2.069 . . . . 0.0 113.652 -175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 60' ' ' ILE . 48.2 pt . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttm . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 m -87.85 78.79 8.27 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.4 m -87.45 87.49 7.42 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.515 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.73 -64.86 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.11 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -89.84 -173.28 3.85 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.999 0.52 . . . . 0.0 109.947 -177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HE3' ' CE1' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -91.53 129.19 43.74 Favored Pre-proline 0 C--N 1.299 -1.607 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.232 -177.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 56.5 Cg_endo -84.27 174.85 7.76 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 121.902 1.735 . . . . 0.0 112.348 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.7 p -144.65 140.48 23.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 55.4 tttp -74.41 109.25 7.75 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -129.22 142.75 43.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.614 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -76.71 119.55 20.66 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.522 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 p -92.35 173.0 5.54 Favored Pre-proline 0 C--N 1.306 -1.285 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.133 -176.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -69.02 -14.56 38.66 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 122.624 2.216 . . . . 0.0 112.003 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.62 -19.34 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.177 0.513 . . . . 0.0 109.938 177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.79 1.69 49.32 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.628 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -106.87 156.56 18.56 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 41.0 tt0 -116.34 107.14 14.45 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.29 159.79 34.17 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.97 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 1.7 mp0 -80.55 108.99 14.65 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.363 0.601 . . . . 0.0 110.707 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.51 146.13 45.72 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.3 p -96.62 127.22 40.42 Favored Pre-proline 0 N--CA 1.419 -1.99 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -59.3 136.29 71.23 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.426 2.084 . . . . 0.0 111.696 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.85 -42.33 81.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HG3' ' CZ3' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -147.64 150.19 33.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 ' HB ' ' A' ' 60' ' ' ILE . 32.2 m -124.36 150.57 29.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.409 ' CZ3' ' HG3' ' A' ' 24' ' ' LYS . 21.9 p90 -156.4 168.56 26.95 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.24 147.38 43.66 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.17 113.94 23.78 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.049 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.6 100.0 10.31 Favored Pre-proline 0 C--N 1.302 -1.463 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.68 -67.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.298 1.999 . . . . 0.0 111.896 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -124.35 -142.53 0.31 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.93 84.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.28 0 O-C-N 122.997 0.186 . . . . 0.0 112.994 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' HD3' ' H ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -149.69 154.12 38.06 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 104.346 -2.464 . . . . 0.0 104.346 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' H ' ' HD3' ' A' ' 33' ' ' ARG . 32.3 mmtp -42.6 -45.5 4.62 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.475 1.11 . . . . 0.0 113.216 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.45 90.27 2.01 Favored Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 106.532 -2.627 . . . . 0.0 106.532 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 m -74.46 115.96 16.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.881 0.848 . . . . 0.0 112.221 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 63.2 mttp -80.97 131.08 35.3 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.096 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 56.7 mt -134.45 142.11 41.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.25 149.24 18.53 Favored Glycine 0 N--CA 1.424 -2.1 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.44 125.62 43.68 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 90.0 m-85 -119.52 171.91 8.02 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.714 -177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -130.45 121.99 26.88 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.4 129.72 85.31 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -68.12 -31.5 29.63 Favored 'Trans proline' 0 C--O 1.244 0.816 0 C-N-CA 122.145 1.897 . . . . 0.0 114.478 -173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -97.55 -34.96 10.78 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -88.44 -25.34 22.69 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.466 0.65 . . . . 0.0 109.688 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.56 -5.64 82.85 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.052 175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -82.46 150.92 26.78 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -174.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 89.5 m-85 -95.09 126.47 40.45 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.612 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -130.55 139.17 50.47 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.672 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -96.08 128.3 42.86 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.51 144.06 47.81 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 62.3 tttt -60.27 139.26 57.7 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 124.039 0.837 . . . . 0.0 109.36 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.517 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 31.6 mt -96.99 168.51 10.17 Favored Pre-proline 0 C--N 1.283 -2.325 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.98 141.76 65.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.569 1.513 . . . . 0.0 109.728 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.34 -41.87 52.11 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.966 0.906 . . . . 0.0 111.181 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -96.36 15.63 20.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.965 -174.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 84.8 t80 -83.31 120.95 76.56 Favored Pre-proline 0 C--O 1.216 -0.66 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -74.47 114.35 4.01 Favored 'Trans proline' 0 C--O 1.248 1.001 0 C-N-CA 122.096 1.864 . . . . 0.0 112.587 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.4 ' HB ' HG21 ' A' ' 25' ' ' VAL . 37.6 pt . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 118.446 -0.787 . . . . 0.0 110.034 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tmm? . . . . . 0 C--O 1.24 0.59 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 74.05 116.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.491 1.516 . . . . 0.0 111.722 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 m -81.62 -24.48 36.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.451 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.1 -25.8 17.3 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -141.44 147.19 37.51 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 124.196 0.999 . . . . 0.0 108.484 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -149.39 90.2 4.67 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.09 164.52 31.24 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.783 2.322 . . . . 0.0 113.409 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.1 p -139.27 151.31 22.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -67.84 109.11 3.25 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -130.3 146.72 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.041 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -83.48 130.73 35.03 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.578 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.7 p -89.9 161.48 38.32 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.201 -177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -71.77 -9.49 24.94 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.786 2.324 . . . . 0.0 109.85 173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB1' ' HZ3' ' A' ' 16' ' ' LYS . . . -82.82 -5.93 59.19 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.093 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.75 -13.69 57.77 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 173.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HZ3' ' HB1' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -114.71 174.03 6.17 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.8 -0.823 . . . . 0.0 111.559 -178.121 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.73 153.77 20.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.163 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.19 152.19 27.53 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 38.2 mt-10 -89.46 104.43 16.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.7 mt -112.96 147.98 35.99 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.72 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.38 123.14 63.11 Favored Pre-proline 0 C--N 1.301 -1.536 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.991 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.57 132.81 28.08 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.964 1.776 . . . . 0.0 112.085 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.93 -47.68 24.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -137.38 142.04 41.73 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.03 144.36 38.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.882 0.373 . . . . 0.0 110.46 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -151.71 164.2 37.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.26 39.63 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.705 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.37 102.8 12.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.63 105.54 45.67 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.45 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 13.1 Cg_exo -77.97 3.81 6.68 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.997 2.465 . . . . 0.0 112.831 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.1 mttm 71.67 107.99 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.042 1.337 . . . . 0.0 111.893 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.63 12.17 38.75 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 92.7 mtt180 -137.63 -166.7 1.99 Allowed 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -80.34 154.37 27.8 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.58 103.87 2.92 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.59 98.72 4.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -85.18 130.03 34.69 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.105 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.5 mt -132.39 140.54 47.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -130.11 149.02 18.77 Favored Glycine 0 N--CA 1.416 -2.636 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.5 tp -96.13 126.24 41.22 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 92.1 m-85 -121.25 170.34 9.68 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -122.25 119.5 31.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.578 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 17.8 t70 -64.86 135.36 96.36 Favored Pre-proline 0 C--N 1.309 -1.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.903 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.85 -21.26 16.4 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.45 2.1 . . . . 0.0 114.575 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.32 -51.12 4.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.438 0.637 . . . . 0.0 111.61 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.6 p -86.65 -29.4 22.53 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.85 -2.72 85.95 Favored Glycine 0 N--CA 1.431 -1.653 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.209 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.0 144.12 41.08 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 117.083 0.441 . . . . 0.0 110.995 -175.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 56.5 m-85 -83.37 125.12 31.32 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 175.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -126.37 139.74 53.04 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.633 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -96.91 123.82 40.72 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -134.87 147.86 49.98 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 54.3 tttm -62.1 142.51 57.54 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 123.737 0.648 . . . . 0.0 110.122 177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 30.7 mt -98.7 171.13 6.08 Favored Pre-proline 0 C--N 1.291 -1.964 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.83 73.67 Favored 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 121.837 1.692 . . . . 0.0 109.368 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.42 -33.67 72.84 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 123.688 0.795 . . . . 0.0 110.536 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.19 5.15 51.48 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.309 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -77.45 123.53 86.82 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -73.63 120.17 6.31 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.66 2.24 . . . . 0.0 111.959 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.6 pt . . . . . 0 C--N 1.298 -1.655 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.157 178.338 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 m 54.79 82.61 0.09 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.114 0.966 . . . . 0.0 111.573 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.4 m -147.05 92.98 2.19 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.047 -0.408 . . . . 0.0 110.11 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.63 -27.87 16.0 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.726 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -93.37 136.55 33.53 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.227 0.537 . . . . 0.0 111.607 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' OH ' ' A' ' 58' ' ' TYR . 39.9 pttt -153.21 106.41 2.61 Favored Pre-proline 0 C--N 1.304 -1.398 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.552 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -81.71 124.64 4.63 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.391 2.061 . . . . 0.0 113.055 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.98 149.03 8.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -73.06 109.27 6.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -135.61 145.61 31.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.238 0.542 . . . . 0.0 110.534 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -89.3 134.66 33.97 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.076 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 p -83.63 169.09 18.4 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.541 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 12.2 Cg_exo -70.99 -22.17 26.78 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.269 1.979 . . . . 0.0 109.095 172.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -51.99 66.29 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.423 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.0 -0.17 3.99 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.985 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -107.47 160.01 15.97 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.361 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -101.62 137.41 39.97 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.1 163.57 36.51 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -94.27 105.4 17.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -117.54 138.55 51.83 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.57 123.29 67.02 Favored Pre-proline 0 C--N 1.3 -1.554 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.304 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.41 142.77 37.58 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.052 1.835 . . . . 0.0 111.65 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -69.38 -37.27 77.48 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -154.79 157.9 38.64 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.86 139.04 51.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 123.759 0.662 . . . . 0.0 110.054 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -141.94 154.23 44.91 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.32 124.45 32.35 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.012 0.434 . . . . 0.0 111.499 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -89.1 96.05 10.57 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.47 107.41 21.08 Favored Pre-proline 0 C--N 1.297 -1.714 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.627 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.71 -69.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 121.792 1.662 . . . . 0.0 110.248 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -160.04 -63.9 0.07 Allowed 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.26 82.96 0.8 Allowed Glycine 0 C--N 1.316 -0.559 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -170.58 154.16 4.45 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -57.82 -46.01 85.31 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.588 0.631 . . . . 0.0 109.366 172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.18 112.8 2.66 Favored Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.99 98.43 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -81.99 126.98 32.59 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 59.0 mt -129.48 137.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.93 148.16 16.68 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.9 tp -97.53 121.88 39.95 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 97.0 m-85 -118.72 169.57 9.72 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 123.541 0.736 . . . . 0.0 110.195 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -112.03 124.3 52.11 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 11.9 t70 -77.67 122.92 86.48 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.85 -2.04 12.1 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 C-N-CA 122.758 2.305 . . . . 0.0 113.844 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -97.53 -54.17 3.21 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.226 0.536 . . . . 0.0 110.153 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.3 p -94.72 -17.47 22.17 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.722 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.93 74.08 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.982 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -106.28 163.66 12.64 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 122.54 -0.388 . . . . 0.0 110.312 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.0 m-85 -94.62 132.05 39.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -130.82 140.5 50.27 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.012 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -139.22 150.11 45.14 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -65.42 141.61 58.47 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 123.669 0.605 . . . . 0.0 109.617 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.55 170.76 5.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -67.12 141.81 58.93 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.05 1.834 . . . . 0.0 108.77 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.21 -21.96 63.91 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.099 0.476 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.61 -1.67 57.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.884 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' OH ' ' HG3' ' A' ' 6' ' ' LYS . 91.8 t80 -81.35 123.24 81.45 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 1.8 Cg_endo -78.35 111.78 3.09 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 121.974 1.783 . . . . 0.0 109.888 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 C--N 1.296 -1.756 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.323 -179.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.763 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 p -90.29 82.45 5.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 121.772 0.796 . . . . 0.0 111.547 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 t -110.85 -66.79 1.04 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.93 -70.88 1.45 Allowed Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.814 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -106.26 146.39 30.41 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 146.27 22.76 Favored Pre-proline 0 N--CA 1.44 -0.967 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 30.0 Cg_endo -75.43 159.46 39.75 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 121.793 1.662 . . . . 0.0 112.586 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -142.4 146.87 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -69.06 109.84 4.19 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -125.34 139.16 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 121.727 0.775 . . . . 0.0 111.822 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 64.8 mttm -80.98 115.71 20.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.26 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.2 p -87.85 158.8 50.05 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.261 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.518 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 9.9 Cg_exo -71.03 -12.86 31.04 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.873 2.382 . . . . 0.0 110.702 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.91 64.07 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.516 174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.9 9.42 24.52 Favored Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 120.248 -0.977 . . . . 0.0 114.601 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.26 26.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.706 177.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 48.2 mt-10 -94.31 121.48 35.87 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.34 138.73 52.51 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -82.93 105.54 14.02 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.27 151.29 39.39 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.882 -1.053 . . . . 0.0 108.381 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.6 p -100.55 127.61 32.28 Favored Pre-proline 0 C--N 1.285 -2.231 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.59 143.31 56.35 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.008 1.805 . . . . 0.0 112.397 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.85 -37.55 64.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -152.42 149.01 28.13 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.91 149.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 O-C-N 123.57 0.544 . . . . 0.0 110.395 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -156.74 159.88 38.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.66 137.08 49.41 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.9 91.85 7.12 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.22 84.34 20.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.731 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -79.91 89.51 1.33 Allowed 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 121.676 1.584 . . . . 0.0 111.443 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.279 19.2 ptpt 57.37 -54.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 127.301 2.241 . . . . 0.0 116.256 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.0 70.76 0.29 Allowed Glycine 0 N--CA 1.432 -1.607 0 O-C-N 121.971 -0.456 . . . . 0.0 112.544 -175.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -161.07 148.76 15.49 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.1 -39.18 91.62 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 123.385 0.428 . . . . 0.0 110.236 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.77 105.82 2.91 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.473 -0.87 . . . . 0.0 114.098 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.15 107.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.906 0.86 . . . . 0.0 109.116 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.46 131.35 34.67 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.753 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.9 mt -131.84 140.47 48.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.94 149.49 18.83 Favored Glycine 0 N--CA 1.424 -2.129 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -97.32 123.47 41.15 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.0 m-85 -118.11 179.9 3.96 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.5 0.72 . . . . 0.0 110.563 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.7 tttp -128.96 113.44 15.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 10.1 t70 -65.94 133.21 94.82 Favored Pre-proline 0 N--CA 1.476 0.859 0 C-N-CA 124.031 0.932 . . . . 0.0 112.54 -174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.36 -31.37 62.53 Favored 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 123.375 2.717 . . . . 0.0 115.986 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -97.77 -30.69 12.64 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.615 -175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -104.21 -20.73 13.7 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.85 -2.68 67.66 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.661 -0.304 . . . . 0.0 113.524 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -78.35 160.74 27.65 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.934 0.397 . . . . 0.0 111.266 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 42.2 m-85 -93.0 120.63 33.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.334 176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -124.46 139.83 53.52 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -93.71 135.85 34.58 Favored 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.368 175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -139.61 146.38 39.71 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.5 tttt -64.51 140.28 58.85 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 28.8 mt -96.51 176.06 2.34 Favored Pre-proline 0 C--N 1.287 -2.117 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -66.93 140.04 53.55 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.663 1.575 . . . . 0.0 108.788 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.31 -24.11 67.12 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -108.28 15.02 24.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 122.112 -0.367 . . . . 0.0 111.595 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -68.8 128.81 92.76 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.27 108.0 1.28 Allowed 'Trans proline' 0 C--O 1.251 1.132 0 C-N-CA 123.341 2.694 . . . . 0.0 114.971 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.6 pt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -59.24 113.02 1.94 Allowed 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.496 0.497 . . . . 0.0 110.27 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 p -149.68 157.13 42.95 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.716 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.56 -33.31 2.78 Favored Glycine 0 CA--C 1.49 -1.47 0 N-CA-C 107.983 -2.047 . . . . 0.0 107.983 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -132.59 173.32 11.45 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 0.8 OUTLIER -131.8 84.34 54.67 Favored Pre-proline 0 C--N 1.264 -3.137 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 69.5 Cg_endo -93.85 -171.37 0.27 Allowed 'Trans proline' 0 N--CA 1.438 -1.793 0 C-N-CA 123.117 2.545 . . . . 0.0 112.666 -175.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.4 p -146.45 146.0 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -71.73 110.6 6.38 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.37 143.07 42.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 120.836 0.35 . . . . 0.0 111.153 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 61.1 mttp -76.08 117.02 17.35 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.097 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.453 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 26.1 p -95.49 165.22 17.15 Favored Pre-proline 0 C--N 1.293 -1.887 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.808 -177.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.44 -23.08 73.95 Favored 'Trans proline' 0 C--N 1.359 1.101 0 C-N-CA 123.34 2.693 . . . . 0.0 112.262 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.15 -17.05 64.68 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.038 0.447 . . . . 0.0 111.081 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.31 49.38 4.98 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.925 -0.655 . . . . 0.0 111.557 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.22 159.99 44.02 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.45 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 41.6 mt-10 -106.2 111.76 24.5 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.28 150.83 41.79 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -85.65 104.57 15.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.4 mt -115.49 138.12 51.35 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.527 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 p -90.77 123.58 64.61 Favored Pre-proline 0 C--N 1.29 -1.996 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.25 139.89 62.19 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.087 1.858 . . . . 0.0 111.907 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -73.2 -49.46 27.89 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -134.94 143.73 47.05 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.718 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.7 m -123.62 145.17 31.05 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 O-C-N 123.505 0.503 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.32 151.92 31.48 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -121.49 124.32 44.14 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.194 0.521 . . . . 0.0 110.271 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 mp -94.85 112.93 24.62 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.83 86.48 24.78 Favored Pre-proline 0 C--N 1.305 -1.369 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.783 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.51 149.19 23.92 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.657 2.238 . . . . 0.0 110.825 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -71.49 100.53 2.25 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.24 -13.31 5.98 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -126.95 -176.14 3.62 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.89 -179.45 4.57 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.78 123.75 6.19 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.3 t -102.64 112.72 36.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 58' ' ' TYR . 65.9 mttp -84.6 125.5 32.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.4 mt -131.09 142.14 44.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.0 148.29 18.43 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 49' ' ' TYR . 65.1 tp -98.07 126.32 43.45 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 91.2 m-85 -125.63 168.19 14.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.292 0.637 . . . . 0.0 110.567 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -120.13 114.81 22.52 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 172.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 15.3 t70 -58.14 132.36 84.09 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.893 0.877 . . . . 0.0 111.032 -177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.74 -19.83 30.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.935 2.423 . . . . 0.0 114.728 -175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -98.16 -54.08 3.18 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.67 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.3 p -82.71 -33.1 27.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.545 -175.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.13 18.19 59.72 Favored Glycine 0 N--CA 1.426 -1.98 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.837 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -99.86 161.42 13.62 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 117.388 0.594 . . . . 0.0 110.755 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 61.9 m-85 -89.45 133.12 34.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.647 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.77 139.74 42.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.8 ptt-85 -100.48 125.76 46.82 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -136.73 145.19 44.37 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -173.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 82.2 tttt -60.94 144.01 53.98 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 123.549 0.531 . . . . 0.0 109.958 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.3 mt -101.37 170.58 6.33 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.73 141.17 71.03 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.701 1.601 . . . . 0.0 109.319 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -56.43 -30.58 63.0 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.547 0.739 . . . . 0.0 112.37 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.71 18.7 21.53 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.418 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 77.3 t80 -78.84 128.31 77.2 Favored Pre-proline 0 C--N 1.316 -0.859 0 O-C-N 122.458 -0.151 . . . . 0.0 110.774 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.64 119.97 6.74 Favored 'Trans proline' 0 C--O 1.248 0.978 0 C-N-CA 122.307 2.005 . . . . 0.0 111.442 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.4 pt . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.727 179.646 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.8 ptp . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.2 m -155.1 -54.93 0.09 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.813 0.34 . . . . 0.0 110.96 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 m -110.17 138.11 46.99 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.93 -62.13 0.29 Allowed Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.486 ' HB2' HG21 ' A' ' 21' ' ' VAL . 51.2 mtmt 57.37 -162.18 0.21 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.792 0.837 . . . . 0.0 110.95 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 95.6 mttt -104.99 112.79 65.24 Favored Pre-proline 0 C--N 1.309 -1.194 0 O-C-N 122.067 -0.396 . . . . 0.0 110.062 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -90.34 156.82 4.56 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.954 2.436 . . . . 0.0 112.507 176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.4 154.92 22.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -74.18 115.83 14.13 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.11 138.95 51.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-O 121.17 0.51 . . . . 0.0 109.678 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -91.15 118.69 30.64 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 121.674 0.749 . . . . 0.0 109.16 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.6 p -69.5 161.02 76.86 Favored Pre-proline 0 C--N 1.281 -2.373 0 CA-C-N 113.929 -1.487 . . . . 0.0 109.712 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.99 -19.49 57.82 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.76 2.307 . . . . 0.0 111.435 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.86 -25.02 60.95 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.42 -13.42 12.2 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.5 -0.857 . . . . 0.0 114.715 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -88.7 147.28 24.58 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 118.155 0.977 . . . . 0.0 110.995 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -92.35 121.8 34.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -136.09 158.25 44.86 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -94.87 105.47 17.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.85 153.97 41.74 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.827 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 5' ' ' LYS . 14.5 p -107.25 128.52 25.85 Favored Pre-proline 0 N--CA 1.422 -1.83 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.885 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 34.7 Cg_endo -68.18 137.84 41.65 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.804 1.669 . . . . 0.0 112.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.43 -44.5 44.11 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.293 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -137.51 146.69 44.49 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.38 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -130.11 144.65 37.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 O-C-N 123.654 0.596 . . . . 0.0 109.878 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -152.73 155.58 37.48 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.624 -0.509 . . . . 0.0 109.624 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.28 134.12 55.33 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.96 0.409 . . . . 0.0 111.35 -178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.49 120.67 41.29 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . . . -98.91 122.34 53.04 Favored Pre-proline 0 C--N 1.29 -2.005 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.859 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 29' ' ' ALA . 3.3 Cg_endo -86.13 61.77 4.95 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.752 2.302 . . . . 0.0 109.505 173.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 64.15 53.53 1.78 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.763 1.225 . . . . 0.0 110.462 -174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.07 -118.6 6.01 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.392 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 70.97 -66.94 0.27 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.453 1.501 . . . . 0.0 110.734 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.3 tttt 179.55 -47.43 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.79 132.5 4.14 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.99 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.62 118.6 33.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.03 125.41 41.46 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.9 mt -124.56 136.94 58.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.76 148.27 16.71 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 49' ' ' TYR . 57.3 tp -98.85 125.82 44.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 89.6 m-85 -120.25 168.85 10.82 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 123.201 0.601 . . . . 0.0 109.907 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -131.9 120.0 21.93 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -79.62 124.23 83.79 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.47 -14.75 25.03 Favored 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 122.772 2.315 . . . . 0.0 113.721 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.34 -46.83 7.18 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.734 0.302 . . . . 0.0 111.28 -174.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.6 p -82.84 -36.8 25.17 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.485 0.66 . . . . 0.0 109.268 174.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.8 25.62 24.56 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.229 -0.896 . . . . 0.0 114.213 175.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -124.44 162.68 23.4 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 117.672 0.736 . . . . 0.0 111.491 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.442 ' HB3' HD11 ' A' ' 40' ' ' LEU . 59.8 m-85 -91.64 142.99 27.02 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.212 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -146.93 139.92 25.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -94.92 141.53 28.54 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -146.95 149.0 32.32 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.264 0.0 OUTLIER -78.25 145.03 35.69 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.073 -179.966 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.6 mt -96.64 172.92 4.56 Favored Pre-proline 0 C--N 1.276 -2.598 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -66.51 142.88 66.86 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 121.449 1.433 . . . . 0.0 109.275 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.02 -24.32 67.66 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.905 0.383 . . . . 0.0 111.288 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -87.32 -12.91 45.09 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 120.943 0.402 . . . . 0.0 111.506 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 53.5 t80 -64.62 121.15 71.44 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.504 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 7.2 Cg_endo -79.08 107.78 2.28 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 122.157 1.904 . . . . 0.0 112.587 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 N--CA 1.426 -1.637 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.827 177.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 CA--C 1.496 -1.1 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -104.35 132.44 50.6 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.08 0.467 . . . . 0.0 110.79 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.8 m -146.29 44.48 1.23 Allowed 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.34 -66.87 3.81 Favored Glycine 0 C--O 1.247 0.963 0 N-CA-C 106.881 -2.488 . . . . 0.0 106.881 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 pttt -84.93 151.14 24.46 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 113.389 -1.406 . . . . 0.0 107.617 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -153.12 137.77 11.01 Favored Pre-proline 0 C--N 1.294 -1.839 0 C-N-CA 122.87 0.468 . . . . 0.0 111.04 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 20' ' ' LEU . 12.1 Cg_endo -58.47 141.06 96.91 Favored 'Trans proline' 0 C--O 1.256 1.378 0 C-N-CA 122.957 2.438 . . . . 0.0 113.989 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.17 150.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -75.24 109.13 8.49 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.55 153.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.619 -173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 16.3 ptpt -88.22 134.22 33.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -102.2 172.61 4.2 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.664 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.79 -10.44 27.73 Favored 'Trans proline' 0 C--N 1.366 1.483 0 C-N-CA 122.962 2.441 . . . . 0.0 111.841 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.48 -5.79 51.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.3 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.08 33.59 28.94 Favored Glycine 0 CA--C 1.497 -1.058 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.944 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -142.79 168.55 19.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 11' ' ' LYS . 42.6 mt-10 -120.26 130.75 54.64 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -149.13 165.11 32.76 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -88.38 110.7 21.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.204 0.526 . . . . 0.0 109.889 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 79.3 mt -122.16 152.21 40.18 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.721 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.34 124.5 42.74 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.677 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.23 131.69 21.09 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 121.779 1.653 . . . . 0.0 110.323 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.95 -34.34 66.46 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.801 0.81 . . . . 0.0 109.175 -178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -144.66 144.17 31.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.9 139.79 50.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 O-C-N 123.707 0.629 . . . . 0.0 109.798 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -147.28 148.01 30.98 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.97 0.414 . . . . 0.0 110.861 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.21 129.99 53.47 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.891 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -106.08 89.49 3.08 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.82 84.41 25.44 Favored Pre-proline 0 C--N 1.296 -1.758 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.837 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 33' ' ' ARG . 6.2 Cg_exo -75.68 125.68 9.03 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 122.115 1.877 . . . . 0.0 108.194 175.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.92 106.16 0.55 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.32 -12.75 8.42 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 3.5 mpt_? -105.45 -173.22 2.25 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.505 -0.409 . . . . 0.0 111.328 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tmtt? -70.6 -50.05 41.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.14 103.42 1.6 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.24 165.07 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.188 0.518 . . . . 0.0 111.798 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -117.82 140.24 49.97 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 58.6 mt -131.14 138.7 52.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -127.74 145.34 15.86 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 50.2 tp -94.2 121.95 36.24 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.1 m-85 -114.4 172.76 6.82 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -130.63 116.42 18.06 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -70.72 130.5 88.65 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.0 -24.76 28.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.436 2.091 . . . . 0.0 114.762 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -97.45 -37.85 9.83 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.423 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 34.7 p -87.03 -36.87 17.96 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.38 -0.54 71.52 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.471 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.423 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 21.8 ptmt -85.22 143.92 28.46 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.326 0.584 . . . . 0.0 111.607 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 55.8 m-85 -83.98 129.14 34.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.464 -0.789 . . . . 0.0 108.97 174.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -133.58 139.69 46.7 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 31.6 ptt180 -93.21 133.12 36.73 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -136.71 148.55 47.39 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.99 139.05 58.72 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 123.936 0.772 . . . . 0.0 109.675 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.2 mt -101.93 170.59 6.24 Favored Pre-proline 0 C--N 1.293 -1.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.34 147.19 77.54 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.515 2.144 . . . . 0.0 109.939 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.32 -33.33 75.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.129 0.49 . . . . 0.0 111.144 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -88.69 7.91 31.31 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.919 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -84.12 115.86 62.1 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -76.84 117.23 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.408 2.072 . . . . 0.0 113.115 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.2 pt . . . . . 0 C--N 1.3 -1.567 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.176 178.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.378 0.132 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 m -88.73 -5.58 58.0 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.239 0.542 . . . . 0.0 109.688 178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -56.03 121.6 9.72 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 124.733 1.213 . . . . 0.0 110.122 175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.02 -36.05 4.61 Favored Glycine 0 C--N 1.302 -1.358 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 89.8 mttt 61.19 -162.2 0.28 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.845 1.658 . . . . 0.0 111.065 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -128.74 107.66 18.59 Favored Pre-proline 0 C--N 1.296 -1.748 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.884 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 46.0 Cg_endo -73.53 158.73 47.33 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.938 1.759 . . . . 0.0 111.882 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.2 p -132.72 151.21 34.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -74.99 109.47 8.47 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.0 p -133.62 149.91 31.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.252 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -85.85 128.36 34.8 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 121.597 0.713 . . . . 0.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 170.57 14.55 Favored Pre-proline 0 C--N 1.284 -2.246 0 CA-C-N 113.74 -1.573 . . . . 0.0 110.592 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 23.9 Cg_exo -66.72 -16.79 51.39 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.618 2.212 . . . . 0.0 110.788 175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.34 -21.02 58.7 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.393 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.04 12.75 48.48 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.685 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -115.26 166.62 11.65 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.617 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -88.82 137.81 31.98 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 123.461 0.476 . . . . 0.0 110.581 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -161.09 154.53 21.79 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 105.36 17.76 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.556 0.693 . . . . 0.0 109.179 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.9 mt -108.1 139.18 43.13 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.42 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 5' ' ' LYS . 7.2 p -91.8 118.22 68.17 Favored Pre-proline 0 N--CA 1.428 -1.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.26 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.29 136.47 24.28 Favored 'Trans proline' 0 C--O 1.246 0.917 0 C-N-CA 122.962 2.442 . . . . 0.0 113.408 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.4 -41.23 18.38 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.576 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HB2' ' HZ3' ' A' ' 26' ' ' TRP . 28.9 mtpp -129.1 143.77 50.97 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.28 137.96 50.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.447 ' HZ3' ' HB2' ' A' ' 24' ' ' LYS . 27.2 p90 -151.29 164.42 36.68 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.74 132.71 35.19 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.134 0.492 . . . . 0.0 110.92 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -92.88 95.56 9.58 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.17 103.24 14.09 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -60.61 -56.44 1.01 Allowed 'Trans proline' 0 C--O 1.238 0.507 0 C-N-CA 122.386 2.057 . . . . 0.0 111.083 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -169.85 -64.81 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.57 47.86 2.33 Favored Glycine 0 CA--C 1.504 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 -175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -141.65 152.92 44.37 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -64.61 -33.99 77.21 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 124.088 0.867 . . . . 0.0 110.18 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.9 130.85 6.75 Favored Glycine 0 N--CA 1.422 -2.291 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.457 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.4 t -90.28 105.91 16.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 65.9 mttp -83.59 132.37 34.91 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 52.2 mt -135.64 144.11 34.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -132.74 150.95 19.84 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.7 123.38 42.88 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.36 168.04 11.7 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.293 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -128.23 120.97 28.27 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 15.3 t70 -76.61 123.74 87.7 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 -20.53 21.58 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 C-N-CA 122.332 2.021 . . . . 0.0 113.742 -174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -92.55 -45.56 8.05 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.964 -175.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -82.82 -31.12 28.27 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.433 0.635 . . . . 0.0 109.515 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.27 -9.28 67.34 Favored Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.867 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -90.98 154.32 19.53 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -91.14 132.13 36.26 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.962 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -135.89 139.92 43.71 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -95.81 126.39 41.04 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -130.58 144.19 51.25 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -172.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -65.98 144.04 57.0 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 123.693 0.62 . . . . 0.0 109.448 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 28.3 mt -102.97 168.66 8.49 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -67.05 145.03 72.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.592 2.195 . . . . 0.0 109.16 176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -55.25 -41.92 72.8 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -88.96 5.31 44.75 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.54 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 86.5 t80 -73.88 125.18 90.51 Favored Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 121.844 -0.535 . . . . 0.0 110.047 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.2 Cg_exo -76.06 113.58 3.73 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 122.318 2.012 . . . . 0.0 110.363 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 pt . . . . . 0 C--N 1.296 -1.719 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.341 -179.9 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.845 0.355 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -139.41 20.1 2.56 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.507 0.67 . . . . 0.0 110.238 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 p -80.19 -30.43 38.76 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.459 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.22 -125.25 8.2 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.2 mttm 67.62 -178.9 0.22 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 123.874 0.87 . . . . 0.0 111.418 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -128.47 105.88 19.24 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-O 120.754 0.312 . . . . 0.0 110.988 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -81.08 157.26 20.28 Favored 'Trans proline' 0 N--CA 1.439 -1.709 0 C-N-CA 121.846 1.697 . . . . 0.0 111.609 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.2 p -141.69 148.71 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HG2' ' OE2' ' A' ' 19' ' ' GLU . 62.2 mttm -71.52 111.51 6.88 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.63 138.03 55.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-O 121.03 0.443 . . . . 0.0 109.817 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.32 123.69 29.87 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.9 p -92.91 165.69 18.18 Favored Pre-proline 0 N--CA 1.418 -2.054 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.32 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.3 -27.01 82.62 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.051 2.5 . . . . 0.0 112.445 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.27 -25.79 63.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.652 178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.62 -12.29 8.33 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.113 -1.518 . . . . 0.0 115.085 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -100.66 154.44 18.59 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 118.253 1.026 . . . . 0.0 110.211 -178.048 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -113.47 106.06 14.11 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.43 165.05 18.43 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.23 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 3.2 mp0 -82.82 104.77 13.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.118 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.6 mt -111.22 157.12 20.47 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.86 129.03 24.39 Favored Pre-proline 0 N--CA 1.403 -2.818 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.071 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.13 123.56 7.9 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 C-N-CA 121.775 1.65 . . . . 0.0 111.351 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.52 -35.22 65.54 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.35 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -134.52 136.92 43.44 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.51 139.05 52.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.36 0.412 . . . . 0.0 110.4 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -149.53 155.39 40.25 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.74 136.51 53.92 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.58 0.705 . . . . 0.0 111.057 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 6.6 mp -108.01 100.02 9.41 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.81 96.34 16.98 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 123.243 0.34 . . . . 0.0 110.676 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 6.2 Cg_exo -80.7 155.4 20.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.523 2.149 . . . . 0.0 109.848 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -72.85 127.86 33.79 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 121.064 0.459 . . . . 0.0 110.111 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' C ' ' HD2' ' A' ' 33' ' ' ARG . . . 99.36 -15.48 60.1 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.231 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 32' ' ' GLY . 6.1 mpt_? -117.46 159.06 23.42 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 122.324 -0.515 . . . . 0.0 110.485 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.26 -33.3 73.03 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.467 0.479 . . . . 0.0 111.19 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.85 163.07 22.23 Favored Glycine 0 N--CA 1.419 -2.451 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.74 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.28 156.75 40.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -113.42 137.64 51.23 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 71.9 mt -134.04 141.04 44.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.83 150.65 19.38 Favored Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 49' ' ' TYR . 60.8 tp -94.8 124.99 39.16 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.14 -179.86 4.44 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.246 1.018 . . . . 0.0 109.162 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 49' ' ' TYR . 84.0 tttt -134.05 132.09 39.61 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.76 121.34 82.26 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.99 -9.8 20.95 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.262 1.975 . . . . 0.0 114.851 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -99.13 -41.44 7.52 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.938 -0.705 . . . . 0.0 112.105 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.6 p -92.21 -25.95 18.42 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.982 0.42 . . . . 0.0 111.088 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.35 30.64 36.46 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.065 -0.516 . . . . 0.0 113.266 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -119.85 145.23 46.85 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.642 -0.328 . . . . 0.0 110.259 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 46.0 m-85 -80.55 138.53 36.51 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -141.3 140.2 33.78 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -93.54 137.82 32.44 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -142.51 147.03 35.34 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.5 ptpt -68.94 144.53 54.14 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.179 0.514 . . . . 0.0 110.428 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.6 mt -102.66 169.16 7.86 Favored Pre-proline 0 C--N 1.288 -2.1 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 24.6 Cg_exo -67.1 151.28 81.85 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.704 2.269 . . . . 0.0 109.895 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -64.22 -36.16 83.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.75 6.99 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.003 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.405 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 88.6 t80 -84.69 122.85 74.77 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.47 -0.769 . . . . 0.0 109.986 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.87 98.59 1.22 Allowed 'Trans proline' 0 N--CA 1.437 -1.794 0 C-N-CA 122.444 2.096 . . . . 0.0 111.916 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.2 pt . . . . . 0 N--CA 1.423 -1.79 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.002 179.463 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.307 0.099 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 62.41 74.44 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.415 1.086 . . . . 0.0 111.827 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.7 m -141.36 70.04 1.34 Allowed 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.062 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.36 53.49 2.44 Favored Glycine 0 N--CA 1.438 -1.2 0 N-CA-C 108.411 -1.876 . . . . 0.0 108.411 175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -139.0 -172.95 3.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -175.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.03 134.93 9.05 Favored Pre-proline 0 C--N 1.297 -1.702 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -78.81 141.95 17.42 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 121.945 1.764 . . . . 0.0 111.203 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 58' ' ' TYR . 14.6 p -120.96 149.82 23.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 17' ' ' GLU . 60.6 mttp -75.07 108.82 8.06 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 174.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.2 p -129.24 141.0 47.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.031 0.443 . . . . 0.0 110.162 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -78.54 115.64 18.39 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.52 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.596 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 76.6 p -83.49 165.03 42.5 Favored Pre-proline 0 C--N 1.292 -1.902 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.11 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -65.52 -17.4 57.21 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.436 2.091 . . . . 0.0 111.18 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.28 -17.97 61.26 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.674 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.4 31.24 6.55 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.72 -0.752 . . . . 0.0 114.772 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.64 38.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 117.601 0.701 . . . . 0.0 109.932 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' A' ' 9' ' ' LYS . 36.7 tt0 -91.84 93.57 8.9 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 121.942 0.877 . . . . 0.0 109.563 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.29 160.28 14.82 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.535 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG2' ' HG2' ' A' ' 9' ' ' LYS . 52.3 mt-10 -92.29 105.61 17.78 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.462 0.649 . . . . 0.0 109.926 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.1 mt -117.54 141.89 47.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.136 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 10.9 p -95.63 125.08 50.69 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 12.5 Cg_exo -66.6 141.17 59.53 Favored 'Trans proline' 0 C--O 1.245 0.855 0 C-N-CA 122.145 1.896 . . . . 0.0 114.088 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.22 -47.12 65.69 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -142.26 144.32 33.25 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 114.095 -1.411 . . . . 0.0 107.527 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 m -124.99 152.73 31.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -157.36 153.48 27.38 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.074 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.96 125.05 42.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.239 0.542 . . . . 0.0 110.761 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 5.2 mp -89.43 87.16 6.98 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 98.85 8.96 Favored Pre-proline 0 N--CA 1.423 -1.784 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.43 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.77 -66.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.646 1.564 . . . . 0.0 108.501 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 175.39 148.19 0.09 Allowed 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.26 -5.6 79.67 Favored Glycine 0 C--N 1.31 -0.915 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -105.85 150.18 25.83 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.941 -1.504 . . . . 0.0 106.941 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -57.88 -39.1 77.03 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.298 0.374 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.48 95.34 2.21 Favored Glycine 0 CA--C 1.495 -1.218 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 28' ' ' LEU . 24.5 t -82.19 104.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 -176.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -89.69 126.23 35.57 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.502 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.6 mt -129.19 142.72 43.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.86 147.66 18.49 Favored Glycine 0 N--CA 1.422 -2.294 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.1 tp -96.35 125.37 40.8 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 95.0 m-85 -123.23 173.98 7.57 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 122.979 0.511 . . . . 0.0 109.972 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -125.34 125.3 43.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.596 ' OD2' ' HB ' ' A' ' 12' ' ' THR . 9.0 t70 -78.38 120.03 79.56 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.5 -12.37 27.06 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.728 2.285 . . . . 0.0 115.022 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.07 -34.38 10.8 Favored 'General case' 0 C--N 1.313 -0.986 0 O-C-N 121.907 -0.496 . . . . 0.0 112.053 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -93.77 -34.41 13.21 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.29 0.567 . . . . 0.0 110.496 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.69 30.83 22.93 Favored Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.373 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.94 151.34 43.7 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.0 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 78.3 m-85 -87.83 129.81 35.08 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.971 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -134.59 139.33 45.28 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -95.23 131.68 41.02 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -139.07 149.96 45.19 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -67.22 142.02 57.09 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.5 mt -97.85 -179.82 0.95 Allowed Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.12 137.87 59.02 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.579 1.519 . . . . 0.0 108.162 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.11 -20.28 57.48 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 123.392 0.677 . . . . 0.0 112.625 -174.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -112.26 11.62 20.2 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.632 0.73 . . . . 0.0 111.01 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.464 ' CZ ' ' HB ' ' A' ' 8' ' ' VAL . 13.8 t80 -67.09 127.72 93.6 Favored Pre-proline 0 C--N 1.318 -0.779 0 O-C-N 121.399 -0.813 . . . . 0.0 110.211 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.35 92.36 0.75 Allowed 'Trans proline' 0 C--O 1.244 0.8 0 C-N-CA 122.308 2.005 . . . . 0.0 113.535 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.202 177.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.0 p -139.81 169.66 17.32 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.805 0.336 . . . . 0.0 111.591 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -151.91 79.92 1.26 Allowed 'General case' 0 C--O 1.246 0.877 0 C-N-CA 124.062 0.945 . . . . 0.0 108.725 175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.73 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.797 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -85.17 83.07 8.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.578 0.704 . . . . 0.0 109.654 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -127.16 115.82 21.75 Favored Pre-proline 0 C--N 1.297 -1.695 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -80.01 159.63 23.97 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 C-N-CA 121.514 1.476 . . . . 0.0 112.342 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.2 p -140.87 150.52 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -72.1 109.32 5.81 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.6 p -125.22 137.68 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.544 0 CA-C-O 121.658 0.742 . . . . 0.0 109.859 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -83.6 119.81 25.2 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.4 p -92.18 155.64 42.64 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.8 -16.09 33.21 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 122.905 2.404 . . . . 0.0 110.476 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.24 72.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.343 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.3 -18.47 4.42 Favored Glycine 0 N--CA 1.432 -1.605 0 C-N-CA 120.016 -1.087 . . . . 0.0 114.62 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.64 173.51 6.81 Favored 'General case' 0 C--O 1.253 1.262 0 CA-C-N 118.102 0.951 . . . . 0.0 112.141 -174.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -84.38 126.16 32.97 Favored 'General case' 0 C--O 1.249 1.036 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.31 144.89 50.89 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 54.7 mt-10 -94.74 104.42 16.33 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.99 141.5 48.16 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.854 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -90.35 121.72 68.19 Favored Pre-proline 0 N--CA 1.416 -2.151 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 173.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.36 134.69 60.32 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.168 1.912 . . . . 0.0 111.448 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.62 -32.43 64.06 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.276 1.03 . . . . 0.0 108.633 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -153.02 138.74 17.89 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.74 144.86 31.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -153.9 160.66 42.23 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.68 130.62 30.23 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.25 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.11 97.05 8.21 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.76 97.71 32.56 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.606 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.79 -64.78 0.08 OUTLIER 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.612 2.208 . . . . 0.0 111.794 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.3 tttm 169.69 119.88 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.531 1.132 . . . . 0.0 108.963 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.26 43.73 89.31 Favored Glycine 0 C--O 1.246 0.886 0 CA-C-O 121.79 0.661 . . . . 0.0 111.93 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -140.21 176.2 8.96 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -70.21 107.83 3.88 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.55 89.84 0.74 Allowed Glycine 0 N--CA 1.428 -1.891 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.3 m -75.63 100.47 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-O 122.252 1.025 . . . . 0.0 112.167 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -77.59 127.55 32.66 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.109 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 54.9 mt -128.86 139.0 53.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -126.95 145.75 15.93 Favored Glycine 0 N--CA 1.412 -2.959 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.1 tp -93.9 126.18 38.96 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.31 178.46 4.52 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -129.71 125.44 35.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 11.0 t70 -63.66 127.78 91.89 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 124.074 0.859 . . . . 0.0 109.375 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 26.1 Cg_exo -63.31 -40.86 29.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.463 2.109 . . . . 0.0 114.183 -176.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -88.44 -48.93 7.26 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -90.52 -19.93 23.24 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.06 -174.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.95 0.54 89.72 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 115.003 0.761 . . . . 0.0 115.003 174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -73.87 138.81 44.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 117.011 0.405 . . . . 0.0 111.272 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -81.45 121.29 26.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -126.32 139.44 53.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -96.02 134.03 39.54 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -137.33 139.95 41.17 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.21 139.19 52.24 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.035 178.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.71 173.12 6.83 Favored Pre-proline 0 C--N 1.277 -2.572 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -66.61 140.0 55.23 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 N-CA-C 107.788 -1.658 . . . . 0.0 107.788 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.23 -28.31 68.63 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.34 -4.94 57.18 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.801 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -79.27 122.07 83.72 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -82.39 112.31 2.19 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.428 2.086 . . . . 0.0 111.658 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--N 1.298 -1.648 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.103 178.2 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tmm? . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 p -95.11 -40.71 9.48 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.355 0.598 . . . . 0.0 110.455 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -124.76 107.33 10.82 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-O 121.321 0.581 . . . . 0.0 109.885 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.92 46.0 1.23 Allowed Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -72.97 82.05 1.21 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.013 -0.594 . . . . 0.0 111.959 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -125.36 78.59 67.52 Favored Pre-proline 0 C--N 1.296 -1.736 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.427 174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -83.89 123.94 3.33 Favored 'Trans proline' 0 N--CA 1.425 -2.538 0 C-N-CA 121.585 1.524 . . . . 0.0 110.645 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 p -104.83 148.39 9.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -81.13 109.65 15.89 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.19 153.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 -172.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 16' ' ' LYS . 54.1 mttp -86.09 135.47 33.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.032 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.7 p -88.75 170.45 11.08 Favored Pre-proline 0 N--CA 1.425 -1.676 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.06 -13.62 28.75 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.315 2.01 . . . . 0.0 112.526 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.65 -6.76 58.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.919 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.4 15.1 62.69 Favored Glycine 0 C--N 1.328 0.123 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 49.9 mtpt -98.02 163.92 12.56 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -129.41 125.64 37.0 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.727 -176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.77 164.58 36.71 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.32 121.57 28.25 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.35 137.89 52.89 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.22 126.15 61.61 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.99 141.02 68.67 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.11 1.873 . . . . 0.0 113.159 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG3' ' CE2' ' A' ' 49' ' ' TYR . 20.4 mm-40 -72.78 -45.61 57.64 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.919 178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -139.63 148.7 42.83 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -131.83 143.5 40.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 O-C-N 123.406 0.441 . . . . 0.0 109.942 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -149.61 156.05 41.28 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 120.726 0.298 . . . . 0.0 110.62 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.67 125.2 33.36 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.676 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -82.78 92.84 7.31 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 35' ' ' GLY . . . -137.6 87.74 17.18 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.083 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -55.19 -41.2 80.88 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 123.014 2.476 . . . . 0.0 110.685 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -171.68 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.29 92.98 0.31 Allowed Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -153.43 37.66 0.48 Allowed 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 70.72 -55.04 0.64 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.017 1.727 . . . . 0.0 111.315 -174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 29' ' ' ALA . . . 103.96 72.74 0.91 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -174.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -74.69 114.44 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -173.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -96.89 130.7 44.15 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.8 mt -133.64 142.9 40.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.55 146.16 16.66 Favored Glycine 0 N--CA 1.407 -3.289 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.3 tp -96.19 128.14 42.83 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -119.74 169.54 10.02 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.977 0.418 . . . . 0.0 110.5 -177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -122.28 116.82 24.76 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.95 123.23 39.01 Favored Pre-proline 0 C--N 1.316 -0.881 0 C-N-CA 125.256 1.422 . . . . 0.0 109.689 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.79 -26.13 52.8 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.964 2.443 . . . . 0.0 114.087 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -99.05 -48.19 4.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 p -94.79 -13.14 25.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.405 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.25 18.67 79.12 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.862 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.97 148.04 22.5 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.886 0.343 . . . . 0.0 111.384 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.478 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 19.9 m-85 -87.86 128.4 35.35 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.14 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -136.47 140.45 43.09 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -97.88 132.34 43.56 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.246 0.546 . . . . 0.0 110.37 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -138.5 141.1 39.4 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 17.8 ptmt -70.89 149.24 46.96 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 118.01 -1.476 . . . . 0.0 109.86 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 28.9 mt -94.6 175.29 3.0 Favored Pre-proline 0 C--N 1.28 -2.431 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.96 141.65 59.16 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 N-CA-C 108.177 -1.509 . . . . 0.0 108.177 173.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -66.87 -23.06 65.97 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.482 0.658 . . . . 0.0 110.243 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -88.34 -5.25 58.43 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.413 1.485 . . . . 0.0 111.732 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -72.29 136.76 81.41 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.9 115.69 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.434 2.089 . . . . 0.0 114.538 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.925 173.271 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tmm? . . . . . 0 C--O 1.243 0.72 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.7 m 64.86 88.77 0.1 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.782 1.233 . . . . 0.0 111.5 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 t -94.79 -2.22 51.35 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.232 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.53 -60.11 0.6 Allowed Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 21' ' ' VAL . 99.0 mttt -104.69 151.99 23.05 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 88.0 tttt -142.4 135.18 13.81 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 18.5 Cg_endo -75.49 131.85 14.17 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.453 1.435 . . . . 0.0 112.167 176.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.39 147.55 19.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.135 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -69.05 108.63 3.63 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 151.72 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-O 121.497 0.665 . . . . 0.0 111.624 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -94.46 141.17 28.89 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.252 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.0 p -93.14 171.69 6.97 Favored Pre-proline 0 C--N 1.29 -1.992 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.67 -12.88 35.83 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.1 1.867 . . . . 0.0 111.581 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.16 -20.75 47.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.148 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.66 -16.7 36.96 Favored Glycine 0 C--O 1.242 0.635 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.906 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -83.76 158.14 21.85 Favored 'General case' 0 C--O 1.255 1.377 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -112.17 145.04 40.56 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.48 154.87 32.5 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.47 104.88 17.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -117.04 148.23 41.67 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.498 -173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG2' ' HB3' ' A' ' 5' ' ' LYS . 14.6 p -96.18 125.97 45.98 Favored Pre-proline 0 N--CA 1.426 -1.66 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 56.9 Cg_endo -74.85 142.07 27.9 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.99 1.793 . . . . 0.0 111.871 178.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.33 -40.73 64.22 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.353 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -145.85 147.34 31.71 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.856 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.29 144.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -146.5 155.98 42.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.23 153.06 32.56 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.132 0.491 . . . . 0.0 110.719 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -120.81 85.85 2.47 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.7 94.85 24.43 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -83.12 136.62 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.844 0 C-N-CA 121.721 1.614 . . . . 0.0 108.413 170.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -60.86 113.63 2.61 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.108 0.48 . . . . 0.0 111.933 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.96 2.01 56.07 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.138 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -116.47 -72.83 0.67 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -142.25 174.66 10.41 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 120.679 0.276 . . . . 0.0 111.15 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.54 42.28 0.89 Allowed Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -83.16 149.88 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.352 0.596 . . . . 0.0 110.826 -175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -127.65 144.58 51.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 56.8 mt -136.11 143.82 34.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -131.57 148.9 19.16 Favored Glycine 0 N--CA 1.424 -2.165 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.2 tp -98.22 122.72 41.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.53 173.41 6.85 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.038 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -134.64 125.77 27.82 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 172.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -78.54 128.5 77.3 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.54 -12.8 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.085 2.523 . . . . 0.0 114.254 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -97.68 -52.62 3.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.26 0.552 . . . . 0.0 111.69 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 45.0 p -82.79 -35.14 26.74 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.379 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.52 4.25 62.4 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.025 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.9 ptpt -88.29 150.0 23.49 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.265 0.555 . . . . 0.0 111.87 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -95.15 136.5 35.41 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -143.93 139.92 29.41 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.98 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -100.38 119.92 39.18 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 121.38 0.609 . . . . 0.0 109.77 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -127.49 144.28 51.08 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -173.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -68.58 141.48 55.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.611 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 25.7 mt -93.95 172.15 6.13 Favored Pre-proline 0 C--N 1.284 -2.272 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.92 140.48 55.15 Favored 'Trans proline' 0 N--CA 1.433 -2.039 0 C-N-CA 121.526 1.484 . . . . 0.0 108.412 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.05 -26.72 68.97 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.36 0.6 . . . . 0.0 109.775 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.12 0.26 56.23 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.779 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 66.1 t80 -80.31 126.68 78.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 5.6 Cg_exo -76.96 107.88 2.53 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.145 1.897 . . . . 0.0 112.54 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 38.0 pt . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 174.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.479 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -92.99 95.38 9.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.299 0.571 . . . . 0.0 110.847 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -95.33 86.3 4.49 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.573 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.35 -143.33 17.87 Favored Glycine 0 N--CA 1.432 -1.601 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.578 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -89.63 138.33 31.56 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 121.571 0.701 . . . . 0.0 112.829 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 54.3 mtmt -139.39 94.17 9.66 Favored Pre-proline 0 C--N 1.291 -1.935 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -84.55 120.03 2.38 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.328 2.019 . . . . 0.0 111.611 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 9.8 p -103.91 145.46 12.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.162 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -74.94 108.45 7.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -130.48 149.52 33.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.539 -175.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.05 124.39 28.24 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.741 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.423 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 30.4 p -76.41 169.17 22.24 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.51 -24.38 36.22 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.266 1.978 . . . . 0.0 110.148 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.53 85.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.589 177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.61 31.37 1.25 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.095 -1.05 . . . . 0.0 114.463 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.53 160.01 41.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 117.331 0.565 . . . . 0.0 109.772 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.68 127.47 34.51 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.202 0.525 . . . . 0.0 111.505 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.23 146.96 52.37 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -89.87 105.3 17.71 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.99 0.9 . . . . 0.0 108.952 177.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.01 141.74 48.42 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.535 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.97 121.87 68.39 Favored Pre-proline 0 N--CA 1.424 -1.762 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 6' ' ' LYS . 30.8 Cg_endo -66.44 134.72 36.83 Favored 'Trans proline' 0 N--CA 1.444 -1.435 0 C-N-CA 122.073 1.849 . . . . 0.0 112.28 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -61.27 -48.98 78.93 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -145.89 153.98 41.45 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.648 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.94 152.0 30.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 O-C-N 123.628 0.58 . . . . 0.0 110.544 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 20.4 p90 -155.53 168.37 27.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.256 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.56 139.79 36.92 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.006 0.431 . . . . 0.0 110.758 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 94.56 4.91 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 91.82 40.06 Favored Pre-proline 0 C--N 1.301 -1.542 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.006 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -82.73 173.67 10.19 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 122.43 2.087 . . . . 0.0 108.621 172.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.39 139.62 51.92 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.682 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.21 32.4 25.87 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.741 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -156.37 154.12 30.02 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -69.93 -45.75 66.84 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.82 117.94 2.21 Favored Glycine 0 N--CA 1.42 -2.405 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.921 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.15 119.93 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 121.42 0.629 . . . . 0.0 110.078 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -95.04 136.5 35.29 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 63.4 mt -133.14 140.11 47.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.07 149.6 18.58 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.8 tp -96.14 125.51 40.71 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -122.88 175.07 6.76 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -133.4 122.93 24.47 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 13.3 t70 -78.74 125.72 83.75 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 3.2 Cg_exo -80.13 -8.34 14.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.247 1.965 . . . . 0.0 113.354 -174.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.44 -40.74 8.54 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 29.3 p -90.29 -34.16 15.85 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.346 0.593 . . . . 0.0 109.577 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.76 29.79 22.78 Favored Glycine 0 N--CA 1.432 -1.619 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.704 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -118.89 144.24 46.52 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.912 0.356 . . . . 0.0 111.6 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -80.68 124.65 29.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.725 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -135.4 140.05 44.66 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -92.76 138.83 31.15 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -144.43 147.91 33.93 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -70.46 146.52 50.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.647 178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 16.2 mt -102.07 168.98 8.2 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.89 143.47 66.75 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 121.919 1.746 . . . . 0.0 108.908 175.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -73.05 -15.25 61.51 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.842 -0.536 . . . . 0.0 110.868 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -90.25 -1.82 57.97 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.597 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 89.0 t80 -81.7 133.83 51.68 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 122.761 0.424 . . . . 0.0 111.059 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 3.4 Cg_exo -78.95 106.19 2.05 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 122.572 2.182 . . . . 0.0 112.256 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.1 pt . . . . . 0 N--CA 1.432 -1.365 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.665 178.473 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.5 mtp . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.0 t 62.67 -158.64 0.32 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.5 t -139.59 111.59 7.43 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.49 -82.99 1.67 Allowed Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 55.68 73.43 0.43 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.433 1.093 . . . . 0.0 111.517 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB2' ' OH ' ' A' ' 58' ' ' TYR . 82.2 mttt -121.81 99.4 44.49 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.622 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HB2' ' HG2' ' A' ' 19' ' ' GLU . 47.2 Cg_endo -71.67 138.91 32.9 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.104 1.869 . . . . 0.0 112.914 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.06 143.09 41.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' GLU . 27.6 mtmm -74.43 108.51 7.25 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.15 144.89 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.112 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -75.52 115.67 15.43 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.297 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.2 p -83.85 162.75 51.53 Favored Pre-proline 0 C--N 1.291 -1.939 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.957 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.47 -18.03 44.25 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 123.419 2.746 . . . . 0.0 114.782 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.04 -5.52 59.14 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.884 0.373 . . . . 0.0 111.803 -178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.66 37.41 9.54 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.568 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -140.33 166.25 25.2 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -113.65 147.51 37.99 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.212 -177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.32 146.7 28.67 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 7' ' ' PRO . 31.1 tt0 -92.32 105.89 18.0 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.72 0.771 . . . . 0.0 109.358 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.56 145.56 48.22 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.296 -173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.82 128.37 46.25 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.09 144.7 93.07 Favored 'Trans proline' 0 C--O 1.248 1.01 0 C-N-CA 122.453 2.102 . . . . 0.0 113.789 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.03 -42.51 23.64 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.726 1.211 . . . . 0.0 109.447 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -145.31 141.4 28.52 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -125.43 139.97 49.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 123.31 0.381 . . . . 0.0 110.009 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -146.33 158.2 43.86 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.95 125.78 38.22 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.057 0.456 . . . . 0.0 110.223 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.3 mp -79.73 89.6 5.19 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -118.76 116.6 34.53 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.662 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -59.28 -48.85 12.33 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.695 1.597 . . . . 0.0 107.986 172.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.3 tptp 177.92 -64.52 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.044 -1.435 . . . . 0.0 108.197 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.59 103.77 2.09 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.5 -176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -169.91 -79.23 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -172.11 -56.13 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.082 0 C-N-CA 126.071 1.749 . . . . 0.0 106.693 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.28 112.56 2.34 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.564 -1.815 . . . . 0.0 108.564 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' A' ' 53' ' ' LYS . 59.4 t -75.33 105.42 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -80.68 125.93 30.65 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.534 -172.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.0 mt -132.26 139.36 50.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -128.1 147.39 17.3 Favored Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 58.5 tp -94.9 130.01 41.68 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 49' ' ' TYR . 98.5 m-85 -124.89 176.4 6.66 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 122.917 0.487 . . . . 0.0 110.084 -178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -130.58 115.84 17.31 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.61 126.02 92.01 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 -20.47 25.38 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 122.196 1.931 . . . . 0.0 113.39 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.82 -60.46 2.1 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -175.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 39.8 p -82.52 -32.05 28.89 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 120.906 0.384 . . . . 0.0 110.906 -177.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.04 -3.88 62.45 Favored Glycine 0 N--CA 1.425 -2.067 0 CA-C-N 115.994 -0.548 . . . . 0.0 113.113 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.3 ptpt -80.98 153.63 27.37 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 41' ' ' PHE . 10.2 m-85 -90.9 125.37 35.74 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.138 177.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.69 139.78 47.83 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 39.4 ptt180 -94.06 138.3 32.29 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -143.99 144.51 31.71 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HE2' HG13 ' A' ' 36' ' ' VAL . 61.1 tttm -62.53 142.94 57.73 Favored 'General case' 0 N--CA 1.436 -1.166 0 O-C-N 123.655 0.597 . . . . 0.0 109.761 177.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 25.5 mt -102.39 172.14 4.62 Favored Pre-proline 0 C--N 1.283 -2.287 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -67.01 139.77 52.25 Favored 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 122.093 1.862 . . . . 0.0 107.708 173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -74.84 -11.17 60.08 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.718 -0.614 . . . . 0.0 110.382 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -95.39 0.52 53.57 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.714 1.205 . . . . 0.0 110.448 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.423 ' OH ' ' HB2' ' A' ' 6' ' ' LYS . 77.4 t80 -80.75 119.49 76.33 Favored Pre-proline 0 C--N 1.314 -0.951 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -76.36 104.71 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.487 2.125 . . . . 0.0 112.444 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.6 pt . . . . . 0 N--CA 1.425 -1.722 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.56 -179.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 C--O 1.217 -0.616 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -57.9 113.59 1.94 Allowed 'General case' 0 C--O 1.245 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 111.806 -177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m 63.75 44.56 4.93 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.289 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.88 92.99 1.15 Allowed Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.184 -1.967 . . . . 0.0 108.184 173.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 21' ' ' VAL . 22.1 pttm -92.13 147.37 22.99 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.119 0.962 . . . . 0.0 113.576 -170.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 6' ' ' LYS . 7.9 tmtt? -150.19 104.6 3.15 Favored Pre-proline 0 N--CA 1.414 -2.243 0 N-CA-C 102.566 -3.124 . . . . 0.0 102.566 168.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -83.28 149.25 13.26 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.946 1.764 . . . . 0.0 112.373 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.0 p -121.52 144.92 29.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -73.57 108.39 6.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 7.8 p -121.28 141.41 41.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.05 -174.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -78.93 117.26 19.84 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.517 ' HB ' ' OD2' ' A' ' 43' ' ' ASP . 46.0 p -85.96 169.01 16.74 Favored Pre-proline 0 C--N 1.286 -2.191 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.035 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 31.2 Cg_exo -63.16 -22.26 72.82 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.143 2.562 . . . . 0.0 111.079 174.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.8 -14.75 62.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.51 4.74 62.12 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 121.345 -0.455 . . . . 0.0 113.17 175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -115.64 161.09 19.16 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.496 -0.414 . . . . 0.0 110.049 -177.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 52.6 mt-10 -102.29 135.57 43.66 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-O 121.132 0.492 . . . . 0.0 110.521 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -142.23 155.5 45.26 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 48.9 mt-10 -89.85 105.22 17.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -116.98 138.14 51.76 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.961 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 5' ' ' LYS . 6.9 p -94.59 121.75 62.44 Favored Pre-proline 0 N--CA 1.415 -2.213 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.11 140.55 90.11 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.472 2.114 . . . . 0.0 113.013 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.2 -43.65 77.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.276 1.036 . . . . 0.0 109.005 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.32 138.34 38.26 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.201 -178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.06 144.41 32.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.191 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -152.2 161.84 42.02 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.57 128.16 32.69 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.248 0.547 . . . . 0.0 111.497 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 mp -93.54 94.79 8.85 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.432 -0.804 . . . . 0.0 108.887 177.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -106.83 110.35 63.61 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.3 -69.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.19 1.926 . . . . 0.0 111.505 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -164.4 115.47 1.26 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.884 0.473 . . . . 0.0 110.153 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.16 45.34 96.24 Favored Glycine 0 C--N 1.318 -0.469 0 O-C-N 123.505 0.503 . . . . 0.0 112.724 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.536 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.3 OUTLIER -127.07 167.4 16.01 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -68.83 -34.95 76.34 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.31 120.67 4.77 Favored Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.245 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.6 t -76.08 103.26 3.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -86.83 137.02 32.76 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.224 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 60.5 mt -136.38 141.47 41.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 147.32 18.37 Favored Glycine 0 N--CA 1.415 -2.726 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.5 tp -95.76 124.12 39.64 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -118.97 170.1 9.32 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.697 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -117.21 125.99 52.05 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 172.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.584 ' OD2' ' HD2' ' A' ' 13' ' ' PRO . 16.0 t70 -69.56 132.54 89.26 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.9 -12.52 10.84 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.118 1.879 . . . . 0.0 114.185 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -97.48 -51.02 4.29 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.367 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.8 p -88.27 -37.28 16.16 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 122.899 0.479 . . . . 0.0 110.522 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -4.98 55.15 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.513 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -81.44 151.95 27.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.175 0.487 . . . . 0.0 111.641 -176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -89.63 125.33 35.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.184 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -127.25 140.66 52.07 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -101.4 136.6 40.96 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.63 143.82 37.39 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -70.47 139.54 51.72 Favored 'General case' 0 N--CA 1.435 -1.179 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.79 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 22.7 mt -93.67 174.78 3.53 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -64.62 141.46 73.11 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 N-CA-C 108.183 -1.507 . . . . 0.0 108.183 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -26.05 68.39 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.226 0.536 . . . . 0.0 110.998 -175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -100.11 12.19 37.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.194 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -72.8 128.08 88.72 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.16 103.34 1.73 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.647 1.565 . . . . 0.0 113.397 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.739 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.6 mtp . . . . . 0 CA--C 1.503 -0.853 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -110.23 111.98 23.64 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.9 p -67.23 104.9 1.58 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 121.433 0.635 . . . . 0.0 111.413 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.52 -44.63 0.13 Allowed Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.376 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -73.07 132.24 43.09 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.566 0.698 . . . . 0.0 111.792 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -116.5 96.17 47.44 Favored Pre-proline 0 C--N 1.293 -1.875 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.153 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.32 143.65 14.03 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 122.407 2.072 . . . . 0.0 110.995 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -102.12 135.69 37.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -70.43 109.31 4.71 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.3 p -127.77 145.94 34.24 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.554 -173.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 67.4 mttm -78.06 124.47 28.07 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -81.63 163.12 55.57 Favored Pre-proline 0 C--N 1.282 -2.333 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 -7.1 20.49 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.482 2.122 . . . . 0.0 111.404 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.89 -32.37 20.24 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.177 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.96 -39.44 1.66 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.255 -0.974 . . . . 0.0 113.808 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -71.67 164.91 25.06 Favored 'General case' 0 C--O 1.249 1.034 0 CA-C-O 120.844 0.354 . . . . 0.0 110.379 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.526 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 33.2 mt-10 -115.77 129.25 56.38 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -141.48 147.49 37.92 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 123.178 0.299 . . . . 0.0 110.209 -176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -80.53 105.26 11.64 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.61 138.14 51.65 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.948 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.39 122.08 63.72 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.86 146.41 77.96 Favored 'Trans proline' 0 C--O 1.239 0.539 0 C-N-CA 122.89 2.393 . . . . 0.0 113.39 -175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -67.0 -45.94 76.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.45 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -149.63 152.55 35.6 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.598 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -132.68 151.14 33.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 O-C-N 123.576 0.547 . . . . 0.0 110.465 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -148.72 161.4 41.85 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.133 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.53 137.31 40.14 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 120.857 0.36 . . . . 0.0 111.289 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.47 119.98 41.09 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.12 90.91 47.7 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.21 105.55 2.1 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 122.708 2.272 . . . . 0.0 112.233 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? 70.08 -64.08 0.37 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.682 1.593 . . . . 0.0 112.124 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.03 111.44 0.49 Allowed Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -159.95 163.8 33.9 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -79.3 -9.8 59.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.061 0.934 . . . . 0.0 108.712 176.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 37' ' ' LYS . . . 100.12 108.14 2.96 Favored Glycine 0 N--CA 1.418 -2.563 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.834 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.99 112.44 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 35' ' ' GLY . 60.0 mttp -99.1 136.3 39.26 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.847 -171.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -132.33 136.77 55.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -125.75 146.43 16.2 Favored Glycine 0 N--CA 1.422 -2.233 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 62.2 tp -96.6 123.68 40.35 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.79 174.17 6.6 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.664 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -132.41 127.56 35.65 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 173.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.0 t70 -86.93 116.34 65.69 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 43' ' ' ASP . 11.3 Cg_exo -72.34 -8.68 23.11 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.006 2.471 . . . . 0.0 113.108 -175.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.3 -53.57 4.49 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.507 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.3 p -84.68 -30.73 24.58 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.225 0.536 . . . . 0.0 111.1 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.96 28.71 30.62 Favored Glycine 0 N--CA 1.426 -1.975 0 CA-C-N 115.982 -0.554 . . . . 0.0 113.177 178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -123.53 152.0 42.26 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.789 178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.22 135.51 33.63 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -137.06 139.86 41.61 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -99.37 129.57 45.58 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 -134.37 147.48 50.53 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 54' ' ' LEU . 38.7 ttmt -66.83 140.77 57.83 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 17.9 mt -101.51 172.4 4.47 Favored Pre-proline 0 C--N 1.289 -2.03 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -67.17 139.52 50.74 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.607 1.538 . . . . 0.0 109.641 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.45 -30.48 68.54 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.098 0.475 . . . . 0.0 110.539 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -86.31 -1.09 57.2 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.895 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -74.76 126.65 88.25 Favored Pre-proline 0 C--N 1.313 -1.018 0 O-C-N 121.599 -0.688 . . . . 0.0 109.898 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.86 120.99 6.01 Favored 'Trans proline' 0 C--O 1.249 1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 112.581 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.131 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -55.08 112.1 0.99 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.237 0.615 . . . . 0.0 110.261 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.9 m -109.36 40.66 1.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.581 -175.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.2 29.53 5.57 Favored Glycine 0 C--O 1.236 0.256 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -139.09 -179.34 5.79 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -141.21 118.02 7.57 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.305 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 21' ' ' VAL . 14.0 Cg_endo -72.35 141.91 36.24 Favored 'Trans proline' 0 N--CA 1.442 -1.538 0 C-N-CA 121.597 1.532 . . . . 0.0 110.134 173.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.08 141.8 41.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.82 109.08 5.45 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -125.12 146.27 31.07 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.847 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -79.08 120.7 24.0 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.573 ' HB ' ' OD1' ' A' ' 43' ' ' ASP . 77.0 p -78.48 161.3 70.29 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.063 -177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.66 -15.99 37.73 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 122.487 2.125 . . . . 0.0 110.194 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.41 -51.28 24.84 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.893 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.8 -17.09 2.4 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.93 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -92.24 168.3 11.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -110.71 130.69 55.51 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.611 -0.436 . . . . 0.0 109.912 175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.26 152.46 51.54 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.96 104.74 16.57 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.62 141.93 44.58 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 14.9 p -93.13 125.55 54.33 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.96 116.86 3.94 Favored 'Trans proline' 0 N--CA 1.435 -1.945 0 C-N-CA 121.403 1.402 . . . . 0.0 110.525 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -71.81 -17.61 62.14 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.247 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -152.76 140.26 19.71 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 172.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.46 138.95 52.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 O-C-N 123.27 0.356 . . . . 0.0 110.421 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.4 p90 -152.24 154.32 35.51 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -120.4 137.92 54.04 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 5.2 mp -112.08 106.78 15.51 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.415 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . . . -97.51 102.1 12.0 Favored Pre-proline 0 C--N 1.295 -1.769 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.301 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 28' ' ' LEU . 8.4 Cg_exo -73.94 154.46 48.01 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.024 1.816 . . . . 0.0 109.847 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -61.32 -44.59 96.95 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -172.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.81 26.72 20.14 Favored Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.447 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -136.07 -176.81 4.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' N ' ' HD2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -87.38 -56.43 3.36 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.393 0.616 . . . . 0.0 110.053 -176.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 29' ' ' ALA . . . 150.31 137.17 2.67 Favored Glycine 0 N--CA 1.428 -1.862 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.56 124.31 70.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.325 0.583 . . . . 0.0 109.998 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -96.83 128.27 43.62 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.247 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.517 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 47.4 mt -125.27 140.54 47.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.019 0.438 . . . . 0.0 109.99 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA3' HD21 ' A' ' 54' ' ' LEU . . . -128.05 149.92 18.26 Favored Glycine 0 N--CA 1.408 -3.181 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.2 tp -94.25 126.13 39.3 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.81 166.61 14.09 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.377 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -126.93 122.68 35.28 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' OD1' ' HB ' ' A' ' 12' ' ' THR . 18.2 t70 -65.83 129.57 94.32 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.502 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.09 -4.18 12.5 Favored 'Trans proline' 0 CA--C 1.533 0.473 0 C-N-CA 122.869 2.379 . . . . 0.0 113.095 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 16.6 tp10 -93.79 -51.46 4.89 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.329 0.585 . . . . 0.0 109.647 -176.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.422 ' OG1' ' HG2' ' A' ' 48' ' ' LYS . 31.2 p -108.78 -22.01 12.41 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.72 11.99 69.89 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 119.986 -1.102 . . . . 0.0 112.538 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HG2' ' OG1' ' A' ' 46' ' ' THR . 18.7 ptpt -84.31 147.64 27.09 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -90.58 142.71 27.47 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.645 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -149.99 138.97 21.03 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -93.15 139.76 30.24 Favored 'General case' 0 N--CA 1.405 -2.702 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -143.01 143.7 32.0 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 38' ' ' ILE 0.282 0.1 OUTLIER -74.46 140.19 44.45 Favored 'General case' 0 N--CA 1.419 -1.977 0 C-N-CA 118.84 -1.144 . . . . 0.0 110.604 179.529 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.474 HD21 ' HA3' ' A' ' 39' ' ' GLY . 17.8 mt -85.86 -177.22 0.89 Allowed Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -174.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -67.27 132.94 28.98 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 N-CA-C 105.185 -2.659 . . . . 0.0 105.185 166.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -74.43 -7.97 54.74 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.921 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.34 -14.4 40.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.363 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -60.16 129.56 88.62 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 124.204 1.001 . . . . 0.0 110.064 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -84.15 118.24 2.29 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.678 2.252 . . . . 0.0 112.757 -175.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--N 1.293 -1.854 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.671 177.045 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 CA--C 1.509 -0.629 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 60.44 68.67 0.74 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.467 1.107 . . . . 0.0 111.367 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.5 m -90.53 -6.82 54.27 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.392 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.11 76.05 2.1 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -141.32 -174.19 3.96 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -152.1 131.41 6.75 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -65.67 136.4 45.8 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.913 1.742 . . . . 0.0 111.462 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 14.3 p -114.23 149.78 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.36 -176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -68.71 109.18 3.7 Favored 'General case' 0 CA--C 1.486 -1.494 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p -125.29 136.56 60.46 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.944 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HG2' ' A' ' 17' ' ' GLU . 60.9 mttp -79.37 115.72 19.18 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.4 p -85.42 166.48 30.33 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -62.52 -18.69 64.76 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.556 2.171 . . . . 0.0 111.875 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.43 -14.82 62.27 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.481 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.94 50.11 4.51 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.017 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 22.1 ptmt -148.43 164.77 33.13 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 11' ' ' LYS . 36.2 mt-10 -106.06 120.37 41.61 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.02 149.43 50.37 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 42.6 mt-10 -90.01 104.15 16.75 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.5 mt -118.01 147.23 43.41 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.638 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.18 129.36 26.44 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -68.0 129.92 20.54 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.225 1.284 . . . . 0.0 111.645 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.25 -51.18 60.08 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.152 -0.931 . . . . 0.0 108.973 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -132.78 153.26 51.41 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.662 -1.153 . . . . 0.0 108.685 176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.66 148.65 33.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 124.266 0.979 . . . . 0.0 109.429 -177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 21.7 p90 -157.18 163.97 38.28 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.47 132.91 39.84 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.127 0.489 . . . . 0.0 110.36 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 mp -97.99 92.11 5.64 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -117.82 100.31 52.25 Favored Pre-proline 0 C--N 1.294 -1.829 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.12 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HG2' ' HD2' ' A' ' 33' ' ' ARG . 34.5 Cg_exo -62.46 -69.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.717 2.278 . . . . 0.0 112.426 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -168.62 -50.08 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.568 0.347 . . . . 0.0 111.893 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -128.58 40.37 1.73 Allowed Glycine 0 C--N 1.317 -0.507 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.809 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HD2' ' HG2' ' A' ' 30' ' ' PRO . 99.4 mtt180 -129.36 25.98 5.42 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.55 -65.42 0.35 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.358 1.063 . . . . 0.0 112.514 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 129.44 118.82 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.31 116.67 37.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -89.16 131.04 35.48 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 66.8 mt -134.42 142.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.95 150.32 19.34 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.0 tp -94.63 124.29 38.58 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -117.62 170.66 8.59 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.076 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -123.82 125.87 45.45 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.06 119.99 79.53 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.46 -24.79 42.18 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.82 2.347 . . . . 0.0 114.164 -173.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -97.22 -21.86 17.04 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -173.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.8 p -111.45 -18.73 12.8 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.075 -0.65 . . . . 0.0 112.672 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.61 9.74 85.27 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.522 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -100.22 156.97 16.92 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.515 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -94.82 146.99 23.81 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.49 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -147.57 139.47 24.16 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -94.49 133.46 38.08 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -141.38 149.53 41.21 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 38' ' ' ILE . 21.5 ptmt -69.46 150.38 47.28 Favored 'General case' 0 C--O 1.254 1.32 0 CA-C-O 121.135 0.493 . . . . 0.0 111.467 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.86 171.16 5.23 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.014 -177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.34 148.72 80.28 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.922 2.415 . . . . 0.0 109.167 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -69.55 -23.53 63.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -93.84 4.62 53.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.369 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -73.12 122.66 88.2 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -72.7 101.45 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.813 2.342 . . . . 0.0 113.783 -175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 C--N 1.31 -1.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.91 175.82 . . . . . . . . 0 0 . 1 stop_ save_